<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Photodynamic therapy</title><meta name="description" content="Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="PDT"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Photodynamic_therapy"/><meta property="og:title" content="Photodynamic therapy"/><meta property="og:description" content="Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and..."/><meta property="og:url" content="https://grokipedia.com/page/Photodynamic_therapy"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Photodynamic therapy"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.076Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Photodynamic therapy"/><meta name="twitter:description" content="Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="a8ecafb9e9530a2d5775222d918ef25f-1c7aef8c55578e71-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=a8ecafb9e9530a2d5775222d918ef25f,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.10820041470417552,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photodynamic-therapy" class="transition-opacity hover:opacity-100 opacity-50">Photodynamic therapy</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photodynamic-therapy-1" class="transition-opacity hover:opacity-100 opacity-50">Photodynamic Therapy</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#basics" class="transition-opacity hover:opacity-100 opacity-50">Basics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#reactive-oxygen-species" class="transition-opacity hover:opacity-100 opacity-50">Reactive oxygen species</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photochemical-processes" class="transition-opacity hover:opacity-100 opacity-50">Photochemical processes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photochemical-mechanisms" class="transition-opacity hover:opacity-100 opacity-50">Photochemical mechanisms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photosensitisers-and-photochemistry" class="transition-opacity hover:opacity-100 opacity-50">Photosensitisers and photochemistry</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photochemical-reactions" class="transition-opacity hover:opacity-100 opacity-50">Photochemical reactions</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#type-i-processes" class="transition-opacity hover:opacity-100 opacity-50">Type-I processes</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#type-ii-processes" class="transition-opacity hover:opacity-100 opacity-50">Type-II processes</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photosensitizers" class="transition-opacity hover:opacity-100 opacity-50">Photosensitizers</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cyclic-tetrapyrrolic-chromophores" class="transition-opacity hover:opacity-100 opacity-50">Cyclic tetrapyrrolic chromophores</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#porphyrins" class="transition-opacity hover:opacity-100 opacity-50">Porphyrins</a></li><li style="padding-left:3rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#absorption-spectroscopy" class="transition-opacity hover:opacity-100 opacity-50">Absorption spectroscopy</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#ideal-photosensitisers" class="transition-opacity hover:opacity-100 opacity-50">Ideal photosensitisers</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#first-generation" class="transition-opacity hover:opacity-100 opacity-50">First generation</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#second-generation" class="transition-opacity hover:opacity-100 opacity-50">Second generation</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#5-aminolaevulinic-acid" class="transition-opacity hover:opacity-100 opacity-50">5-Aminolaevulinic acid</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#verteporfin" class="transition-opacity hover:opacity-100 opacity-50">Verteporfin</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#purlytin" class="transition-opacity hover:opacity-100 opacity-50">Purlytin</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#foscan" class="transition-opacity hover:opacity-100 opacity-50">Foscan</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lutex" class="transition-opacity hover:opacity-100 opacity-50">Lutex</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#atmpn" class="transition-opacity hover:opacity-100 opacity-50">ATMPn</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#zinc-phthalocyanine" class="transition-opacity hover:opacity-100 opacity-50">Zinc phthalocyanine</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#naphthalocyanines" class="transition-opacity hover:opacity-100 opacity-50">Naphthalocyanines</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#functional-groups" class="transition-opacity hover:opacity-100 opacity-50">Functional groups</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#third-generation" class="transition-opacity hover:opacity-100 opacity-50">Third generation</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metallation" class="transition-opacity hover:opacity-100 opacity-50">Metallation</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#expanded-metallo-porphyrins" class="transition-opacity hover:opacity-100 opacity-50">Expanded metallo-porphyrins</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metallochlorinsbacteriochlorins" class="transition-opacity hover:opacity-100 opacity-50">Metallochlorins/bacteriochlorins</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metallo-phthalocyanines" class="transition-opacity hover:opacity-100 opacity-50">Metallo-phthalocyanines</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metallo-naphthocyaninesulfobenzo-porphyrazines-m-nsbp" class="transition-opacity hover:opacity-100 opacity-50">Metallo-naphthocyaninesulfobenzo-porphyrazines (M-NSBP)</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#metallo-naphthalocyanines" class="transition-opacity hover:opacity-100 opacity-50">Metallo-naphthalocyanines</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#applications" class="transition-opacity hover:opacity-100 opacity-50">Applications</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acne" class="transition-opacity hover:opacity-100 opacity-50">Acne</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cancer" class="transition-opacity hover:opacity-100 opacity-50">Cancer</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#photoimmunotherapy" class="transition-opacity hover:opacity-100 opacity-50">Photoimmunotherapy</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#vascular-targeting" class="transition-opacity hover:opacity-100 opacity-50">Vascular targeting</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#ophthalmology" class="transition-opacity hover:opacity-100 opacity-50">Ophthalmology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#antimicrobial-effects" class="transition-opacity hover:opacity-100 opacity-50">Antimicrobial effects</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#modern-era" class="transition-opacity hover:opacity-100 opacity-50">Modern era</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#miscellany" class="transition-opacity hover:opacity-100 opacity-50">Miscellany</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="photodynamic-therapy" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Photodynamic therapy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Photodynamic therapy</strong> (<strong>PDT</strong>) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> including head and neck, lung, bladder and skin.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and disfigurement. A side effect is the associated photosensitisation of skin tissue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h1 id="photodynamic-therapy-1" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Photodynamic Therapy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">PDT applications involve three components:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> a photosensitizer, a light source and tissue oxygen. The wavelength of the light source needs to be appropriate for exciting the photosensitizer to produce radicals and/or reactive oxygen species. These are free radicals (Type I) generated through electron abstraction or transfer from a substrate molecule and highly reactive state of oxygen known as singlet oxygen (Type II).</span>
<span class="mb-4 block break-words text-[1em] leading-7">PDT is a multi-stage process. First a photosensitiser, ideally with negligible toxicity other than its phototoxicity, is administered in the absence of light, either systemically or topically. When a sufficient amount of photosensitiser appears in diseased tissue, the photosensitiser is activated by exposure to light for a specified period. The light dose supplies sufficient energy to stimulate the photosensitiser, but not enough to damage neighbouring healthy tissue. The reactive oxygen kills the target cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h2 id="basics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Basics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="reactive-oxygen-species" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Reactive oxygen species<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In air and tissue, molecular oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) occurs in a triplet state, whereas almost all other molecules are in a singlet state. Reactions between triplet and singlet molecules are forbidden by quantum mechanics, making oxygen relatively non-reactive at physiological conditions. A photosensitizer is a chemical compound that can be promoted to an excited state upon absorption of light and undergo intersystem crossing (ISC) with oxygen to produce singlet oxygen. This species is highly cytotoxic, rapidly attacking any organic compounds it encounters. It is rapidly eliminated from cells, in an average of 3 Î¼s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<h3 id="photochemical-processes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Photochemical processes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">When a photosensitiser is in its excited state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^3 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>) it can interact with molecular triplet oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) and produce radicals and reactive oxygen species (ROS), crucial to the Type II mechanism. These species include singlet oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^1 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>), hydroxyl radicals (â€¢OH) and superoxide (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msubsup><mi>O</mi><mn>2</mn><mo>âˆ’</mo></msubsup></mrow><annotation encoding="application/x-tex">O_2^-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.0778em;vertical-align:-0.2663em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.8115em"><span style="top:-2.4337em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span><span style="top:-3.1031em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2663em"><span></span></span></span></span></span></span></span></span></span>) ions. They can interact with cellular components including unsaturated lipids, amino acid residues and nucleic acids. If sufficient oxidative damage ensues, this will result in target-cell death (only within the illuminated area).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_185qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="photochemical-mechanisms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Photochemical mechanisms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">When a chromophore molecule, such as a cyclic tetrapyrrolic molecule, absorbs a photon, one of its electrons is promoted into a higher-energy orbital, elevating the chromophore from the ground state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) into a short-lived, electronically excited state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mi>n</mi></msub></mrow><annotation encoding="application/x-tex">S_n</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">n</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) composed of vibrational sub-levels (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msubsup><mi>S</mi><mi>n</mi><mo mathvariant="normal" lspace="0em" rspace="0em">â€²</mo></msubsup></mrow><annotation encoding="application/x-tex">S_n&#x27;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9989em;vertical-align:-0.247em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.7519em"><span style="top:-2.453em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">n</span></span></span><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">â€²</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.247em"><span></span></span></span></span></span></span></span></span></span>). The excited chromophore can lose energy by rapidly decaying through these sub-levels via internal conversion (IC) to populate the first excited singlet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">S_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>), before quickly relaxing back to the ground state.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_186qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The decay from the excited singlet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">S_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) to the ground state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) is via fluorescence (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">S_1 \rightarrow S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>). Singlet state lifetimes of excited fluorophores are very short (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mrow><mi>f</mi><mi>l</mi><mi mathvariant="normal">.</mi></mrow></msub><mo>=</mo><mn>1</mn><msup><mn>0</mn><mrow><mo>âˆ’</mo><mn>9</mn></mrow></msup><mtext>â€“</mtext><mn>1</mn><msup><mn>0</mn><mrow><mo>âˆ’</mo><mn>6</mn></mrow></msup></mrow><annotation encoding="application/x-tex">\tau_{fl.} = 10^{-9}â€“10^{-6}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.7167em;vertical-align:-0.2861em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3361em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathnormal mtight" style="margin-right:0.10764em">f</span><span class="mord mathnormal mtight" style="margin-right:0.01968em">l</span><span class="mord mtight">.</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord">1</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">9</span></span></span></span></span></span></span></span></span><span class="mord">â€“1</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">6</span></span></span></span></span></span></span></span></span></span></span></span> seconds) since transitions between the same spin states (S â†’ S or T â†’ T) conserve the spin multiplicity of the electron and, according to the Spin Selection Rules, are therefore considered &quot;allowed&quot; transitions. Alternatively, an excited singlet state electron (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">S_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) can undergo spin inversion and populate the lower-energy first excited triplet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">T_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) via intersystem crossing (ISC); a spin-forbidden process, since the spin of the electron is no longer conserved. The excited electron can then undergo a second spin-forbidden inversion and depopulate the excited triplet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">T_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) by decaying to the ground state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) via phosphorescence (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">T_1 \rightarrow S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>). Owing to the spin-forbidden triplet to singlet transition, the lifetime of phosphorescence (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>P</mi></msub><mo>=</mo><mn>1</mn><msup><mn>0</mn><mrow><mo>âˆ’</mo><mn>3</mn></mrow></msup><mo>âˆ’</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">\tau_P = 10^{-3} âˆ’ 1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">P</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8974em;vertical-align:-0.0833em"></span><span class="mord">1</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">3</span></span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2222em"></span><span class="mbin">âˆ’</span><span class="mspace" style="margin-right:0.2222em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">1</span></span></span></span> second) is considerably longer than that of fluorescence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2o7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="photosensitisers-and-photochemistry" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Photosensitisers and photochemistry<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Tetrapyrrolic photosensitisers in the excited singlet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^1 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>, S&gt;0) are relatively efficient at intersystem crossing and can consequently have a high triplet-state quantum yield. The longer lifetime of this species is sufficient to allow the excited triplet state photosensitiser to interact with surrounding bio-molecules, including cell membrane constituents.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="photochemical-reactions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Photochemical reactions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Excited triplet-state photosensitisers can react via Type-I and Type-II processes. Type-I processes can involve the excited singlet or triplet photosensitiser (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^1 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">S_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>; <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^3 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">T_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>), however due to the short lifetime of the excited singlet state, the photosensitiser can only react if it is intimately associated with a substrate. In both cases the interaction is with readily oxidisable or reducible substrates. Type-II processes involve the direct interaction of the excited triplet photosensitiser (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^3 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">T_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) with molecular oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^3 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>). The relative contributions of Type I and Type II pathways depend on factors such as photosensitizer properties, oxygen concentration, and local environment, with Type II often predominating in well-oxygenated tissues.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_289abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2c9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<h4 id="type-i-processes" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Type-I processes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Type-I processes can be divided into Type I(i) and Type I(ii). Type I (i) involves the transfer of an electron (oxidation) from a substrate molecule to the excited state photosensitiser (Psen*), generating a photosensitiser radical anion (Psen<span class="katex-error" title="ParseError: KaTeX parse error: Double superscript at position 3: ^â€¢^Ì²-" style="color:#cc0000">^â€¢^-</span>) and a substrate radical cation (Subs<span class="katex-error" title="ParseError: KaTeX parse error: Double superscript at position 3: ^â€¢^Ì²+" style="color:#cc0000">^â€¢^+</span>). The majority of the radicals produced from Type-I(i) reactions react instantaneously with molecular oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>), generating a mixture of oxygen intermediates. For example, the photosensitiser radical anion can react instantaneously with molecular oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) to generate a superoxide radical anion (<span class="katex-error" title="ParseError: KaTeX parse error: Double superscript at position 6: O_2^â€¢^Ì²-" style="color:#cc0000">O_2^â€¢^-</span>), which can go on to produce the highly reactive hydroxyl radical (OHâ€¢), initiating a cascade of cytotoxic free radicals; this process is common in the oxidative damage of fatty acids and other lipids.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1gaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The Type-I process (ii) involves the transfer of a hydrogen atom (reduction) to the excited state photosensitiser (Psen*). This generates free radicals capable of rapidly reacting with molecular oxygen and creating a complex mixture of reactive oxygen intermediates, including reactive peroxides.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="type-ii-processes" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Type-II processes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Type-II processes involve the direct interaction of the excited triplet state photosensitiser (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup></mrow><annotation encoding="application/x-tex">^3 Psen^*</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span></span></span></span>) with ground state molecular oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^3 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>); a spin allowed transitionâ€”the excited state photosensitiser and ground state molecular oxygen are of the same spin state (T).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">When the excited photosensitiser collides with molecular oxygen, a process of triplet-triplet annihilation takes place (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><msup><mi>n</mi><mo>âˆ—</mo></msup><msup><mo>â†’</mo><mn>1</mn></msup><mi>P</mi><mi>s</mi><mi>e</mi><mi>n</mi></mrow><annotation encoding="application/x-tex">^3 Psen^* \rightarrow ^1 Psen</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.6887em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ—</span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel"><span class="mrel">â†’</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6833em"></span><span class="mord mathnormal" style="margin-right:0.13889em">P</span><span class="mord mathnormal">se</span><span class="mord mathnormal">n</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub><msup><mo>â†’</mo><mn>1</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2 \rightarrow ^1 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel"><span class="mrel">â†’</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>). This inverts the spin of one oxygen molecule&#x27;s (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^3 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) outermost antibonding electrons, generating two forms of singlet oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi mathvariant="normal">Î”</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^1 \Delta_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î”</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^1 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>), while simultaneously depopulating the photosensitiser&#x27;s excited triplet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>T</mi><mn>1</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">T_1 \rightarrow S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.13889em">T</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.1389em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>). The higher-energy singlet oxygen state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^1 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>, 157 kJ mol<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span> &gt; <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^3 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>) is very short-lived (on the order of 10-100 ns in methanol, undetectable in <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>2</mn></msub><mi>O</mi><mi mathvariant="normal">/</mi><msub><mi>D</mi><mn>2</mn></msub><mi>O</mi></mrow><annotation encoding="application/x-tex">H_2 O / D_2 O</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1em;vertical-align:-0.25em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.08125em">H</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0813em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="mord">/</span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">D</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right:0.02778em">O</span></span></span></span> due to rapid quenching) and rapidly relaxes to the lower-energy excited state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi mathvariant="normal">Î”</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^1 \Delta_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î”</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>, 94 kJ mol<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span> &gt; <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>3</mn></msup><msub><mi mathvariant="normal">Î£</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^3 \Sigma_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">3</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î£</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>). It is, therefore, this lower-energy form of singlet oxygen (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi mathvariant="normal">Î”</mi><mi>g</mi></msub></mrow><annotation encoding="application/x-tex">^1 \Delta_g</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1002em;vertical-align:-0.2861em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord">Î”</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.03588em">g</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.2861em"><span></span></span></span></span></span></span></span></span></span>) that is implicated in cell injury and cell death.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3ocabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3scabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The highly-reactive singlet oxygen species (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup><msub><mi>O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">^1 O_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.9641em;vertical-align:-0.15em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.02778em">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0278em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) produced via the Type-II process act near to their site generation and within a radius of approximately 20 nm in lipid environments, but can diffuse up to ~100-300 nm in aqueous cellular compartments, with a typical lifetime of ~10-100 ns in lipid bilayers and up to ~3 Î¼s in aqueous environments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Singlet oxygen can theoretically only interact with proximal molecules and structures within this radius. ROS initiate reactions with many biomolecules, including amino acid residues in proteins, such as tryptophan; unsaturated lipids like cholesterol and nucleic acid bases, particularly guanosine and guanine derivatives, with the latter base more susceptible to ROS. These interactions cause damage and potential destruction to cellular membranes and enzyme deactivation, culminating in cell death.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">It is probable that in the presence of molecular oxygen and as a direct result of the photoirradiation of the photosensitiser molecule, both Type-I and II pathways play a pivotal role in disrupting cellular mechanisms and cellular structure. Nevertheless, considerable evidence suggests that the Type-II photo-oxygenation process predominates in the induction of cell damage, a consequence of the interaction between the irradiated photosensitiser and molecular oxygen. Cells in vivo may be partially protected against the effects of photodynamic therapy by the presence of singlet oxygen scavengers (such as histidine). Certain skin cells are somewhat resistant to PDT in the absence of molecular oxygen; further supporting the proposal that the Type-II process is at the heart of photoinitiated cell death.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The efficiency of Type-II processes is dependent upon the triplet state lifetime <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>T</mi></msub></mrow><annotation encoding="application/x-tex">\tau_T</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span> and the triplet quantum yield (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub></mrow><annotation encoding="application/x-tex">\Phi_T</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>) of the photosensitiser. Both of these parameters have been implicated in phototherapeutic effectiveness; further supporting the distinction between Type-I and Type-II mechanisms. However, the success of a photosensitiser is not exclusively dependent upon a Type-II process. Multiple photosensitisers display excited triplet lifetimes that are too short to permit a Type-II process to occur. For example, the copper metallated octaethylbenzochlorin photosensitiser has a triplet state lifetime of less than 20 nanoseconds and is still deemed to be an efficient photodynamic agent.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h1 id="photosensitizers" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Photosensitizers<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Many photosensitizers for PDT exist. They divide into <span class="inline text-[1em] leading-7">porphyrins</span>, <span class="inline text-[1em] leading-7">chlorins</span> and <span class="inline text-[1em] leading-7">dyes</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Examples include <span class="inline text-[1em] leading-7">aminolevulinic acid</span> (ALA), Silicon Phthalocyanine Pc 4, <span class="inline text-[1em] leading-7">m-tetrahydroxyphenylchlorin</span> (mTHPC) and mono-L-aspartyl <span class="inline text-[1em] leading-7">chlorin</span> e6 (<span class="inline text-[1em] leading-7">NPe6</span>).</span>
<span class="mb-4 block break-words text-[1em] leading-7">Photosensitizers commercially available for clinical use include <span class="inline text-[1em] leading-7">Photofrin</span>, <span class="inline text-[1em] leading-7">Visudyne</span>, <span class="inline text-[1em] leading-7">Levulan</span>, <span class="inline text-[1em] leading-7">Foscan</span>, <span class="inline text-[1em] leading-7">Metvix</span>, <span class="inline text-[1em] leading-7">Hexvix</span>, <span class="inline text-[1em] leading-7">Cysview</span> and <span class="inline text-[1em] leading-7">Laserphyrin</span>, with others in development, e.g. <span class="inline text-[1em] leading-7">Antrin</span>, <span class="inline text-[1em] leading-7">Photochlor</span>, <span class="inline text-[1em] leading-7">Photosens</span>, Photrex, Lumacan, <span class="inline text-[1em] leading-7">Cevira</span>, Visonac, BF-200 ALA,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3cfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> <span class="inline text-[1em] leading-7">Amphinex</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3ofqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> and <span class="inline text-[1em] leading-7">Azadipyrromethenes</span>. More recent approvals include Ameluz (BF-200 ALA) for actinic keratosis (FDA 2016).</span>
<span class="mb-4 block break-words text-[1em] leading-7">The major difference between photosensitizers is the parts of the cell that they target. Unlike in <span class="inline text-[1em] leading-7">radiation therapy</span>, where damage is done by targeting cell DNA, most photosensitizers target other cell structures. For example, mTHPC localizes in the nuclear envelope.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> In contrast, ALA localizes in the <span class="inline text-[1em] leading-7">mitochondria</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_sgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> and <span class="inline text-[1em] leading-7">methylene blue</span> in the lysosomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1cgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup></span>
<h3 id="cyclic-tetrapyrrolic-chromophores" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cyclic tetrapyrrolic chromophores<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cyclic <span class="inline text-[1em] leading-7">tetrapyrrolic</span> molecules are <span class="inline text-[1em] leading-7">fluorophores</span> and photosensitisers. Cyclic tetrapyrrolic derivatives have an inherent similarity to the naturally occurring porphyrins present in living matter.</span>
<h4 id="porphyrins" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Porphyrins<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Porphyrins</span> are a group of naturally occurring and intensely coloured compounds, whose name is drawn from the Greek word <em>porphura</em>, or purple. These molecules perform biologically important roles, including oxygen transport and <span class="inline text-[1em] leading-7">photosynthesis</span> and have applications in fields ranging from fluorescent imaging to medicine. Porphyrins are tetrapyrrolic molecules, with the heart of the skeleton a heterocyclic macrocycle, known as a <span class="inline text-[1em] leading-7">porphine</span>. The fundamental porphine frame consists of four pyrrolic sub-units linked on opposing sides (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î±</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.4306em"></span><span class="mord mathnormal" style="margin-right:0.0037em">Î±</span></span></span></span>-positions, numbered 1, 4, 6, 9, 11, 14, 16 and 19) through four <span class="inline text-[1em] leading-7">methine</span> (CH) bridges (5, 10, 15 and 20), known as the <em>meso</em> -carbon atoms/positions. The resulting conjugated planar macrocycle may be substituted at the <em>meso</em> - and/or <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î²</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em"></span><span class="mord mathnormal" style="margin-right:0.05278em">Î²</span></span></span></span>-positions (2, 3, 7, 8, 12, 13, 17 and 18): if the <em>meso-</em> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î²</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em"></span><span class="mord mathnormal" style="margin-right:0.05278em">Î²</span></span></span></span>-hydrogens are substituted with non-hydrogen atoms or groups, the resulting compounds are known as porphyrins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2siabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The inner two protons of a free-base porphyrin can be removed by strong bases such as <span class="inline text-[1em] leading-7">alkoxides</span>, forming a dianionic molecule; conversely, the inner two pyrrolenine nitrogens can be protonated with acids such as <span class="inline text-[1em] leading-7">trifluoroacetic acid</span> affording a dicationic intermediate. The <span class="inline text-[1em] leading-7">tetradentate</span> anionic species can readily form complexes with most metals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h5 id="absorption-spectroscopy" class="group relative mb-1 mt-4 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Absorption spectroscopy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h5>
<span class="mb-4 block break-words text-[1em] leading-7">Porphyrin&#x27;s highly conjugated skeleton produces a characteristic ultra-violet visible (UV-VIS) spectrum. The spectrum typically consists of an intense, narrow absorption band (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Ïµ</mi><mo>&gt;</mo><mn>200000</mn><mtext>â€‰</mtext><mrow><mi mathvariant="normal">L</mi><mo>â‹…</mo><mi mathvariant="normal">m</mi><mi mathvariant="normal">o</mi><msup><mi mathvariant="normal">l</mi><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup><mtext>â€‰</mtext><mi mathvariant="normal">c</mi><msup><mi mathvariant="normal">m</mi><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup></mrow></mrow><annotation encoding="application/x-tex">\epsilon &gt; 200000 \, \mathrm{L \cdot mol^{-1} \, cm^{-1}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em"></span><span class="mord mathnormal">Ïµ</span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">&gt;</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord">200000</span><span class="mspace" style="margin-right:0.1667em"></span><span class="mord"><span class="mord mathrm">L</span><span class="mspace" style="margin-right:0.2222em"></span><span class="mbin">â‹…</span><span class="mspace" style="margin-right:0.2222em"></span><span class="mord mathrm">mo</span><span class="mord"><span class="mord mathrm">l</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mathrm mtight">1</span></span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.1667em"></span><span class="mord mathrm">c</span><span class="mord"><span class="mord mathrm">m</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mathrm mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span>) at around 400 nm, known as the <span class="inline text-[1em] leading-7">Soret band</span> or B band, followed by four longer wavelength (450â€“700 nm), weaker absorptions (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Ïµ</mi><mo>&gt;</mo><mn>20000</mn><mtext>â€‰</mtext><mrow><mi mathvariant="normal">L</mi><mo>â‹…</mo><mi mathvariant="normal">m</mi><mi mathvariant="normal">o</mi><msup><mi mathvariant="normal">l</mi><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup><mo>â‹…</mo><mi mathvariant="normal">c</mi><msup><mi mathvariant="normal">m</mi><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup></mrow></mrow><annotation encoding="application/x-tex">\epsilon &gt; 20000 \, \mathrm{L \cdot mol^{-1} \cdot cm^{-1}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em"></span><span class="mord mathnormal">Ïµ</span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">&gt;</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord">20000</span><span class="mspace" style="margin-right:0.1667em"></span><span class="mord"><span class="mord mathrm">L</span><span class="mspace" style="margin-right:0.2222em"></span><span class="mbin">â‹…</span><span class="mspace" style="margin-right:0.2222em"></span><span class="mord mathrm">mo</span><span class="mord"><span class="mord mathrm">l</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mathrm mtight">1</span></span></span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2222em"></span><span class="mbin">â‹…</span><span class="mspace" style="margin-right:0.2222em"></span><span class="mord mathrm">c</span><span class="mord"><span class="mord mathrm">m</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mathrm mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span> (<span class="inline text-[1em] leading-7">free-base</span> porphyrins)) referred to as the Q bands.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The Soret band arises from a strong electronic transition from the ground state to the second excited singlet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>0</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">S_0 \rightarrow S_2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">2</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>); whereas the Q band is a result of a weak transition to the first excited singlet state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>0</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">S_0 \rightarrow S_1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>). The dissipation of energy via internal conversion (IC) is so rapid that fluorescence is only observed from depopulation of the first excited singlet state to the lower-energy ground state (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>S</mi><mn>1</mn></msub><mo>â†’</mo><msub><mi>S</mi><mn>0</mn></msub></mrow><annotation encoding="application/x-tex">S_1 \rightarrow S_0</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â†’</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05764em">S</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em"><span style="top:-2.55em;margin-left:-0.0576em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">0</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="ideal-photosensitisers" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Ideal photosensitisers<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The key characteristic of a photosensitiser is the ability to preferentially accumulate in diseased tissue and induce a desired biological effect via the generation of cytotoxic species. Specific criteria:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">Strong absorption with a high extinction coefficient in the red/near infrared region of the electromagnetic spectrum (600â€“850 nm)â€”allows deeper tissue penetration. (Tissue is much more transparent at longer wavelengths (~700â€“850 nm). Longer wavelengths allow the light to penetrate deeper<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> and treat larger structures.)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g8lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></li>
<li class="text-[1em]">Suitable photophysical characteristics: a high-quantum yield of triplet formation (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub><mo>â‰¥</mo><mn>0.5</mn></mrow><annotation encoding="application/x-tex">\Phi_T \geq 0.5</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â‰¥</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.5</span></span></span></span>); a high singlet oxygen quantum yield (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub><mo>â‰¥</mo><mn>0.5</mn></mrow><annotation encoding="application/x-tex">\Phi_\Delta \geq 0.5</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â‰¥</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.5</span></span></span></span>); a relatively long triplet state lifetime (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>T</mi></msub></mrow><annotation encoding="application/x-tex">\tau_T</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>, Î¼s range); and a high triplet-state energy (â‰¥ 94 kJ mol<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>1</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span>). Values of <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub><mo>=</mo><mn>0.83</mn></mrow><annotation encoding="application/x-tex">\Phi_T= 0.83</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.83</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub><mo>=</mo><mn>0.65</mn></mrow><annotation encoding="application/x-tex">\Phi_\Delta = 0.65</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.65</span></span></span></span> (haematoporphyrin); <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub><mo>=</mo><mn>0.83</mn></mrow><annotation encoding="application/x-tex">\Phi_T = 0.83</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.83</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub><mo>=</mo><mn>0.72</mn></mrow><annotation encoding="application/x-tex">\Phi_\Delta = 0.72</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.72</span></span></span></span> (etiopurpurin); and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub><mo>=</mo><mn>0.96</mn></mrow><annotation encoding="application/x-tex">\Phi_T = 0.96</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.96</span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub><mo>=</mo><mn>0.82</mn></mrow><annotation encoding="application/x-tex">\Phi_\Delta = 0.82</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.82</span></span></span></span> (tin etiopurpurin) have been achieved</li>
<li class="text-[1em]">Low dark toxicity and negligible cytotoxicity in the absence of light. (The photosensitizer should not be harmful to the target tissue until the treatment beam is applied.)</li>
<li class="text-[1em]">Preferential accumulation in diseased/target tissue over healthy tissue</li>
<li class="text-[1em]">Rapid clearance from the body post-procedure</li>
<li class="text-[1em]">High chemical stability: single, well-characterised compounds, with a known and constant composition</li>
<li class="text-[1em]">Short and high-yielding synthetic route (with easy translation into multi-gram scales/reactions)</li>
<li class="text-[1em]">Simple and stable formulation</li>
<li class="text-[1em]">Soluble in biological media, allowing intravenous administration. Otherwise, a hydrophilic delivery system must enable efficient and effective transportation of the photosensitiser to the target site via the bloodstream.</li>
<li class="text-[1em]">Low <span class="inline text-[1em] leading-7">photobleaching</span> to prevent degradation of the photosensitizer so it can continue producing singlet oxygen</li>
<li class="text-[1em]">Natural <span class="inline text-[1em] leading-7">fluorescence</span> (Many optical dosimetry techniques, such as <span class="inline text-[1em] leading-7">fluorescence spectroscopy</span>, depend on fluorescence.)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qolqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></li>
</ul>
<h3 id="first-generation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">First generation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Porfimer sodium</strong></span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Porfimer sodium</span> is a drug used to treat some types of cancer. When absorbed by cancer cells and exposed to light, porfimer sodium becomes active and kills the cancer cells. It is a type of photodynamic therapy (PDT) agent and also called Photofrin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">PDT was first discovered more than a century ago in Germany, it was not until <a href="https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Thomas Dougherty&#x27;s</a><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> when PDT became more mainstream. Prior to Dr. Dougherty, researchers had ways of using light-sensitive compounds to treat disease. Dougherty successfully treated cancer with PDT in preclinical models in 1975. Three years later, he conducted the first controlled clinical study in humans. In 1994, the FDA approved PDT with the photosensitizer porfimer sodium for palliative treatment of advanced esophageal cancer, specifically the palliation of patients with completely obstructing esophageal cancer, or for patients with partially obstructing esophageal cancer. Porfimer Sodium is also FDA-approved for the treatment of types of lung cancer, more specifically for the treatment of microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated and also FDA approved in the US for high grade dysplasia in Barrett&#x27;s Esophagus.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_knqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_onqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_snqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Disadvantages associated with first generation photosensitisers include skin sensitivity and absorption at 630 nm permitted some therapeutic use, but they markedly limited application to the wider field of disease. Second generation photosensitisers were key to the development of photodynamic therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="second-generation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Second generation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<h4 id="5-aminolaevulinic-acid" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">5-Aminolaevulinic acid<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">5-Aminolaevulinic acid</span> (ALA) is a <span class="inline text-[1em] leading-7">prodrug</span> used to treat and image multiple superficial cancers and tumours. ALA a key precursor in the biosynthesis of the naturally occurring porphyrin, <span class="inline text-[1em] leading-7">haem</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_spqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Haem is synthesised in every energy-producing cell in the body and is a key structural component of haemoglobin, <span class="inline text-[1em] leading-7">myoglobin</span> and other <span class="inline text-[1em] leading-7">haemproteins</span>. The immediate precursor to haem is <span class="inline text-[1em] leading-7">protoporphyrin IX</span> (PPIX), an effective photosensitiser. Haem itself is not a photosensitiser, due to the coordination of a paramagnetic ion in the centre of the macrocycle, causing significant reduction in excited state lifetimes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The haem molecule is synthesised from <span class="inline text-[1em] leading-7">glycine</span> and <span class="inline text-[1em] leading-7">succinyl coenzyme A</span> (succinyl CoA). The rate-limiting step in the biosynthesis pathway is controlled by a tight (negative) feedback mechanism in which the concentration of haem regulates the production of ALA. However, this controlled feedback can be by-passed by artificially adding excess exogenous ALA to cells. The cells respond by producing PPIX (photosensitiser) at a faster rate than the <span class="inline text-[1em] leading-7">ferrochelatase</span> enzyme can convert it to haem.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">ALA, marketed as <span class="inline text-[1em] leading-7">Levulan</span>, has shown promise in photodynamic therapy (tumours) via both intravenous and oral administration, as well as through topical administration in the treatment of malignant and non-malignant dermatological conditions, including psoriasis, <span class="inline text-[1em] leading-7">Bowen&#x27;s disease</span> and <span class="inline text-[1em] leading-7">Hirsutism</span> (Phase II/III clinical trials).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">ALA accumulates more rapidly in comparison to other intravenously administered sensitisers. Typical peak tumour accumulation levels post-administration for PPIX are usually achieved within several hours; other (intravenous) photosensitisers may take up to 96 hours to reach peak levels. ALA is also excreted more rapidly from the body (~24 hours) than other photosensitisers, minimising photosensitivity side effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Esterified ALA derivatives with improved bioavailability have been examined. A methyl ALA ester (<span class="inline text-[1em] leading-7">Metvix</span>) is now available for basal cell carcinoma and other skin lesions. <span class="inline text-[1em] leading-7">Benzyl</span> (Benvix) and hexyl ester (<span class="inline text-[1em] leading-7">Hexvix</span>) derivatives are used for gastrointestinal cancers and for the diagnosis of bladder cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="verteporfin" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Verteporfin<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Benzoporphyrin derivative monoacid ring A (BPD-MA), marketed as <span class="inline text-[1em] leading-7">Visudyne</span> (<span class="inline text-[1em] leading-7">Verteporfin</span>, for injection), has been approved by health authorities in multiple jurisdictions, including US FDA, for the treatment of wet AMD beginning in 1999. It has also undergone Phase III clinical trials (USA) for the treatment of cutaneous non-melanoma skin cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_otabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The chromophore of BPD-MA has a red-shifted and intensified long-wavelength absorption maxima at approximately 690 nm. Tissue penetration by light at this wavelength is 50% greater than that achieved for Photofrin (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Î»</mi><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">x</mi><mi mathvariant="normal">.</mi></mrow></msub><mo>=</mo><mn>630</mn></mrow><annotation encoding="application/x-tex">\lambda_\mathrm{max.} = 630</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8444em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal">Î»</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.1514em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">max.</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">630</span></span></span></span> nm).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gtqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Verteporfin has further advantages over the first generation sensitiser Photofrin. It is rapidly absorbed by the tumour (optimal tumour-normal tissue ratio 30â€“150 minutes post-intravenous injection) and is rapidly cleared from the body, minimising patient photosensitivity (1â€“2 days).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="purlytin" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Purlytin<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Chlorin photosensitiser tin etiopurpurin is marketed as Purlytin. Purlytin has undergone Phase II clinical trials for cutaneous metastatic breast cancer and Kaposi&#x27;s sarcoma in patients with AIDS (acquired immunodeficiency syndrome). Purlytin has been used successfully to treat the non-malignant conditions psoriasis and <span class="inline text-[1em] leading-7">restenosis</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chlorins are distinguished from the parent porphyrins by a reduced exocyclic double bond, decreasing the symmetry of the conjugated macrocycle. This leads to increased absorption in the long-wavelength portion of the visible region of the electromagnetic spectrum (650â€“680 nm). Purlytin is a purpurin; a degradation product of chlorophyll.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Purlytin has a tin atom chelated in its central cavity that causes a red-shift of approximately 20â€“30 nm (with respect to Photofrin and non-metallated etiopurpurin, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Î»</mi><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">a</mi><mi mathvariant="normal">x</mi><mi mathvariant="normal">.</mi><mi mathvariant="normal">S</mi><mi mathvariant="normal">n</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">t</mi><mn>2</mn></mrow></msub><mo>=</mo><mn>650</mn></mrow><annotation encoding="application/x-tex">\lambda_\mathrm{max.SnEt2} = 650</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8444em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal">Î»</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">max.SnEt2</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">650</span></span></span></span> nm). Purlytin has been reported to localise in skin and produce a photoreaction 7â€“14 days post-administration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="foscan" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Foscan<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Tetra(<em>m</em> -hydroxyphenyl)chlorin (<em>m</em> THPC), marketed as <span class="inline text-[1em] leading-7">Foscan</span>, is approved in the European Union for palliative treatment of head and neck squamous cell carcinoma. It has also been investigated in clinical trials for gastric and pancreatic cancers, hyperplasia, field sterilisation after cancer surgery and for the control of antibiotic-resistant bacteria.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_111abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Foscan has a singlet oxygen quantum yield comparable to other chlorin photosensitisers but lower drug and light doses (approximately 100 times more photoactive than Photofrin).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Foscan can render patients photosensitive for up to 20 days after initial illumination.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="lutex" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Lutex<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Lutetium texaphyrin</span>, marketed under the trade name Lutex and Lutrin, is a large porphyrin-like molecule. <span class="inline text-[1em] leading-7">Texaphyrins</span> are expanded porphyrins that have a penta-aza core. It offers strong absorption in the 730â€“770 nm region. Tissue transparency is optimal in this range. As a result, Lutex-based PDT can (potentially) be carried out more effectively at greater depths and on larger tumours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Lutex has entered Phase II clinical trials for evaluation against breast cancer and malignant melanomas.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A Lutex derivative, Antrin, has undergone Phase I clinical trials for the prevention of restenosis of vessels after cardiac <span class="inline text-[1em] leading-7">angioplasty</span> by photoinactivating foam cells that accumulate within arteriolar plaques. A second Lutex derivative, Optrin, is in Phase I trials for AMD.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Texaphyrins also have potential as radiosensitisers (<span class="inline text-[1em] leading-7">Xcytrin</span>) and chemosensitisers. Xcytrin, a gadolinium texaphyrin (motexafin gadolinium), has been evaluated in Phase III clinical trials against brain metastases and Phase I clinical trials for primary brain tumours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="atmpn" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">ATMPn<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">9-Acetoxy-2,7,12,17-tetrakis-(<em>Î²</em> -methoxyethyl)-porphycene has been evaluated as an agent for dermatological applications against psoriasis vulgaris and superficial non-melanoma skin cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="zinc-phthalocyanine" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Zinc phthalocyanine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">A liposomal formulation of zinc phthalocyanine (<a href="https://www.ncbi.nlm.nih.gov/protein/CGP55847" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">CGP55847</a>) has undergone clinical trials (Phase I/II, Switzerland) against squamous cell carcinomas of the upper aerodigestive tract. Phthalocyanines (PCs) are related to tetra-aza porphyrins. Instead of four bridging carbon atoms at the <em>meso-</em> positions, as for the porphyrins, PCs have four nitrogen atoms linking the pyrrolic sub-units. PCs also have an extended conjugate pathway: a <span class="inline text-[1em] leading-7">benzene ring</span> is fused to the <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î²</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em"></span><span class="mord mathnormal" style="margin-right:0.05278em">Î²</span></span></span></span>-positions of each of the four-pyrrolic sub-units. These rings strengthen the absorption of the chromophore at longer wavelengths (with respect to porphyrins). The absorption band of PCs is almost two orders of magnitude stronger than the highest Q band of haematoporphyrin. These favourable characteristics, along with the ability to selectively functionalise their peripheral structure, make PCs favourable photosensitiser candidates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_196qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A sulphonated aluminium PC derivative (Photosense) has entered clinical trials (Russia) against skin, breast and lung malignancies and cancer of the gastrointestinal tract. Sulphonation significantly increases PC solubility in polar solvents including water, circumventing the need for alternative delivery vehicles.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">PC4 is a silicon complex under investigation for the sterilisation of blood components against human colon, breast and ovarian cancers and against glioma.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A shortcoming of many of the metallo-PCs is their tendency to aggregate in aqueous buffer (pH 7.4), resulting in a decrease, or total loss, of their photochemical activity. This behaviour can be minimised in the presence of detergents.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Metallated cationic porphyrazines (PZ), including PdPZ+, CuPZ+, CdPZ+, MgPZ+, AlPZ+ and GaPZ+, have been tested <em>in vitro</em> on V-79 (Chinese hamster lung fibroblast) cells. These photosensitisers display substantial dark toxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="naphthalocyanines" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Naphthalocyanines<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Naphthalocyanines (NCs) are an extended PC derivative. They have an additional benzene ring attached to each <span class="inline text-[1em] leading-7">isoindole</span> sub-unit on the periphery of the PC structure. Subsequently, NCs absorb strongly at even longer wavelengths (approximately 740â€“780 nm) than PCs (670â€“780 nm). This absorption in the near infrared region makes NCs candidates for highly pigmented tumours, including melanomas, which present significant absorption problems for visible light.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">However, problems associated with NC photosensitisers include lower stability, as they decompose in the presence of light and oxygen. Metallo-NCs, which lack axial ligands, have a tendency to form H-aggregates in solution. These aggregates are photoinactive, thus compromising the photodynamic efficacy of NCs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="functional-groups" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Functional groups<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Altering the peripheral functionality of porphyrin-type chromophores can affect photodynamic activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Diamino platinum porphyrins show high anti-tumour activity, demonstrating the combined effect of the cytotoxicity of the platinum complex and the photodynamic activity of the porphyrin species.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Positively charged PC derivatives have been investigated. Cationic species are believed to selectively localise in the mitochondria.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Zinc and copper cationic derivatives have been investigated. The positively charged zinc complexed PC is less photodynamically active than its neutral counterpart <em>in vitro</em> against V-79 cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Water-soluble cationic porphyrins bearing <span class="inline text-[1em] leading-7">nitrophenyl</span>, <span class="inline text-[1em] leading-7">aminophenyl</span>, <span class="inline text-[1em] leading-7">hydroxyphenyl</span> and/or pyridiniumyl functional groups exhibit varying cytotoxicity to cancer cells <em>in vitro</em> , depending on the nature of the metal ion (Mn, Fe, Zn, Ni) and on the number and type of functional groups. The manganese pyridiniumyl derivative has shown the highest photodynamic activity, while the nickel analogue is photoinactive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Another metallo-porphyrin complex, the iron chelate, is more photoactive (towards HIV and simian immunodeficiency virus in MT-4 cells) than the manganese complexes; the zinc derivative is photoinactive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The hydrophilic sulphonated porphyrins and PCs (AlPorphyrin and AlPC) compounds were tested for photodynamic activity. The disulphonated analogues (with adjacent substituted sulphonated groups) exhibited greater photodynamic activity than their di-(symmetrical), mono-, tri- and tetra-sulphonated counterparts; tumour activity increased with increasing degree of sulphonation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h3 id="third-generation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Third generation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Many photosensitisers are poorly soluble in aqueous media, particularly at physiological pH, limiting their use.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Ongoing research focuses on nanoparticle-encapsulated photosensitizers for enhanced delivery.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Alternate delivery strategies range from the use of oil-in-water (o/w) emulsions to carrier vehicles such as liposomes and nanoparticles. Although these systems may increase therapeutic effects, the carrier system may inadvertently decrease the &quot;observed&quot; singlet oxygen quantum yield (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub></mrow><annotation encoding="application/x-tex">\Phi_\Delta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span>): the singlet oxygen generated by the photosensitiser must diffuse out of the carrier system; and since singlet oxygen is believed to have a narrow radius of action, it may not reach the target cells. The carrier may limit light absorption, reducing singlet oxygen yield.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Another alternative that does not display the scattering problem is the use of <span class="inline text-[1em] leading-7">moieties</span>. Strategies include directly attaching photosensitisers to biologically active molecules such as <span class="inline text-[1em] leading-7">antibodies</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="metallation" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Metallation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Various metals form into complexes with photosensitiser macrocycles. Multiple second generation photosensitisers contain a chelated central metal ion. The main candidates are <span class="inline text-[1em] leading-7">transition metals</span>, although photosensitisers co-ordinated to <span class="inline text-[1em] leading-7">group 13</span> (Al, AlPcS4) and <span class="inline text-[1em] leading-7">group 14</span> (Si, SiNC and Sn, SnEt2) metals have been synthesised.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The metal ion does not confer definite photoactivity on the complex. Copper (II), cobalt (II), iron (II) and zinc (II) complexes of Hp are all photoinactive in contrast to metal-free porphyrins. However, <span class="inline text-[1em] leading-7">texaphyrin</span> and PC photosensitisers do not contain metals; only the metallo-complexes have demonstrated efficient photosensitisation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The central metal ion, bound by a number of photosensitisers, strongly influences the photophysical properties of the photosensitiser. Chelation of paramagnetic metals to a PC chromophore appears to shorten triplet lifetimes (down to nanosecond range), generating variations in the triplet quantum yield and triplet lifetime of the photoexcited triplet state.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Certain heavy metals are known to enhance inter-system crossing (ISC). Generally, diamagnetic metals promote ISC and have a long triplet lifetime. In contrast, paramagnetic species deactivate excited states, reducing the excited-state lifetime and preventing photochemical reactions. However, exceptions to this generalisation include copper octaethylbenzochlorin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Many metallated paramagnetic texaphyrin species exhibit triplet-state lifetimes in the nanosecond range. These results are mirrored by metallated PCs. PCs metallated with diamagnetic ions, such as Zn<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">^{2+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span>, Al<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mn>3</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">^{3+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">3</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span> and Ga<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mn>3</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">^{3+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">3</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span>, generally yield photosensitisers with desirable quantum yields and lifetimes (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub></mrow><annotation encoding="application/x-tex">\Phi_T</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span> 0.56, 0.50 and 0.34 and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>T</mi></msub></mrow><annotation encoding="application/x-tex">\tau_T</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span> 187, 126 and 35 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î¼</mi></mrow><annotation encoding="application/x-tex">\mu</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.1944em"></span><span class="mord mathnormal">Î¼</span></span></span></span> s, respectively). Photosensitiser ZnPcS4 has a singlet oxygen quantum yield of 0.70; nearly twice that of most other mPCs (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub></mrow><annotation encoding="application/x-tex">\Phi_\Delta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span> at least 0.40).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="expanded-metallo-porphyrins" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Expanded metallo-porphyrins<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Expanded porphyrins have a larger central binding cavity, increasing the range of potential metals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Diamagnetic metallo-texaphyrins have shown photophysical properties; high triplet quantum yields and efficient generation of singlet oxygen. In particular, the zinc and cadmium derivatives display triplet quantum yields close to unity. In contrast, the paramagnetic metallo-texaphyrins, Mn-Tex, Sm-Tex and Eu-Tex, have undetectable triplet quantum yields. This behaviour is parallel with that observed for the corresponding metallo-porphyrins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The cadmium-texaphyrin derivative has shown <em>in vitro</em> photodynamic activity against human leukemia cells and <span class="inline text-[1em] leading-7">Gram positive</span> (<em><span class="inline text-[1em] leading-7">Staphylococcus</span></em>) and <span class="inline text-[1em] leading-7">Gram negative</span> (<em><span class="inline text-[1em] leading-7">Escherichia coli</span></em>) bacteria. Although follow-up studies have been limited with this photosensitiser due to the toxicity of the complexed cadmium ion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1hlabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A zinc-metallated <em>seco</em> -<span class="inline text-[1em] leading-7">porphyrazine</span> has a high quantum singlet oxygen yield (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub></mrow><annotation encoding="application/x-tex">\Phi_\Delta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span></span></span></span> 0.74). This expanded porphyrin-like photosensitiser has shown the best singlet oxygen photosensitising ability of any of the reported <em>seco-</em> porphyrazines. Platinum and palladium derivatives have been synthesised with singlet oxygen quantum yields of 0.59 and 0.54, respectively.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="metallochlorinsbacteriochlorins" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Metallochlorins/bacteriochlorins<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">The tin (IV) purpurins are more active when compared with analogous zinc (II) purpurins, against human cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Sulphonated benzochlorin derivatives demonstrated a reduced phototherapeutic response against murine leukemia <span class="inline text-[1em] leading-7">L1210</span> cells <em>in vitro</em> and transplanted urothelial cell carcinoma in rats, whereas the tin (IV) metallated benzochlorins exhibited an increased photodynamic effect in the same tumour model.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Copper octaethylbenzochlorin demonstrated greater photoactivity towards leukemia cells <em>in vitro</em> and a rat bladder tumour model. It may derive from interactions between the cationic <span class="inline text-[1em] leading-7">iminium</span> group and biomolecules. Such interactions may allow electron-transfer reactions to take place via the short-lived excited singlet state and lead to the formation of radicals and radical ions. The copper-free derivative exhibited a tumour response with short intervals between drug administration and photodynamic activity. Increased <em>in vivo</em> activity was observed with the zinc benzochlorin analogue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="metallo-phthalocyanines" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Metallo-phthalocyanines<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">PCs properties are strongly influenced by the central metal ion. Co-ordination of transition metal ions gives metallo-complexes with short triplet lifetimes (nanosecond range), resulting in different triplet quantum yields and lifetimes (with respect to the non-metallated analogues). Diamagnetic metals such as zinc, aluminium and gallium, generate metallo-phthalocyanines (MPC) with high triplet quantum yields (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi>T</mi></msub><mo>â‰¥</mo><mn>0.4</mn></mrow><annotation encoding="application/x-tex">\Phi_T \geq 0.4</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â‰¥</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.4</span></span></span></span>) and short lifetimes (ZnPCS4 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>T</mi></msub><mo>=</mo><mn>490</mn></mrow><annotation encoding="application/x-tex">\tau_T = 490</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">490</span></span></span></span> Fs and AlPcS4 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>Ï„</mi><mi>T</mi></msub><mo>=</mo><mn>400</mn></mrow><annotation encoding="application/x-tex">\tau_T = 400</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5806em;vertical-align:-0.15em"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.1132em">Ï„</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:-0.1132em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em">T</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">400</span></span></span></span> Fs) and high singlet oxygen quantum yields (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">Î¦</mi><mi mathvariant="normal">Î”</mi></msub><mo>â‰¥</mo><mn>0.7</mn></mrow><annotation encoding="application/x-tex">\Phi_\Delta \geq 0.7</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8333em;vertical-align:-0.15em"></span><span class="mord"><span class="mord">Î¦</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3283em"><span style="top:-2.55em;margin-left:0em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">Î”</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em"><span></span></span></span></span></span></span><span class="mspace" style="margin-right:0.2778em"></span><span class="mrel">â‰¥</span><span class="mspace" style="margin-right:0.2778em"></span></span><span class="base"><span class="strut" style="height:0.6444em"></span><span class="mord">0.7</span></span></span></span>). As a result, ZnPc and AlPc have been evaluated as second generation photosensitisers active against certain tumours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="metallo-naphthocyaninesulfobenzo-porphyrazines-m-nsbp" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Metallo-naphthocyaninesulfobenzo-porphyrazines (M-NSBP)<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Aluminium (Al<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mn>3</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">^{3+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">3</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span>) has been successfully coordinated to M-NSBP. The resulting complex showed photodynamic activity against EMT-6 tumour-bearing Balb/c mice (disulphonated analogue demonstrated greater photoactivity than the mono-derivative).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h4 id="metallo-naphthalocyanines" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Metallo-naphthalocyanines<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Work with zinc NC with various amido substituents revealed that the best phototherapeutic response (<span class="inline text-[1em] leading-7">Lewis lung carcinoma</span> in mice) with a tetrabenzamido analogue. Complexes of silicon (IV) NCs with two axial ligands in anticipation the ligands minimise aggregation. Disubstituted analogues as potential photodynamic agents (a siloxane NC substituted with two methoxyethyleneglycol ligands) are an efficient photosensitiser against Lewis lung carcinoma in mice. SiNC[OSi(i-Bu)2-n-C18H37]2 is effective against Balb/c mice MS-2 fibrosarcoma cells. Siloxane NCs may be efficacious photosensitisers against EMT-6 tumours in Balb/c mice. The ability of metallo-NC derivatives (AlNc) to generate singlet oxygen is weaker than the analogous (sulphonated) metallo-PCs (AlPC); reportedly 1.6â€“3 orders of magnitude less.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In porphyrin systems, the zinc ion (Zn<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">^{2+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span>) appears to hinder the photodynamic activity of the compound. By contrast, in the higher/expanded <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Ï€</mi></mrow><annotation encoding="application/x-tex">\pi</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.4306em"></span><span class="mord mathnormal" style="margin-right:0.03588em">Ï€</span></span></span></span>-systems, zinc-chelated dyes form complexes with good to high results.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_prabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">An extensive study of metallated texaphyrins focused on the lanthanide (III) metal ions, Y, In, Lu, Cd, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm and Yb found that when diamagnetic Lu (III) was complexed to texaphyrin, an effective photosensitiser (Lutex) was generated. However, using the paramagnetic Gd (III) ion for the Lu metal, exhibited no photodynamic activity. The study found a correlation between the excited-singlet and triplet state lifetimes and the rate of ISC of the diamagnetic texaphyrin complexes, Y(III), In (III) and Lu (III) and the atomic number of the cation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Paramagnetic metallo-texaphyrins displayed rapid ISC. Triplet lifetimes were strongly affected by the choice of metal ion. The diamagnetic ions (Y, In and Lu) displayed triplet lifetimes ranging from 187, 126 and 35 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î¼</mi></mrow><annotation encoding="application/x-tex">\mu</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.1944em"></span><span class="mord mathnormal">Î¼</span></span></span></span> s, respectively. Comparable lifetimes for the paramagnetic species (Eu-Tex 6.98 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>Î¼</mi></mrow><annotation encoding="application/x-tex">\mu</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.625em;vertical-align:-0.1944em"></span><span class="mord mathnormal">Î¼</span></span></span></span> s, Gd-Tex 1.11, Tb-Tex &lt; 0.2, Dy-Tex 0.44 Ã— 10<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>3</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-3}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">3</span></span></span></span></span></span></span></span></span></span></span></span>, Ho-Tex 0.85 Ã— 10<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>3</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-3}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">3</span></span></span></span></span></span></span></span></span></span></span></span>, Er-Tex 0.76 Ã— 10<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>3</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-3}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">3</span></span></span></span></span></span></span></span></span></span></span></span>, Tm-Tex 0.12 Ã— 10<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mrow><mo>âˆ’</mo><mn>3</mn></mrow></msup></mrow><annotation encoding="application/x-tex">^{-3}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8141em"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.8141em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span><span class="mord mtight">3</span></span></span></span></span></span></span></span></span></span></span></span> and Yb-Tex 0.46) were obtained.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1psabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Three measured paramagnetic complexes measured significantly lower than the diamagnetic metallo-texaphyrins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In general, singlet oxygen quantum yields closely followed the triplet quantum yields.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Various diamagnetic and paramagnetic texaphyrins investigated have independent photophysical behaviour with respect to a complex&#x27;s magnetism. The diamagnetic complexes were characterised by relatively high fluorescence quantum yields, excited-singlet and triplet lifetimes and singlet oxygen quantum yields; in distinct contrast to the paramagnetic species.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The +2 charged diamagnetic species appeared to exhibit a direct relationship between their fluorescence quantum yields, excited state lifetimes, rate of ISC and the atomic number of the metal ion. The greatest diamagnetic ISC rate was observed for Lu-Tex; a result ascribed to the heavy atom effect. The heavy atom effect also held for the Y-Tex, In-Tex and Lu-Tex triplet quantum yields and lifetimes. The triplet quantum yields and lifetimes both decreased with increasing atomic number. The singlet oxygen quantum yield correlated with this observation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Photophysical properties displayed by paramagnetic species were more complex. The observed data/behaviour was not correlated with the number of unpaired electrons located on the metal ion. For example:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">ISC rates and the fluorescence lifetimes gradually decreased with increasing atomic number.</li>
<li class="text-[1em]">Gd-Tex and Tb-Tex chromophores showed (despite more unpaired electrons) slower rates of ISC and longer lifetimes than Ho-Tex or Dy-Tex.</li>
</ul>
<h2 id="applications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Applications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="acne" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acne<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Photodynamic therapy (PDT) is under investigation in clinical trials as a treatment for moderate to severe <span class="inline text-[1em] leading-7">acne</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> A systematic review conducted in 2016 found that PDT is a &quot;safe and effective method of treatment&quot; for acne of different severities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> As of 2025, phase 2b trials for topical aminolevulinic acid (ALA)-PDT (Ameluz) in moderate to severe acne vulgaris are ongoing, with FDA submission planned for 2026.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_120qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> The treatment may cause severe redness and moderate to severe pain and burning sensation in some people. <em>(<span class="inline text-[1em] leading-7">see also: Levulan</span>)</em> One phase II trial, while it showed improvement, was not superior to blue/violet light alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<h3 id="cancer" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cancer<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The FDA has approved photodynamic therapy to treat actinic keratosis, advanced cutaneous T-cell lymphoma, Barrett esophagus, basal cell skin cancer, esophageal (throat) cancer, non-small cell lung cancer, and squamous cell skin cancer (Stage 0). Photodynamic therapy is also used to relieve symptoms of some cancers, including esophageal cancer when it blocks the throat and non-small cell lung cancer when it blocks the airways.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">When cells that have absorbed photosensitizers are exposed to a specific wavelength of light, the photosensitizer produces a form of oxygen, called an oxygen radical, that kills them. Photodynamic therapy (PDT) may also damage blood vessels in the tumor, which prevents it from receiving the blood it needs to keep growing. PDT may trigger the immune system to attack tumor cells, even in other areas of the body.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">PDT is a minimally invasive treatment approved for age-related macular degeneration and certain cancers such as skin, lung,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> esophageal, and head and neck cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_u2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> It is under investigation for other cancers, including mesothelioma<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_162qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1a2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> and bile-duct cancers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1i2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> Psoriasis and acne treatments with PDT remain investigational.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In February 2019, medical scientists announced that <span class="inline text-[1em] leading-7">iridium</span> attached to <span class="inline text-[1em] leading-7">albumin</span>, creating a <span class="inline text-[1em] leading-7">photosensitized molecule</span>, can penetrate <span class="inline text-[1em] leading-7">cancer cells</span> and, after being irradiated with light, destroy the cancer cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1a3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1e3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<h4 id="photoimmunotherapy" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Photoimmunotherapy<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Photoimmunotherapy</span> is an oncological treatment for various cancers that combines photodynamic therapy of tumor with immunotherapy treatment. Combining photodynamic therapy with immunotherapy enhances the immunostimulating response and has synergistic effects for metastatic cancer treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup></span>
<h4 id="vascular-targeting" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Vascular targeting<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Some photosensitisers naturally accumulate in the <span class="inline text-[1em] leading-7">endothelial cells</span> of <span class="inline text-[1em] leading-7">vascular tissue</span> allowing &#x27;vascular targeted&#x27; PDT.</span>
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Verteporfin</span> was shown to target the neovasculature resulting from macular degeneration in the macula within the first thirty minutes after intravenous administration of the drug.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Compared to normal tissues, most types of cancers are especially active in both the uptake and accumulation of photosensitizers agents, which makes cancers especially vulnerable to PDT.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> Since photosensitizers can also have a high affinity for <span class="inline text-[1em] leading-7">vascular</span> <span class="inline text-[1em] leading-7">endothelial cells</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_126abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup></span>
<h3 id="ophthalmology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Ophthalmology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">As cited above, verteporfin was widely approved for the treatment of <span class="inline text-[1em] leading-7">wet age-related macular degeneration</span> beginning in 1999. The drug targets the neovasculature that is caused by the condition.</span>
<h3 id="antimicrobial-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Antimicrobial effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Photodynamic skin disinfection is effective at killing <span class="inline text-[1em] leading-7">topical</span> <span class="inline text-[1em] leading-7">microbes</span>, including <span class="inline text-[1em] leading-7">drug-resistant</span> <span class="inline text-[1em] leading-7">bacteria</span>, <span class="inline text-[1em] leading-7">viruses</span>, and <span class="inline text-[1em] leading-7">fungi</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1q8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> Photodynamic disinfection remains effective after repeat treatments, with no evidence of resistance formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_228abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> The method can effectively treat polymicrobial antibiotic resistant <span class="inline text-[1em] leading-7"><em>Pseudomonas aeruginosa</em></span> and <span class="inline text-[1em] leading-7">methicillin-resistant <em>Staphylococcus aureus</em></span> biofilms in a maxillary sinus cavity model.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2q8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="modern-era" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Modern era<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In the late nineteenth century, Finsen successfully demonstrated phototherapy by employing heat-filtered light from a carbon-arc lamp (the &quot;Finsen lamp&quot;) in the treatment of a tubercular condition of the skin known as lupus vulgaris, for which he won the 1903 Nobel Prize in Physiology or Medicine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1913 another German scientist, Meyer-Betz, described the major stumbling block of photodynamic therapy. After injecting himself with haematoporphyrin (Hp, a photosensitiser), he swiftly experienced a general skin sensitivity upon exposure to sunlightâ€”a recurrent problem with many photosensitisers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The first evidence that agents, photosensitive synthetic dyes, in combination with a light source and oxygen could have potential therapeutic effect was made at the turn of the 20th century in the laboratory of Hermann von Tappeiner in Munich, Germany. Germany was leading the world in industrial dye synthesis at the time.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">While studying the effects of acridine on paramecia cultures, Oscar Raab, a student of von Tappeiner observed a toxic effect. Fortuitously Raab also observed that light was required to kill the paramecia.<!-- --> Subsequent work in von Tappeiner&#x27;s laboratory showed that oxygen was essential for the &#x27;photodynamic action&#x27; â€“ a term coined by von Tappeiner.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Von Tappeiner and colleagues performed the first PDT trial in patients with skin carcinoma using the photosensitizer, eosin. Of six patients with a facial basal cell carcinoma, treated with a 1% eosin solution and long-term exposure either to sunlight or arc-lamp light, four patients showed total tumour resolution and a relapse-free period of 12 months.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1924 Policard revealed the diagnostic capabilities of hematoporphyrin fluorescence when he observed that ultraviolet radiation excited red fluorescence in the sarcomas of laboratory rats.<!-- --> Policard hypothesized that the fluorescence was associated with endogenous hematoporphyrin accumulation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1948 Figge and co-workers<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_acqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup> showed on laboratory animals that porphyrins exhibit a preferential affinity to rapidly dividing cells, including malignant, embryonic and regenerative cells. They proposed that porphyrins could be used to treat cancer.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Photosensitizer Haematoporphyrin Derivative (HpD), was first characterised in 1960 by Lipson.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_adabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup> Lipson sought a diagnostic agent suitable for tumor detection. HpD allowed Lipson to pioneer the use of endoscopes and HpD fluorescence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_idabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> HpD is a porphyrin species derived from haematoporphyrin. Porphyrins have long been considered as suitable agents for tumour photodiagnosis and tumour PDT because cancerous cells exhibit significantly greater uptake and affinity for porphyrins compared to normal tissues. This had been observed by other researchers prior to Lipson.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Thomas Dougherty and co-workers<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_adqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> at Roswell Park Comprehensive Cancer Center in Buffalo, New York, clinically tested PDT in 1978. They treated 113 cutaneous or subcutaneous malignant tumors with HpD and observed total or partial resolution of 111 tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_idqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> Dougherty helped expand clinical trials and formed the International Photodynamic Association, in 1986.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">HpD, under the brand name Photofrin, was the first PDT agent approved for clinical use in 1993 to treat a form of bladder cancer in Canada. Over the next decade, both PDT and the use of HpD received international attention and greater clinical acceptance and led to the first PDT treatments approved by U.S. Food and Drug Administration Japan and parts of Europe for use against certain cancers of the oesophagus and non-small cell lung cancer.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> Photofrin had the disadvantages of prolonged patient photosensitivity and a weak long-wavelength absorption (630 nm). This led to the development of second generation photosensitisers, including Verteporfin (a benzoporphyrin derivative, also known as Visudyne) and more recently, third generation targetable photosensitisers, such as antibody-directed photosensitisers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the 1980s, David Dolphin, Julia Levy and colleagues developed a novel photosensitizer, verteporfin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_efabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> Verteporfin, a porphyrin derivative, is activated at 690 nm, a much longer wavelength than Photofrin. It has the property of preferential uptake by neovasculature. It has been widely tested for its use in treating skin cancers and received FDA approval in 2000 for the treatment of wet age related macular degeneration. As such it was the first medical treatment ever approved for this condition, which is a major cause of vision loss.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Russian scientists pioneered a photosensitizer called Photogem which, like HpD, was derived from haematoporphyrin in 1990 by Mironov and coworkers. Photogem was approved by the Ministry of Health of Russia and tested clinically from February 1992 to 1996. A pronounced therapeutic effect was observed in 91 percent of the 1500 patients. 62 percent had total tumor resolution. A further 29 percent had &gt;50% tumor shrinkage. In early diagnosis patients 92 percent experienced complete resolution.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Russian scientists collaborated with NASA scientists who were looking at the use of LEDs as more suitable light sources, compared to lasers, for PDT applications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_egabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Since 1990, the Chinese have been developing clinical expertise with PDT, using domestically produced photosensitizers, derived from Haematoporphyrin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> China is notable for its expertise in resolving difficult-to-reach tumours.</span>
<h2 id="miscellany" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Miscellany<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">PUVA therapy uses psoralen as photosensitiser and UVA ultraviolet as light source, but this form of therapy is usually classified as a separate form of therapy from photodynamic therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ahqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ehqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">To allow treatment of deeper tumours some researchers are using internal chemiluminescence to activate the photosensitiser, with recent advances including &quot;all-in-one&quot; systems and covalent linkage strategies enhancing efficacy in hypoxic environments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dougherty, Thomas J. (17 June 1998). <a href="https://academic.oup.com/jnci/article/90/12/889/960771" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy&quot;</a>. <em>JNCI: Journal of the National Cancer Institute</em>. <strong>90</strong> (12): 889â€“905. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1093%2Fjnci%2F90.12.889" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1093/jnci/90.12.889</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592754" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4592754</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9637138" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9637138</a>.</span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang, SS; J Chen; L Keltner; J Christophersen; F Zheng; M Krouse; A Singhal (2002). &quot;New technology for deep light distribution in tissue for phototherapy&quot;. <em>Cancer Journal</em>. <strong>8</strong> (2): 154â€“63. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1097%2F00130404-200203000-00009" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1097/00130404-200203000-00009</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11999949" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11999949</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:24376095" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24376095</a>.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em><strong>aa</strong></em> <em><strong>ab</strong></em> <em><strong>ac</strong></em> <em><strong>ad</strong></em> <em><strong>ae</strong></em> <em><strong>af</strong></em> <em><strong>ag</strong></em> <em><strong>ah</strong></em> <em><strong>ai</strong></em> <em><strong>aj</strong></em> <em><strong>ak</strong></em> <em><strong>al</strong></em> <em><strong>am</strong></em> <em><strong>an</strong></em> <em><strong>ao</strong></em> <em><strong>ap</strong></em> <em><strong>aq</strong></em> <em><strong>ar</strong></em> <em><strong>as</strong></em> <em><strong>at</strong></em> <em><strong>au</strong></em> <em><strong>av</strong></em> <em><strong>aw</strong></em> <em><strong>ax</strong></em> <em><strong>ay</strong></em> <em><strong>az</strong></em> <em><strong>ba</strong></em> <em><strong>bb</strong></em> <em><strong>bc</strong></em> <em><strong>bd</strong></em> <em><strong>be</strong></em> <em><strong>bf</strong></em> <em><strong>bg</strong></em> <em><strong>bh</strong></em> <em><strong>bi</strong></em> <em><strong>bj</strong></em> <em><strong>bk</strong></em> <em><strong>bl</strong></em> <em><strong>bm</strong></em> <em><strong>bn</strong></em> <em><strong>bo</strong></em> <em><strong>bp</strong></em> <em><strong>bq</strong></em> <em><strong>br</strong></em> <em><strong>bs</strong></em> <em><strong>bt</strong></em> <em><strong>bu</strong></em> <em><strong>bv</strong></em> <em><strong>bw</strong></em> <em><strong>bx</strong></em> <em><strong>by</strong></em> <em><strong>bz</strong></em> <em><strong>ca</strong></em> <em><strong>cb</strong></em> <em><strong>cc</strong></em> <em><strong>cd</strong></em> Josefsen, Leanne B.; Boyle, Ross W. (1 January 2008). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy and the Development of Metal-Based Photosensitisers&quot;</a>. <em>Metal-Based Drugs</em>. <strong>2008</strong> : 276109. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1155%2F2008%2F276109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1155/2008/276109</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0793-0291" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0793-0291</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2535827</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18815617" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18815617</a>. <!-- --> This article contains quotations from this source, which is available under an Attribution 3.0 Unported (CC BY 3.0) license.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Skovsen Esben, Snyder John W., Lambert John D. C., Ogilby Peter R. (2005). &quot;Lifetime and Diffusion of Singlet Oxygen in a Cell&quot;. <em>The Journal of Physical Chemistry B</em>. <strong>109</strong> (18): 8570â€“8573. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1021%2Fjp051163i" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1021/jp051163i</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16852012" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16852012</a>.<code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite journal}}</code>: CS1 maint: multiple names: authors list (link)</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wilson, Brian C; Michael S Patterson (2008). &quot;The physics, biophysics, and technology of photodynamic therapy&quot;. <em><span class="inline text-[1em] leading-7">Physics in Medicine and Biology</span></em>. <strong>53</strong> (9): R61 â€“ R109. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1088%2F0031-9155%2F53%2F9%2FR01" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1088/0031-9155/53/9/R01</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18401068" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18401068</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4366743" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4366743</a>.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Allison, RR; et al. (2004). <a href="http://bmlaser.physics.ecu.edu/literature/2004%2005_Photosensitizers%20in%20clinical%20PDT.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photosensitizers in clinical PDT&quot;</a> (PDF). <em>Photodiagnosis and Photodynamic Therapy</em>. <strong>1</strong> (1): 27â€“42. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS1572-1000%2804%2900007-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S1572-1000(04)00007-9</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25048062" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25048062</a>.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Huang Z (June 2005). <a href="https://web.archive.org/web/20070705002752/http://www.tcrt.org/index.cfm?CFID=14600455&amp;CFTOKEN=63356510&amp;d=3022&amp;c=4179&amp;p=12984&amp;do=detail" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A review of progress in clinical photodynamic therapy&quot;</a>. <em>Technol. Cancer Res. Treat</em>. <strong>4</strong> (3): 283â€“93. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F153303460500400308" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/153303460500400308</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317568" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1317568</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15896084" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15896084</a>. Archived from the original on 5 July 2007. Retrieved 17 April 2012.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">O&#x27;Connor, Aisling E, Gallagher, William M, Byrne, Annette T (2009). <a href="http://findarticles.com/p/articles/mi_qa3931/is_200909/ai_n42040200/pg_7/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochemistry and Photobiology, Sep/Oct 2009&quot;</a>. <em>Photochemistry and Photobiology</em>.<code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite news}}</code>: CS1 maint: multiple names: authors list (link)</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Foster, TH; BD Pearson; S Mitra; CE Bigelow (2005). &quot;Fluorescence anisotropy imaging reveals localization of meso-tetrahydroxyphenyl chlorin in the nuclear envelope&quot;. <em>Photochemistry and Photobiology</em>. <strong>81</strong> (6): 1544â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1562%2F2005-08-11-RN-646" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1562/2005-08-11-RN-646</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16178663" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16178663</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:19671054" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19671054</a>.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wilson, JD; CE Bigelow; DJ Calkins; TH Foster (2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Light Scattering from Intact Cells Reports Oxidative-Stress-Induced Mitochondrial Swelling&quot;</a>. <em><span class="inline text-[1em] leading-7">Biophysical Journal</span></em>. <strong>88</strong> (4): 2929â€“38. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2005BpJ....88.2929W" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2005BpJ....88.2929W</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1529%2Fbiophysj.104.054528" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1529/biophysj.104.054528</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1305387</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15653724" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15653724</a>.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Mellish, Kirste; R Cox; D Vernon; J Griffiths; S Brown (2002). &quot;In Vitro Photodynamic Activity of a Series of Methylene Blue Analogues&quot;. <em>Photochemistry and Photobiology</em>. <strong>75</strong> (4): 392â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1562%2F0031-8655%282002%29075%3C0392%3Aivpaoa%3E2.0.co%3B2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1562/0031-8655(2002)075&lt;0392:ivpaoa&gt;2.0.co;2</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12003129" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12003129</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:198157591" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">198157591</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lee, TK; ED Baron; THH Foster (2008). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy&quot;</a>. <em>Journal of Biomedical Optics</em>. <strong>13</strong> (3): 030507. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2008JBO....13c0507L" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2008JBO....13c0507L</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1117%2F1.2939068" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1117/1.2939068</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2527126</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18601524" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18601524</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/porfimer-sodium" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Definition of porfimer sodium&quot;</a>. <em><a href="http://www.cancer.gov" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">www.cancer.gov</a></em>. 2 February 2011. Retrieved 6 March 2022.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kessel, David (2 October 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy: A Brief History&quot;</a>. <em>Journal of Clinical Medicine</em>. <strong>8</strong> (10): 1581. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.3390%2Fjcm8101581" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.3390/jcm8101581</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/2077-0383" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2077-0383</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6832404</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31581613" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31581613</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Neville, Anne (5 October 2018). <a href="https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Thomas Dougherty, Ph. D., developed modern cancer therapy&quot;</a>. <em>Buffalo News</em>. Retrieved 6 March 2022.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://photobiology.org/remembering-dr-dougherty-chief-emeritus-pdt-center/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Remembering Dr. Dougherty, Chief Emeritus, PDT Center â€“ American Society for Photobiology&quot;</a>. Retrieved 6 March 2022.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20140817050738/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Package Insert Access Data FDA&quot;</a> (PDF). Archived from <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 17 August 2014.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Clinical trial number <em><a href="https://www.clinicaltrials.gov/show/NCT00706433" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">NCT00706433</a></em> for &quot;Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne&quot; at <span class="inline text-[1em] leading-7">ClinicalTrials.gov</span></span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Keyal, U.; Bhatta, A.K.; Wang, X.L. (June 2016). &quot;Photodynamic therapy for the treatment of different severity of acne: A systematic review&quot;. <em>Photodiagnosis and Photodynamic Therapy</em>. <strong>14</strong> : 191â€“199. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.pdpdt.2016.04.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.pdpdt.2016.04.005</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27090488" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27090488</a>.</span></div></li><li id="https://www.biospace.com/press-releases/biofrontera-inc-announces-last-patient-out-in-phase-2b-study-of-ameluz-aminolevulinic-acid-hci-topical-gel-10-for-the-treatment-of-moderate-to-severe-acne-vulgaris" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.biospace.com/press-releases/biofrontera-inc-announces-last-patient-out-in-phase-2b-study-of-ameluz-aminolevulinic-acid-hci-topical-gel-10-for-the-treatment-of-moderate-to-severe-acne-vulgaris" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.biospace.com/press-releases/biofrontera-inc-announces-last-patient-out-in-phase-2b-study-of-ameluz-aminolevulinic-acid-hci-topical-gel-10-for-the-treatment-of-moderate-to-severe-acne-vulgaris</a></span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20090906045231/http://www.biospace.com/news_story.aspx?NewsEntityId=114055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;DUSA Pharmaceuticals (DUSA) to Stop Developing Phase 2 Acne Treatment&quot;</a>. Biospace. 23 October 2008. Archived from <a href="http://www.biospace.com/news_story.aspx?NewsEntityId=114055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 6 September 2009. Retrieved 30 July 2009.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy to Treat Cancer - National Cancer Institute&quot;</a>. <em><a href="http://www.cancer.gov" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">www.cancer.gov</a></em>. 6 September 2011. Retrieved 6 March 2022.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gollnick, Sandra O.; Owczarczak, Barbara; Maier, Patricia (June 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic therapy and anti-tumor immunity&quot;</a>. <em>Lasers in Surgery and Medicine</em>. <strong>38</strong> (5): 509â€“515. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Flsm.20362" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/lsm.20362</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0196-8092" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0196-8092</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3683987</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16788921" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16788921</a>.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Loewen, Gregory M.; Pandey, Ravindra; Bellnier, David; Henderson, Barbara; Dougherty, Thomas (2006). <a href="https://onlinelibrary.wiley.com/doi/10.1002/lsm.20354" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Endobronchial photodynamic therapy for lung cancer&quot;</a>. <em>Lasers in Surgery and Medicine</em>. <strong>38</strong> (5): 364â€“370. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Flsm.20354" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/lsm.20354</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0196-8092" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0196-8092</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16788932" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16788932</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:2773899" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2773899</a>.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.internationalphotodynamic.com/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;International Photodynamic Association (IPA)&quot;</a>. <em>International Photodynamic Association (IPA)</em>. Retrieved 6 March 2022.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Biel, Merrill A. (September 2007). <a href="https://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.2007.00153.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers&quot;</a>. <em>Photochemistry and Photobiology</em>. <strong>83</strong> (5): 1063â€“1068. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1751-1097.2007.00153.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1751-1097.2007.00153.x</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0031-8655" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0031-8655</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17880501" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17880501</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:24183038" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24183038</a>.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schweitzer, Vanessa Gayl; Somers, Melissa L. (January 2010). <a href="https://onlinelibrary.wiley.com/doi/10.1002/lsm.20881" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx&quot;</a>. <em>Lasers in Surgery and Medicine</em>. <strong>42</strong> (1): 1â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Flsm.20881" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/lsm.20881</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0196-8092" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0196-8092</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20077493" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20077493</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:41342278" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">41342278</a>.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rigual, Nestor R.; Thankappan, Krishnakumar; Cooper, Michele; Sullivan, Maureen A.; Dougherty, Thomas; Popat, Saurin R.; Loree, Thom R.; Biel, Merrill A.; Henderson, Barbara (August 2009). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic Therapy for Head and Neck Dysplasia and Cancer&quot;</a>. <em>Archives of Otolaryngologyâ€“Head &amp; Neck Surgery</em>. <strong>135</strong> (8): 784â€“788. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchoto.2009.98" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archoto.2009.98</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0886-4470" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0886-4470</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2810853</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19687399" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19687399</a>.</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ong, Yi Hong; Kim, Michele M.; Finlay, Jarod C.; Dimofte, Andreea; Singhal, Sunil; Glatstein, Eli; Cengel, Keith A.; Zhu, Timothy C. (29 December 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;PDT Dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT)&quot;</a>. <em>Physics in Medicine and Biology</em>. <strong>63</strong> (1): 015031. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1088%2F1361-6560%2Faa9874" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1088/1361-6560/aa9874</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0031-9155" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0031-9155</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5952607</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29106380" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29106380</a>.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Du, Kevin L.; Both, Stefan; Friedberg, Josephy S.; Rengan, Ramesh; Hahn, Stephen M.; Cengel, Keith A. (1 September 2010). <a href="https://doi.org/10.4161%2Fcbt.10.5.12616" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma&quot;</a>. <em>Cancer Biology &amp; Therapy</em>. <strong>10</strong> (5): 425â€“429. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.4161%2Fcbt.10.5.12616" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.4161/cbt.10.5.12616</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/1538-4047" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1538-4047</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20699634" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20699634</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:1516239" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1516239</a>.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Patel, Janaki; Rizk, Nada; Kedia, Prashant; Sharaiha, Reem Z.; Kahaleh, Michel (1 April 2015). <a href="https://www.giejournal.org/article/S0016-5107(14)02280-9/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cholangioscopy-assisted photodynamic therapy for cholangiocarcinoma&quot;</a>. <em>Gastrointestinal Endoscopy</em>. <strong>81</strong> (4): 1012â€“1013. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.gie.2014.09.060" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.gie.2014.09.060</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/0016-5107" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">0016-5107</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25484323" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25484323</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">University of Warwick</span> (3 February 2019). <a href="https://www.eurekalert.org/pub_releases/2019-02/uow-ssl013119.php" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Simply shining light on dinosaur metal compound kills cancer cells&quot;</a>. <em><span class="inline text-[1em] leading-7">EurekAlert!</span></em>. Retrieved 3 February 2019.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang, Pingyu; et al. (15 December 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Nucleus-Targeted Organoiridiumâ€“Albumin Conjugate for Photodynamic Cancer Therapy&quot;</a>. <em><span class="inline text-[1em] leading-7">Angewandte Chemie</span></em>. <strong>58</strong> (8): 2350â€“2354. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fanie.201813002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/anie.201813002</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6468315</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30552796" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30552796</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z (2014). &quot;Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis&quot;. <em>Adv Mater</em>. <strong>26</strong> (48): 8154â€“62. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2014AdM....26.8154W" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2014AdM....26.8154W</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fadma.201402996" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/adma.201402996</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25331930" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25331930</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:5421261" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5421261</a>.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lin, Z.; et al. (2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes&quot;</a>. <em>Sci Rep</em>. <strong>5</strong> 11709. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2015NatSR...511709L" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2015NatSR...511709L</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsrep11709" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/srep11709</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4485034</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26122018" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26122018</a>.</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chen, Q.; et al. (2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy&quot;</a>. <em>Nat Commun</em>. <strong>7</strong> 13193. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2016NatCo...713193C" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2016NatCo...713193C</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fncomms13193" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/ncomms13193</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5078754</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27767031" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27767031</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Park, S (May 2007). &quot;Delivery of photosensitizers for photodynamic therapy&quot;. <em>Korean J Gastroenterol</em>. <strong>49</strong> (5): 300â€“313. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17525518" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17525518</a>.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Chen, B; BW Pogue; PJ Hoopes; T Hasan (2006). &quot;Vascular and cellular targeting for photodynamic therapy&quot;. <em>Crit Rev Eukaryot Gene Expr</em>. <strong>16</strong> (4): 279â€“305. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1615%2Fcritreveukargeneexpr.v16.i4.10" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1615/critreveukargeneexpr.v16.i4.10</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17206921" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17206921</a>.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.internationalphotodynamic.com/pdt-in-photodisinfection" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;PDT in Photodisinfection&quot;</a>. <em>International Photodynamic Association</em>. Retrieved 6 March 2022.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Heger, Michael (2015). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections&quot;</a>. <em>Journal of Clinical and Translational Research</em>. <strong>1</strong> (3): 140â€“167. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6410618</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30873451" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30873451</a>.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Biel, Merrill A.; Pedigo, Lisa; Gibbs, Aaron; Loebel, Nicolas (June 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model&quot;</a>. <em>International Forum of Allergy &amp; Rhinology</em>. <strong>3</strong> (6): 468â€“473. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Falr.21134" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/alr.21134</a>. <span class="inline text-[1em] leading-7">ISSN</span> <a href="https://search.worldcat.org/issn/2042-6984" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2042-6984</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3626737</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23307793" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23307793</a>.</span></div></li><li id="46" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Raab, O. (1904). &quot;Ãœber die Wirkung Fluorescierenden Stoffe auf Infusorien&quot;. <em>Zeitschrift fÃ¼r Biologie</em>. <strong>39</strong> : 524â€“546.</span></div></li><li id="47" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tappeiner, H. von; A. Jodlbauer (1904). &quot;Ãœber die Wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoen und Enzyme&quot;. <em>Deutsches Archiv fÃ¼r Klinische Medizin</em>. <strong>80</strong> : 427â€“487.</span></div></li><li id="48" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tappeiner, H. von; H. Jesionek (1903). &quot;Therapeutische Versuche mit fluoreszierenden Stoffen&quot;. <em>MÃ¼nchener Medizinische Wochenschrift</em>. <strong>50</strong> : 2042â€“4.</span></div></li><li id="49" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Policard, A (1924). &quot;Etudes sur les aspects offerts par des tumeurs experimentales examines a la lumiere de Wood&quot;. <em>Comptes Rendus des SÃ©ances de la SociÃ©tÃ© de Biologie et de Ses Filiales</em>. <strong>91</strong> : 1423â€“1424.</span></div></li><li id="50" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Figge, FH; GS Weiland; L. O Manganiello (August 1948). &quot;Studies on cancer detection and therapy; the affinity of neoplastic, embryonic, and traumatized tissue for porphyrins, metalloporphyrins, and radioactive zinc hematoporphyrin&quot;. <em>Anatomical Record</em>. <strong>101</strong> (4): 657. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/18882442" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">18882442</a>.</span></div></li><li id="51" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lipson, R. L.; E. J. Baldes (October 1960). &quot;The photodynamic properties of a particular hematoporphyrin derivative&quot;. <em>Archives of Dermatology</em>. <strong>82</strong> (4): 508â€“516. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchderm.1960.01580040026005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archderm.1960.01580040026005</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/13762615" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">13762615</a>.</span></div></li><li id="52" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lipson, R. L; E. J Baldes; M. J Gray (December 1967). &quot;Hematoporphyrin derivative for detection and management of cancer&quot;. <em>Cancer</em>. <strong>20</strong> (12): 2255â€“7. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F1097-0142%28196712%2920%3A12%3C2255%3A%3AAID-CNCR2820201229%3E3.0.CO%3B2-U" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/1097-0142(196712)20:12&lt;2255::AID-CNCR2820201229&gt;3.0.CO;2-U</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/6073903" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6073903</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8945080" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8945080</a>.</span></div></li><li id="53" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moan, J.; Q. Peng (2003). <a href="http://www.rsc.org/ebooks/archive/free/BK9780854043064/BK9780854043064-00001.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An outline of the history of PDT&quot;</a> (PDF). In Thierry Patrice (ed.). <em>Photodynamic Therapy</em>. Comprehensive Series in Photochemistry and Photobiology. Vol. 2. The Royal Society of Chemistry. pp. 1â€“18. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1039%2F9781847551658" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1039/9781847551658</a>. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-85404-306-4.</span></div></li><li id="54" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dougherty, T. J; J. E Kaufman; A. Goldfarb; K. R Weishaupt; D. Boyle; A. Mittleman (August 1978). &quot;Photoradiation therapy for the treatment of malignant tumors&quot;. <em>Cancer Research</em>. <strong>38</strong> (8): 2628â€“35. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/667856" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">667856</a>.</span></div></li><li id="55" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.internationalphotodynamic.com/new-blog/2018/12/31/international-photodynamic-association-ipa-newsletter-winter-lights-issue-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;International Photodynamic Association (IPA) Newsletter: Winter Lights - Issue 3&quot;</a>. <em>International Photodynamic Association (IPA)</em>. 1 January 2019. Retrieved 28 July 2025.</span></div></li><li id="56" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Goldman L</span> (1990). &quot;Dye Lasers in Medicine&quot;. In <span class="inline text-[1em] leading-7">Duarte FJ</span>; Hillman LM (eds.). <em>Dye Laser Principles</em>. Boston: <span class="inline text-[1em] leading-7">Academic Press</span>. pp. 419â€“32. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-12-222700-4.</span></div></li><li id="57" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Richter, A.; Sternberg, E.; Waterfield, E.; Dolphin, D.; Levy, J.G. (1990). &quot;Characterization of Benzoporphyrin Derivative, A New Photosensitizer&quot;. In Hasan, Tayyaba (ed.). <em>Advances in Photochemotherapy</em>. Vol. 997. The International Society for Optical Engineering. pp. 145â€“150. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1989SPIE..997..132R" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1989SPIE..997..132R</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1117%2F12.960196" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1117/12.960196</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:95511635" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">95511635</a>. <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">{{cite book}}</code>: <code class="text-fg-solar bg-fg-solar-opaque break-all rounded px-2 align-middle font-mono text-sm" node="[object Object]">|journal=</code> ignored (help)</span></div></li><li id="58" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Richter, A.; Waterfield, E.; Jain, A.K.; Sternberg, E.; Dolphin, D.; Levy, J.G. (1990). &quot;Photosensitizing potency of benzoporphyrin derivative (BPD) in a mouse tumor model&quot;. <em>Photochemistry and Photobiology</em>. <strong>52</strong> (3): 495â€“500. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1751-1097.1990.tb01791.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1751-1097.1990.tb01791.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/2284343" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2284343</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:2913557" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2913557</a>.</span></div></li><li id="59" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.magicray.ru/ENG/lecture/L2/2.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Centre of laser medicine â€” Historical Aspects of Photodynamic Therapy Development&quot;</a>. Retrieved 5 August 2011.</span></div></li><li id="60" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20041030065457/http://ipp.nasa.gov/innovation/Innovation56/light.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Innovation (November/December 97) â€” Space Research Shines Life-Saving Light&quot;</a>. Archived from <a href="https://ipp.nasa.gov/innovation/Innovation56/light.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 30 October 2004. Retrieved 5 August 2011.</span></div></li><li id="61" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20060503201343/http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photonic Clinical Trials&quot;</a>. Archived from <a href="http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 3 May 2006. Retrieved 5 August 2011.</span></div></li><li id="62" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Whelan, HT; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2001). &quot;Hematoporphyrin derivative for detection and management of cancer&quot;. <em>Space Technology and Applications International Forum</em>. CP552: 35â€“45.</span></div></li><li id="63" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Huang, Z; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2006). &quot;Photodynamic therapy in China: Over 25 years of unique clinical experience: Part Oneâ€”History and domestic photosensitizers&quot;. <em>Photodiagnosis and Photodynamic Therapy</em>. <strong>3</strong> (1): 3â€“10. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS1572-1000%2806%2900009-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S1572-1000(06)00009-3</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25049020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25049020</a>.</span></div></li><li id="64" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Qui, HX; Y Gu; FG Liu; NY Huang; HX Chen; J Zeng (2007). &quot;Clinical Experience of Photodynamic Therapy in China&quot;. <em>Complex Medical Engineering</em> : 1181â€“1184.</span></div></li><li id="65" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Finlan, L. E.; Kernohan, N. M.; Thomson, G.; Beattie, P. E.; Hupp, T. R.; Ibbotson, S. H. (2005). &quot;Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet a therapy on p53 phosphorylation in normal human skin in vivo&quot;. <em>British Journal of Dermatology</em>. <strong>153</strong> (5): 1001â€“1010. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1365-2133.2005.06922.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1365-2133.2005.06922.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16225614" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16225614</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:35302348" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">35302348</a>.</span></div></li><li id="66" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Champva Policy Manual, Chapter: 2, Section: 30.11, Title: PDT (Photodynamic Therapy) and PUVA (Photochemotherapy)</a> <a href="https://web.archive.org/web/20120114173954/http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> 2012-01-14 at the <span class="inline text-[1em] leading-7">Wayback Machine</span> at U.S. Department of Veterans Affairs. Date: 12/23/2011</span></div></li><li id="67" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Laptev R, Nisnevitch M, Siboni G, Malik Z, Firer MA (July 2006). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells&quot;</a>. <em>Br. J. Cancer</em>. <strong>95</strong> (2): 189â€“96. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsj.bjc.6603241" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/sj.bjc.6603241</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2360622</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16819545" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16819545</a>.</span></div></li><li id="https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cptc.202500145" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cptc.202500145" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cptc.202500145</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Photodynamic_therapy" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0" id="_R_" async=""></script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Photodynamic_therapy\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Photodynamic_therapy\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Photodynamic_therapy\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"24:I[6367,[],\"IconMark\"]\n1f:T5fb,"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ _**p**_ _**q**_ _**r**_ _**s**_ _**t**_ _**u**_ _**v**_ _**w**_ _**x**_ _**y**_ _**z**_ _**aa**_ _**ab**_ _**ac**_ _**ad**_ _**ae**_ _**af**_ _**ag**_ _**ah**_ _**ai**_ _**aj**_ _**ak**_ _**al**_ _**am**_ _**an**_ _**ao**_ _**ap**_ _**aq**_ _**ar**_ _**as**_ _**at**_ _**au**_ _**av**_ _**aw**_ _**ax**_ _**ay**_ _**az**_ _**ba**_ _**bb**_ _**bc**_ _**bd**_ _**be**_ _**bf**_ _**bg**_ _**bh**_ _**bi**_ _**bj**_ _**bk**_ _**bl**_ _**bm**_ _**bn**_ _**bo**_ _**bp**_ _**bq**_ _**br**_ _**bs**_ _**bt**_ _**bu**_ _**bv**_ _**bw**_ _**bx**_ _**by**_ _**bz**_ _**ca**_ _**cb**_ _**cc**_ _**cd**_ Josefsen, Leanne B.; Boyle, Ross W. (1 January 2008). [\"Photodynamic Therapy and the Development of Metal-Based Photosensitisers\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827). _Metal-Based Drugs_. **2008** : 276109. [doi](Doi_\\(identifier\\) \"Doi \\(identifier\\)\"):[10.1155/2008/276109](https://doi.org/10.1155%2F2008%2F276109). [ISSN](ISSN_\\(identifier\\) \"ISSN \\(identifier\\)\") [0793-0291](https://search.worldcat.org/issn/0793-0291). [PMC](PMC_\\(identifier\\) \"PMC \\(identifier\\)\") [2535827](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827). [PMID](PMID_\\(identifier\\) \"PMID \\(identifier\\)\") [18815617](https://pubmed.ncbi.nlm.nih.gov/18815617). ![](./_assets_/CC_BY_icon.svg.png) This article contains quotations from this source, which is available under an Attribution 3.0 Unported (CC BY 3.0) license."])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"20:T600,"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"3. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ _**p**_ _**q**_ _**r**_ _**s**_ _**t**_ _**u**_ _**v**_ _**w**_ _**x**_ _**y**_ _**z**_ _**aa**_ _**ab**_ _**ac**_ _**ad**_ _**ae**_ _**af**_ _**ag**_ _**ah**_ _**ai**_ _**aj**_ _**ak**_ _**al**_ _**am**_ _**an**_ _**ao**_ _**ap**_ _**aq**_ _**ar**_ _**as**_ _**at**_ _**au**_ _**av**_ _**aw**_ _**ax**_ _**ay**_ _**az**_ _**ba**_ _**bb**_ _**bc**_ _**bd**_ _**be**_ _**bf**_ _**bg**_ _**bh**_ _**bi**_ _**bj**_ _**bk**_ _**bl**_ _**bm**_ _**bn**_ _**bo**_ _**bp**_ _**bq**_ _**br**_ _**bs**_ _**bt**_ _**bu**_ _**bv**_ _**bw**_ _**bx**_ _**by**_ _**bz**_ _**ca**_ _**cb**_ _**cc**_ _**cd**_ Josefsen, Leanne B.; Boyle, Ross W. (1 January 2008). [\"Photodynamic Therapy and the Development of Metal-Based Photosensitisers\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827). _Metal-Based Drugs_. **2008** : 276109. [doi](Doi_\\(identifier\\) \"Doi \\(identifier\\)\"):[10.1155/2008/276109](https://doi.org/10.1155%2F2008%2F276109). [ISSN](ISSN_\\(identifier\\) \"ISSN \\(identifier\\)\") [0793-0291](https://search.worldcat.org/issn/0793-0291). [PMC](PMC_\\(identifier\\) \"PMC \\(identifier\\)\") [2535827](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827). [PMID](PMID_\\(identifier\\) \"PMID \\(identifier\\)\") [18815617](https://pubmed.ncbi.nlm.nih.gov/18815617). ![](./_assets_/CC_BY_icon.svg.png) This article contains quotations from this source, which is available under an Attribution 3.0 Unported (CC BY 3.0) license."])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"21:T4b8,"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"To achieve selective target cell destruction, while protecting normal tissues, either the photosensitizer can be applied locally to the target area, or targets can be locally illuminated. Skin conditions, including [acne](Acne \"Acne\"), [psoriasis](Psoriasis \"Psoriasis\") and also [skin cancers](Skin_cancer \"Skin cancer\"), can be treated topically and locally illuminated. For internal tissues and cancers, intravenously administered photosensitizers can be illuminated using [endoscopes](Endoscopes \"Endoscopes\") and [fiber optic](Fiber_optic \"Fiber optic\") [catheters](Catheters \"Catheters\"). \n\nPhotosensitizers can target viral and microbial species, including [HIV](HIV \"HIV\") and [MRSA](Methicillin-resistant_Staphylococcus_aureus \"Methicillin-resistant Staphylococcus aureus\").[20] Using PDT, pathogens present in samples of blood and [bone marrow](Bone_marrow \"Bone marrow\") can be decontaminated before the samples are used further for transfusions or transplants.[21] PDT can also eradicate a wide variety of pathogens of the skin and of the oral cavities. Given the seriousness that drug resistant pathogens have now become, there is increasing research into PDT as a new antimicrobial therapy.[22]"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"22:Tcacb,"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"# Photodynamic therapy\n\n**Photodynamic therapy** (**PDT**) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1]\n\nPDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. \n\nAdvantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and disfigurement. A side effect is the associated photosensitisation of skin tissue.[3]\n# Photodynamic Therapy\n\nPDT applications involve three components:[2] a photosensitizer, a light source and tissue oxygen. The wavelength of the light source needs to be appropriate for exciting the photosensitizer to produce radicals and/or reactive oxygen species. These are free radicals (Type I) generated through electron abstraction or transfer from a substrate molecule and highly reactive state of oxygen known as singlet oxygen (Type II). \n\nPDT is a multi-stage process. First a photosensitiser, ideally with negligible toxicity other than its phototoxicity, is administered in the absence of light, either systemically or topically. When a sufficient amount of photosensitiser appears in diseased tissue, the photosensitiser is activated by exposure to light for a specified period. The light dose supplies sufficient energy to stimulate the photosensitiser, but not enough to damage neighbouring healthy tissue. The reactive oxygen kills the target cells.[3]\n\n## Basics\n\n### Reactive oxygen species\n\nIn air and tissue, molecular oxygen (\\( O_2 \\)) occurs in a triplet state, whereas almost all other molecules are in a singlet state. Reactions between triplet and singlet molecules are forbidden by quantum mechanics, making oxygen relatively non-reactive at physiological conditions. A photosensitizer is a chemical compound that can be promoted to an excited state upon absorption of light and undergo intersystem crossing (ISC) with oxygen to produce singlet oxygen. This species is highly cytotoxic, rapidly attacking any organic compounds it encounters. It is rapidly eliminated from cells, in an average of 3 Î¼s.[4]\n\n### Photochemical processes\n\nWhen a photosensitiser is in its excited state (\\( ^3 Psen^* \\)) it can interact with molecular triplet oxygen (\\( ^3 O_2 \\)) and produce radicals and reactive oxygen species (ROS), crucial to the Type II mechanism. These species include singlet oxygen (\\( ^1 O_2 \\)), hydroxyl radicals (â€¢OH) and superoxide (\\( O_2^- \\)) ions. They can interact with cellular components including unsaturated lipids, amino acid residues and nucleic acids. If sufficient oxidative damage ensues, this will result in target-cell death (only within the illuminated area).[3]\n\n### Photochemical mechanisms\n\nWhen a chromophore molecule, such as a cyclic tetrapyrrolic molecule, absorbs a photon, one of its electrons is promoted into a higher-energy orbital, elevating the chromophore from the ground state (\\( S_0 \\)) into a short-lived, electronically excited state (\\( S_n \\)) composed of vibrational sub-levels (\\( S_n' \\)). The excited chromophore can lose energy by rapidly decaying through these sub-levels via internal conversion (IC) to populate the first excited singlet state (\\( S_1 \\)), before quickly relaxing back to the ground state.[3]\n\nThe decay from the excited singlet state (\\( S_1 \\)) to the ground state (\\( S_0 \\)) is via fluorescence (\\( S_1 \\rightarrow S_0 \\)). Singlet state lifetimes of excited fluorophores are very short (\\( \\tau_{fl.} = 10^{-9}â€“10^{-6} \\) seconds) since transitions between the same spin states (S â†’ S or T â†’ T) conserve the spin multiplicity of the electron and, according to the Spin Selection Rules, are therefore considered \"allowed\" transitions. Alternatively, an excited singlet state electron (\\( S_1 \\)) can undergo spin inversion and populate the lower-energy first excited triplet state (\\( T_1 \\)) via intersystem crossing (ISC); a spin-forbidden process, since the spin of the electron is no longer conserved. The excited electron can then undergo a second spin-forbidden inversion and depopulate the excited triplet state (\\( T_1 \\)) by decaying to the ground state (\\( S_0 \\)) via phosphorescence (\\( T_1 \\rightarrow S_0 \\)). Owing to the spin-forbidden triplet to singlet transition, the lifetime of phosphorescence (\\( \\tau_P = 10^{-3} âˆ’ 1 \\) second) is considerably longer than that of fluorescence.[3]\n\n### Photosensitisers and photochemistry\n\nTetrapyrrolic photosensitisers in the excited singlet state (\\( ^1 Psen^* \\), S\u003e0) are relatively efficient at intersystem crossing and can consequently have a high triplet-state quantum yield. The longer lifetime of this species is sufficient to allow the excited triplet state photosensitiser to interact with surrounding bio-molecules, including cell membrane constituents.[3]\n\n### Photochemical reactions\n\nExcited triplet-state photosensitisers can react via Type-I and Type-II processes. Type-I processes can involve the excited singlet or triplet photosensitiser (\\( ^1 Psen^* \\), \\( S_1 \\); \\( ^3 Psen^* \\), \\( T_1 \\)), however due to the short lifetime of the excited singlet state, the photosensitiser can only react if it is intimately associated with a substrate. In both cases the interaction is with readily oxidisable or reducible substrates. Type-II processes involve the direct interaction of the excited triplet photosensitiser (\\( ^3 Psen^* \\), \\( T_1 \\)) with molecular oxygen (\\( ^3 O_2 \\), \\( ^3 \\Sigma_g \\)). The relative contributions of Type I and Type II pathways depend on factors such as photosensitizer properties, oxygen concentration, and local environment, with Type II often predominating in well-oxygenated tissues.[3][12]\n\n#### Type-I processes\n\nType-I processes can be divided into Type I(i) and Type I(ii). Type I (i) involves the transfer of an electron (oxidation) from a substrate molecule to the excited state photosensitiser (Psen*), generating a photosensitiser radical anion (Psen\\( ^â€¢^- \\)) and a substrate radical cation (Subs\\( ^â€¢^+ \\)). The majority of the radicals produced from Type-I(i) reactions react instantaneously with molecular oxygen (\\( O_2 \\)), generating a mixture of oxygen intermediates. For example, the photosensitiser radical anion can react instantaneously with molecular oxygen (\\( ^3 O_2 \\)) to generate a superoxide radical anion (\\( O_2^â€¢^- \\)), which can go on to produce the highly reactive hydroxyl radical (OHâ€¢), initiating a cascade of cytotoxic free radicals; this process is common in the oxidative damage of fatty acids and other lipids.[3]\n\nThe Type-I process (ii) involves the transfer of a hydrogen atom (reduction) to the excited state photosensitiser (Psen*). This generates free radicals capable of rapidly reacting with molecular oxygen and creating a complex mixture of reactive oxygen intermediates, including reactive peroxides.[3]\n\n#### Type-II processes\n\nType-II processes involve the direct interaction of the excited triplet state photosensitiser (\\( ^3 Psen^* \\)) with ground state molecular oxygen (\\( ^3 O_2 \\), \\( ^3 \\Sigma_g \\)); a spin allowed transitionâ€”the excited state photosensitiser and ground state molecular oxygen are of the same spin state (T).[3]\n\nWhen the excited photosensitiser collides with molecular oxygen, a process of triplet-triplet annihilation takes place (\\( ^3 Psen^* \\rightarrow ^1 Psen \\) and \\( ^3 O_2 \\rightarrow ^1 O_2 \\)). This inverts the spin of one oxygen molecule's (\\( ^3 O_2 \\)) outermost antibonding electrons, generating two forms of singlet oxygen (\\( ^1 \\Delta_g \\) and \\( ^1 \\Sigma_g \\)), while simultaneously depopulating the photosensitiser's excited triplet state (\\( T_1 \\rightarrow S_0 \\)). The higher-energy singlet oxygen state (\\( ^1 \\Sigma_g \\), 157 kJ mol\\( ^{-1} \\) \u003e \\( ^3 \\Sigma_g \\)) is very short-lived (on the order of 10-100 ns in methanol, undetectable in \\( H_2 O / D_2 O \\) due to rapid quenching) and rapidly relaxes to the lower-energy excited state (\\( ^1 \\Delta_g \\), 94 kJ mol\\( ^{-1} \\) \u003e \\( ^3 \\Sigma_g \\)). It is, therefore, this lower-energy form of singlet oxygen (\\( ^1 \\Delta_g \\)) that is implicated in cell injury and cell death.[3][4]\n\nThe highly-reactive singlet oxygen species (\\( ^1 O_2 \\)) produced via the Type-II process act near to their site generation and within a radius of approximately 20 nm in lipid environments, but can diffuse up to ~100-300 nm in aqueous cellular compartments, with a typical lifetime of ~10-100 ns in lipid bilayers and up to ~3 Î¼s in aqueous environments.[3][4]\n\nSinglet oxygen can theoretically only interact with proximal molecules and structures within this radius. ROS initiate reactions with many biomolecules, including amino acid residues in proteins, such as tryptophan; unsaturated lipids like cholesterol and nucleic acid bases, particularly guanosine and guanine derivatives, with the latter base more susceptible to ROS. These interactions cause damage and potential destruction to cellular membranes and enzyme deactivation, culminating in cell death.[3]\n\nIt is probable that in the presence of molecular oxygen and as a direct result of the photoirradiation of the photosensitiser molecule, both Type-I and II pathways play a pivotal role in disrupting cellular mechanisms and cellular structure. Nevertheless, considerable evidence suggests that the Type-II photo-oxygenation process predominates in the induction of cell damage, a consequence of the interaction between the irradiated photosensitiser and molecular oxygen. Cells in vivo may be partially protected against the effects of photodynamic therapy by the presence of singlet oxygen scavengers (such as histidine). Certain skin cells are somewhat resistant to PDT in the absence of molecular oxygen; further supporting the proposal that the Type-II process is at the heart of photoinitiated cell death.[3]\n\nThe efficiency of Type-II processes is dependent upon the triplet state lifetime \\( \\tau_T \\) and the triplet quantum yield (\\( \\Phi_T \\)) of the photosensitiser. Both of these parameters have been implicated in phototherapeutic effectiveness; further supporting the distinction between Type-I and Type-II mechanisms. However, the success of a photosensitiser is not exclusively dependent upon a Type-II process. Multiple photosensitisers display excited triplet lifetimes that are too short to permit a Type-II process to occur. For example, the copper metallated octaethylbenzochlorin photosensitiser has a triplet state lifetime of less than 20 nanoseconds and is still deemed to be an efficient photodynamic agent.[3]\n# Photosensitizers\n\nMany photosensitizers for PDT exist. They divide into [porphyrins](Porphyrin \"Porphyrin\"), [chlorins](Chlorin \"Chlorin\") and [dyes](Dye \"Dye\").[6] Examples include [aminolevulinic acid](Aminolevulinic_acid \"Aminolevulinic acid\") (ALA), Silicon Phthalocyanine Pc 4, [m-tetrahydroxyphenylchlorin](Foscan \"Foscan\") (mTHPC) and mono-L-aspartyl [chlorin](Chlorin \"Chlorin\") e6 ([NPe6](NPe6 \"NPe6\")). \n\nPhotosensitizers commercially available for clinical use include [Photofrin](Photofrin \"Photofrin\"), [Visudyne](Visudyne \"Visudyne\"), [Levulan](Levulan \"Levulan\"), [Foscan](Foscan \"Foscan\"), [Metvix](Metvix \"Metvix\"), [Hexvix](Hexvix \"Hexvix\"), [Cysview](Cysview \"Cysview\") and [Laserphyrin](Laserphyrin \"Laserphyrin\"), with others in development, e.g. [Antrin](Antrin \"Antrin\"), [Photochlor](Photochlor \"Photochlor\"), [Photosens](Photosens \"Photosens\"), Photrex, Lumacan, [Cevira](Cevira \"Cevira\"), Visonac, BF-200 ALA,[6][7] [Amphinex](Amphinex \"Amphinex\")[8] and [Azadipyrromethenes](Azadipyrromethene \"Azadipyrromethene\"). More recent approvals include Ameluz (BF-200 ALA) for actinic keratosis (FDA 2016).\n\nThe major difference between photosensitizers is the parts of the cell that they target. Unlike in [radiation therapy](Radiation_therapy \"Radiation therapy\"), where damage is done by targeting cell DNA, most photosensitizers target other cell structures. For example, mTHPC localizes in the nuclear envelope.[9] In contrast, ALA localizes in the [mitochondria](Mitochondria \"Mitochondria\")[10] and [methylene blue](Methylene_Blue \"Methylene Blue\") in the lysosomes.[11]\n\n### Cyclic tetrapyrrolic chromophores\n\nCyclic [tetrapyrrolic](Tetrapyrrole \"Tetrapyrrole\") molecules are [fluorophores](Fluorophores \"Fluorophores\") and photosensitisers. Cyclic tetrapyrrolic derivatives have an inherent similarity to the naturally occurring porphyrins present in living matter. \n\n#### Porphyrins\n\n[Porphyrins](Porphyrin \"Porphyrin\") are a group of naturally occurring and intensely coloured compounds, whose name is drawn from the Greek word *porphura*, or purple. These molecules perform biologically important roles, including oxygen transport and [photosynthesis](Photosynthesis \"Photosynthesis\") and have applications in fields ranging from fluorescent imaging to medicine. Porphyrins are tetrapyrrolic molecules, with the heart of the skeleton a heterocyclic macrocycle, known as a [porphine](Porphin \"Porphin\"). The fundamental porphine frame consists of four pyrrolic sub-units linked on opposing sides (\\( \\alpha \\)-positions, numbered 1, 4, 6, 9, 11, 14, 16 and 19) through four [methine](Methine_group \"Methine group\") (CH) bridges (5, 10, 15 and 20), known as the _meso_ -carbon atoms/positions. The resulting conjugated planar macrocycle may be substituted at the _meso_ \\- and/or \\( \\beta \\)-positions (2, 3, 7, 8, 12, 13, 17 and 18): if the _meso-_ and \\( \\beta \\)-hydrogens are substituted with non-hydrogen atoms or groups, the resulting compounds are known as porphyrins.[3]\n\nThe inner two protons of a free-base porphyrin can be removed by strong bases such as [alkoxides](Alkoxide \"Alkoxide\"), forming a dianionic molecule; conversely, the inner two pyrrolenine nitrogens can be protonated with acids such as [trifluoroacetic acid](Trifluoroacetic_acid \"Trifluoroacetic acid\") affording a dicationic intermediate. The [tetradentate](Denticity \"Denticity\") anionic species can readily form complexes with most metals.[3]\n\n##### Absorption spectroscopy\n\nPorphyrin's highly conjugated skeleton produces a characteristic ultra-violet visible (UV-VIS) spectrum. The spectrum typically consists of an intense, narrow absorption band (\\( \\epsilon \u003e 200000 \\, \\mathrm{L \\cdot mol^{-1} \\, cm^{-1}} \\)) at around 400 nm, known as the [Soret band](Soret_peak \"Soret peak\") or B band, followed by four longer wavelength (450â€“700 nm), weaker absorptions (\\( \\epsilon \u003e 20000 \\, \\mathrm{L \\cdot mol^{-1} \\cdot cm^{-1}} \\) ([free-base](Free_base \"Free base\") porphyrins)) referred to as the Q bands. \n\nThe Soret band arises from a strong electronic transition from the ground state to the second excited singlet state (\\( S_0 \\rightarrow S_2 \\)); whereas the Q band is a result of a weak transition to the first excited singlet state (\\( S_0 \\rightarrow S_1 \\)). The dissipation of energy via internal conversion (IC) is so rapid that fluorescence is only observed from depopulation of the first excited singlet state to the lower-energy ground state (\\( S_1 \\rightarrow S_0 \\)).[3]\n\n### Ideal photosensitisers\n\nThe key characteristic of a photosensitiser is the ability to preferentially accumulate in diseased tissue and induce a desired biological effect via the generation of cytotoxic species. Specific criteria:[12]\n\n- Strong absorption with a high extinction coefficient in the red/near infrared region of the electromagnetic spectrum (600â€“850 nm)â€”allows deeper tissue penetration. (Tissue is much more transparent at longer wavelengths (~700â€“850 nm). Longer wavelengths allow the light to penetrate deeper[8] and treat larger structures.)[8]\n- Suitable photophysical characteristics: a high-quantum yield of triplet formation (\\( \\Phi_T \\geq 0.5 \\)); a high singlet oxygen quantum yield (\\( \\Phi_\\Delta \\geq 0.5 \\)); a relatively long triplet state lifetime (\\( \\tau_T \\), Î¼s range); and a high triplet-state energy (â‰¥ 94 kJ mol\\( ^{-1} \\)). Values of \\( \\Phi_T= 0.83 \\) and \\( \\Phi_\\Delta = 0.65 \\) (haematoporphyrin); \\( \\Phi_T = 0.83 \\) and \\( \\Phi_\\Delta = 0.72 \\) (etiopurpurin); and \\( \\Phi_T = 0.96 \\) and \\( \\Phi_\\Delta = 0.82 \\) (tin etiopurpurin) have been achieved\n- Low dark toxicity and negligible cytotoxicity in the absence of light. (The photosensitizer should not be harmful to the target tissue until the treatment beam is applied.)\n- Preferential accumulation in diseased/target tissue over healthy tissue\n- Rapid clearance from the body post-procedure\n- High chemical stability: single, well-characterised compounds, with a known and constant composition\n- Short and high-yielding synthetic route (with easy translation into multi-gram scales/reactions)\n- Simple and stable formulation\n- Soluble in biological media, allowing intravenous administration. Otherwise, a hydrophilic delivery system must enable efficient and effective transportation of the photosensitiser to the target site via the bloodstream.\n- Low [photobleaching](Photobleaching \"Photobleaching\") to prevent degradation of the photosensitizer so it can continue producing singlet oxygen\n- Natural [fluorescence](Fluorescence \"Fluorescence\") (Many optical dosimetry techniques, such as [fluorescence spectroscopy](Fluorescence_spectroscopy \"Fluorescence spectroscopy\"), depend on fluorescence.)[13]\n\n### First generation\n\n**Porfimer sodium**\n\n[Porfimer sodium](Porfimer_sodium \"Porfimer sodium\") is a drug used to treat some types of cancer. When absorbed by cancer cells and exposed to light, porfimer sodium becomes active and kills the cancer cells. It is a type of photodynamic therapy (PDT) agent and also called Photofrin.[14]\n\nPDT was first discovered more than a century ago in Germany, it was not until [Thomas Dougherty's](https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html)[15] when PDT became more mainstream. Prior to Dr. Dougherty, researchers had ways of using light-sensitive compounds to treat disease. Dougherty successfully treated cancer with PDT in preclinical models in 1975. Three years later, he conducted the first controlled clinical study in humans. In 1994, the FDA approved PDT with the photosensitizer porfimer sodium for palliative treatment of advanced esophageal cancer, specifically the palliation of patients with completely obstructing esophageal cancer, or for patients with partially obstructing esophageal cancer. Porfimer Sodium is also FDA-approved for the treatment of types of lung cancer, more specifically for the treatment of microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated and also FDA approved in the US for high grade dysplasia in Barrett's Esophagus.[16][17][18]\n\nDisadvantages associated with first generation photosensitisers include skin sensitivity and absorption at 630 nm permitted some therapeutic use, but they markedly limited application to the wider field of disease. Second generation photosensitisers were key to the development of photodynamic therapy.[3]\n\n### Second generation\n\n#### 5-Aminolaevulinic acid\n\n[5-Aminolaevulinic acid](Aminolevulinic_acid \"Aminolevulinic acid\") (ALA) is a [prodrug](Prodrug \"Prodrug\") used to treat and image multiple superficial cancers and tumours. ALA a key precursor in the biosynthesis of the naturally occurring porphyrin, [haem](Haem \"Haem\").[3]\n\nHaem is synthesised in every energy-producing cell in the body and is a key structural component of haemoglobin, [myoglobin](Myoglobin \"Myoglobin\") and other [haemproteins](Hemeprotein \"Hemeprotein\"). The immediate precursor to haem is [protoporphyrin IX](Protoporphyrin_IX \"Protoporphyrin IX\") (PPIX), an effective photosensitiser. Haem itself is not a photosensitiser, due to the coordination of a paramagnetic ion in the centre of the macrocycle, causing significant reduction in excited state lifetimes.[3]\n\nThe haem molecule is synthesised from [glycine](Glycine \"Glycine\") and [succinyl coenzyme A](Succinyl_coenzyme_A \"Succinyl coenzyme A\") (succinyl CoA). The rate-limiting step in the biosynthesis pathway is controlled by a tight (negative) feedback mechanism in which the concentration of haem regulates the production of ALA. However, this controlled feedback can be by-passed by artificially adding excess exogenous ALA to cells. The cells respond by producing PPIX (photosensitiser) at a faster rate than the [ferrochelatase](Ferrochelatase \"Ferrochelatase\") enzyme can convert it to haem.[3]\n\nALA, marketed as [Levulan](Levulan \"Levulan\"), has shown promise in photodynamic therapy (tumours) via both intravenous and oral administration, as well as through topical administration in the treatment of malignant and non-malignant dermatological conditions, including psoriasis, [Bowen's disease](Bowen's_disease \"Bowen's disease\") and [Hirsutism](Hirsutism \"Hirsutism\") (Phase II/III clinical trials).[3]\n\nALA accumulates more rapidly in comparison to other intravenously administered sensitisers. Typical peak tumour accumulation levels post-administration for PPIX are usually achieved within several hours; other (intravenous) photosensitisers may take up to 96 hours to reach peak levels. ALA is also excreted more rapidly from the body (~24 hours) than other photosensitisers, minimising photosensitivity side effects.[3]\n\nEsterified ALA derivatives with improved bioavailability have been examined. A methyl ALA ester ([Metvix](Methyl_aminolevulinate \"Methyl aminolevulinate\")) is now available for basal cell carcinoma and other skin lesions. [Benzyl](Benzyl \"Benzyl\") (Benvix) and hexyl ester ([Hexvix](Hexvix \"Hexvix\")) derivatives are used for gastrointestinal cancers and for the diagnosis of bladder cancer.[3]\n\n#### Verteporfin\n\nBenzoporphyrin derivative monoacid ring A (BPD-MA), marketed as [Visudyne](Verteporfin \"Verteporfin\") ([Verteporfin](Verteporfin \"Verteporfin\"), for injection), has been approved by health authorities in multiple jurisdictions, including US FDA, for the treatment of wet AMD beginning in 1999. It has also undergone Phase III clinical trials (USA) for the treatment of cutaneous non-melanoma skin cancer.[3]\n\nThe chromophore of BPD-MA has a red-shifted and intensified long-wavelength absorption maxima at approximately 690 nm. Tissue penetration by light at this wavelength is 50% greater than that achieved for Photofrin (\\( \\lambda_\\mathrm{max.} = 630 \\) nm).[3]\n\nVerteporfin has further advantages over the first generation sensitiser Photofrin. It is rapidly absorbed by the tumour (optimal tumour-normal tissue ratio 30â€“150 minutes post-intravenous injection) and is rapidly cleared from the body, minimising patient photosensitivity (1â€“2 days).[3]\n\n#### Purlytin\n\nChlorin photosensitiser tin etiopurpurin is marketed as Purlytin. Purlytin has undergone Phase II clinical trials for cutaneous metastatic breast cancer and Kaposi's sarcoma in patients with AIDS (acquired immunodeficiency syndrome). Purlytin has been used successfully to treat the non-malignant conditions psoriasis and [restenosis](Restenosis \"Restenosis\").[3]\n\nChlorins are distinguished from the parent porphyrins by a reduced exocyclic double bond, decreasing the symmetry of the conjugated macrocycle. This leads to increased absorption in the long-wavelength portion of the visible region of the electromagnetic spectrum (650â€“680 nm). Purlytin is a purpurin; a degradation product of chlorophyll.[3]\n\nPurlytin has a tin atom chelated in its central cavity that causes a red-shift of approximately 20â€“30 nm (with respect to Photofrin and non-metallated etiopurpurin, \\( \\lambda_\\mathrm{max.SnEt2} = 650 \\) nm). Purlytin has been reported to localise in skin and produce a photoreaction 7â€“14 days post-administration.[3]\n\n#### Foscan\n\nTetra(_m_ -hydroxyphenyl)chlorin (_m_ THPC), marketed as [Foscan](Temoporfin \"Temoporfin\"), is approved in the European Union for palliative treatment of head and neck squamous cell carcinoma. It has also been investigated in clinical trials for gastric and pancreatic cancers, hyperplasia, field sterilisation after cancer surgery and for the control of antibiotic-resistant bacteria.[3]\n\nFoscan has a singlet oxygen quantum yield comparable to other chlorin photosensitisers but lower drug and light doses (approximately 100 times more photoactive than Photofrin).[3]\n\nFoscan can render patients photosensitive for up to 20 days after initial illumination.[3]\n\n#### Lutex\n\n[Lutetium texaphyrin](Motexafin_lutetium \"Motexafin lutetium\"), marketed under the trade name Lutex and Lutrin, is a large porphyrin-like molecule. [Texaphyrins](Texaphyrin \"Texaphyrin\") are expanded porphyrins that have a penta-aza core. It offers strong absorption in the 730â€“770 nm region. Tissue transparency is optimal in this range. As a result, Lutex-based PDT can (potentially) be carried out more effectively at greater depths and on larger tumours.[3]\n\nLutex has entered Phase II clinical trials for evaluation against breast cancer and malignant melanomas.[3]\n\nA Lutex derivative, Antrin, has undergone Phase I clinical trials for the prevention of restenosis of vessels after cardiac [angioplasty](Angioplasty \"Angioplasty\") by photoinactivating foam cells that accumulate within arteriolar plaques. A second Lutex derivative, Optrin, is in Phase I trials for AMD.[3]\n\nTexaphyrins also have potential as radiosensitisers ([Xcytrin](Motexafin_gadolinium \"Motexafin gadolinium\")) and chemosensitisers. Xcytrin, a gadolinium texaphyrin (motexafin gadolinium), has been evaluated in Phase III clinical trials against brain metastases and Phase I clinical trials for primary brain tumours.[3]\n\n#### ATMPn\n\n9-Acetoxy-2,7,12,17-tetrakis-(_Î²_ -methoxyethyl)-porphycene has been evaluated as an agent for dermatological applications against psoriasis vulgaris and superficial non-melanoma skin cancer.[3]\n\n#### Zinc phthalocyanine\n\nA liposomal formulation of zinc phthalocyanine ([CGP55847](https://www.ncbi.nlm.nih.gov/protein/CGP55847)) has undergone clinical trials (Phase I/II, Switzerland) against squamous cell carcinomas of the upper aerodigestive tract. Phthalocyanines (PCs) are related to tetra-aza porphyrins. Instead of four bridging carbon atoms at the _meso-_ positions, as for the porphyrins, PCs have four nitrogen atoms linking the pyrrolic sub-units. PCs also have an extended conjugate pathway: a [benzene ring](Benzene_ring \"Benzene ring\") is fused to the \\( \\beta \\)-positions of each of the four-pyrrolic sub-units. These rings strengthen the absorption of the chromophore at longer wavelengths (with respect to porphyrins). The absorption band of PCs is almost two orders of magnitude stronger than the highest Q band of haematoporphyrin. These favourable characteristics, along with the ability to selectively functionalise their peripheral structure, make PCs favourable photosensitiser candidates.[3]\n\nA sulphonated aluminium PC derivative (Photosense) has entered clinical trials (Russia) against skin, breast and lung malignancies and cancer of the gastrointestinal tract. Sulphonation significantly increases PC solubility in polar solvents including water, circumventing the need for alternative delivery vehicles.[3]\n\nPC4 is a silicon complex under investigation for the sterilisation of blood components against human colon, breast and ovarian cancers and against glioma.[3]\n\nA shortcoming of many of the metallo-PCs is their tendency to aggregate in aqueous buffer (pH 7.4), resulting in a decrease, or total loss, of their photochemical activity. This behaviour can be minimised in the presence of detergents.[3]\n\nMetallated cationic porphyrazines (PZ), including PdPZ+, CuPZ+, CdPZ+, MgPZ+, AlPZ+ and GaPZ+, have been tested _in vitro_ on V-79 (Chinese hamster lung fibroblast) cells. These photosensitisers display substantial dark toxicity.[3]\n\n#### Naphthalocyanines\n\nNaphthalocyanines (NCs) are an extended PC derivative. They have an additional benzene ring attached to each [isoindole](Isoindole \"Isoindole\") sub-unit on the periphery of the PC structure. Subsequently, NCs absorb strongly at even longer wavelengths (approximately 740â€“780 nm) than PCs (670â€“780 nm). This absorption in the near infrared region makes NCs candidates for highly pigmented tumours, including melanomas, which present significant absorption problems for visible light.[3]\n\nHowever, problems associated with NC photosensitisers include lower stability, as they decompose in the presence of light and oxygen. Metallo-NCs, which lack axial ligands, have a tendency to form H-aggregates in solution. These aggregates are photoinactive, thus compromising the photodynamic efficacy of NCs.[3]\n\n#### Functional groups\n\nAltering the peripheral functionality of porphyrin-type chromophores can affect photodynamic activity.[3]\n\nDiamino platinum porphyrins show high anti-tumour activity, demonstrating the combined effect of the cytotoxicity of the platinum complex and the photodynamic activity of the porphyrin species.[3]\n\nPositively charged PC derivatives have been investigated. Cationic species are believed to selectively localise in the mitochondria.[3]\n\nZinc and copper cationic derivatives have been investigated. The positively charged zinc complexed PC is less photodynamically active than its neutral counterpart _in vitro_ against V-79 cells.[3]\n\nWater-soluble cationic porphyrins bearing [nitrophenyl](1-\\(2-Nitrophenoxy\\)octane \"1-\\(2-Nitrophenoxy\\)octane\"), [aminophenyl](Aminophenol \"Aminophenol\"), [hydroxyphenyl](Tyrosine \"Tyrosine\") and/or pyridiniumyl functional groups exhibit varying cytotoxicity to cancer cells _in vitro_ , depending on the nature of the metal ion (Mn, Fe, Zn, Ni) and on the number and type of functional groups. The manganese pyridiniumyl derivative has shown the highest photodynamic activity, while the nickel analogue is photoinactive.[3]\n\nAnother metallo-porphyrin complex, the iron chelate, is more photoactive (towards HIV and simian immunodeficiency virus in MT-4 cells) than the manganese complexes; the zinc derivative is photoinactive.[3]\n\nThe hydrophilic sulphonated porphyrins and PCs (AlPorphyrin and AlPC) compounds were tested for photodynamic activity. The disulphonated analogues (with adjacent substituted sulphonated groups) exhibited greater photodynamic activity than their di-(symmetrical), mono-, tri- and tetra-sulphonated counterparts; tumour activity increased with increasing degree of sulphonation.[3]\n\n### Third generation\n\nMany photosensitisers are poorly soluble in aqueous media, particularly at physiological pH, limiting their use.[3] Ongoing research focuses on nanoparticle-encapsulated photosensitizers for enhanced delivery.\n\nAlternate delivery strategies range from the use of oil-in-water (o/w) emulsions to carrier vehicles such as liposomes and nanoparticles. Although these systems may increase therapeutic effects, the carrier system may inadvertently decrease the \"observed\" singlet oxygen quantum yield (\\( \\Phi_\\Delta \\)): the singlet oxygen generated by the photosensitiser must diffuse out of the carrier system; and since singlet oxygen is believed to have a narrow radius of action, it may not reach the target cells. The carrier may limit light absorption, reducing singlet oxygen yield.[3]\n\nAnother alternative that does not display the scattering problem is the use of [moieties](Moiety_\\(chemistry\\) \"Moiety \\(chemistry\\)\"). Strategies include directly attaching photosensitisers to biologically active molecules such as [antibodies](Antibody \"Antibody\").[3]\n\n#### Metallation\n\nVarious metals form into complexes with photosensitiser macrocycles. Multiple second generation photosensitisers contain a chelated central metal ion. The main candidates are [transition metals](Transition_metal \"Transition metal\"), although photosensitisers co-ordinated to [group 13](Boron_group \"Boron group\") (Al, AlPcS4) and [group 14](Carbon_group \"Carbon group\") (Si, SiNC and Sn, SnEt2) metals have been synthesised.[3]\n\nThe metal ion does not confer definite photoactivity on the complex. Copper (II), cobalt (II), iron (II) and zinc (II) complexes of Hp are all photoinactive in contrast to metal-free porphyrins. However, [texaphyrin](Texaphyrin \"Texaphyrin\") and PC photosensitisers do not contain metals; only the metallo-complexes have demonstrated efficient photosensitisation.[3]\n\nThe central metal ion, bound by a number of photosensitisers, strongly influences the photophysical properties of the photosensitiser. Chelation of paramagnetic metals to a PC chromophore appears to shorten triplet lifetimes (down to nanosecond range), generating variations in the triplet quantum yield and triplet lifetime of the photoexcited triplet state.[3]\n\nCertain heavy metals are known to enhance inter-system crossing (ISC). Generally, diamagnetic metals promote ISC and have a long triplet lifetime. In contrast, paramagnetic species deactivate excited states, reducing the excited-state lifetime and preventing photochemical reactions. However, exceptions to this generalisation include copper octaethylbenzochlorin.[3]\n\nMany metallated paramagnetic texaphyrin species exhibit triplet-state lifetimes in the nanosecond range. These results are mirrored by metallated PCs. PCs metallated with diamagnetic ions, such as Zn\\( ^{2+} \\), Al\\( ^{3+} \\) and Ga\\( ^{3+} \\), generally yield photosensitisers with desirable quantum yields and lifetimes (\\( \\Phi_T \\) 0.56, 0.50 and 0.34 and \\( \\tau_T \\) 187, 126 and 35 \\( \\mu \\) s, respectively). Photosensitiser ZnPcS4 has a singlet oxygen quantum yield of 0.70; nearly twice that of most other mPCs (\\( \\Phi_\\Delta \\) at least 0.40).[3]\n\n#### Expanded metallo-porphyrins\n\nExpanded porphyrins have a larger central binding cavity, increasing the range of potential metals.[3]\n\nDiamagnetic metallo-texaphyrins have shown photophysical properties; high triplet quantum yields and efficient generation of singlet oxygen. In particular, the zinc and cadmium derivatives display triplet quantum yields close to unity. In contrast, the paramagnetic metallo-texaphyrins, Mn-Tex, Sm-Tex and Eu-Tex, have undetectable triplet quantum yields. This behaviour is parallel with that observed for the corresponding metallo-porphyrins.[3]\n\nThe cadmium-texaphyrin derivative has shown _in vitro_ photodynamic activity against human leukemia cells and [Gram positive](Gram-positive_bacteria \"Gram-positive bacteria\") (_[Staphylococcus](Staphylococcus \"Staphylococcus\")_) and [Gram negative](Gram-negative_bacteria \"Gram-negative bacteria\") (_[Escherichia coli](Escherichia_coli \"Escherichia coli\")_) bacteria. Although follow-up studies have been limited with this photosensitiser due to the toxicity of the complexed cadmium ion.[3]\n\nA zinc-metallated _seco_ -[porphyrazine](Porphyrazine \"Porphyrazine\") has a high quantum singlet oxygen yield (\\( \\Phi_\\Delta \\) 0.74). This expanded porphyrin-like photosensitiser has shown the best singlet oxygen photosensitising ability of any of the reported _seco-_ porphyrazines. Platinum and palladium derivatives have been synthesised with singlet oxygen quantum yields of 0.59 and 0.54, respectively.[3]\n\n#### Metallochlorins/bacteriochlorins\n\nThe tin (IV) purpurins are more active when compared with analogous zinc (II) purpurins, against human cancers.[3]\n\nSulphonated benzochlorin derivatives demonstrated a reduced phototherapeutic response against murine leukemia [L1210](FN_Minimi \"FN Minimi\") cells _in vitro_ and transplanted urothelial cell carcinoma in rats, whereas the tin (IV) metallated benzochlorins exhibited an increased photodynamic effect in the same tumour model.[3]\n\nCopper octaethylbenzochlorin demonstrated greater photoactivity towards leukemia cells _in vitro_ and a rat bladder tumour model. It may derive from interactions between the cationic [iminium](Iminium \"Iminium\") group and biomolecules. Such interactions may allow electron-transfer reactions to take place via the short-lived excited singlet state and lead to the formation of radicals and radical ions. The copper-free derivative exhibited a tumour response with short intervals between drug administration and photodynamic activity. Increased _in vivo_ activity was observed with the zinc benzochlorin analogue.[3]\n\n#### Metallo-phthalocyanines\n\nPCs properties are strongly influenced by the central metal ion. Co-ordination of transition metal ions gives metallo-complexes with short triplet lifetimes (nanosecond range), resulting in different triplet quantum yields and lifetimes (with respect to the non-metallated analogues). Diamagnetic metals such as zinc, aluminium and gallium, generate metallo-phthalocyanines (MPC) with high triplet quantum yields (\\( \\Phi_T \\geq 0.4 \\)) and short lifetimes (ZnPCS4 \\( \\tau_T = 490 \\) Fs and AlPcS4 \\( \\tau_T = 400 \\) Fs) and high singlet oxygen quantum yields (\\( \\Phi_\\Delta \\geq 0.7 \\)). As a result, ZnPc and AlPc have been evaluated as second generation photosensitisers active against certain tumours.[3]\n\n#### Metallo-naphthocyaninesulfobenzo-porphyrazines (M-NSBP)\n\nAluminium (Al\\( ^{3+} \\)) has been successfully coordinated to M-NSBP. The resulting complex showed photodynamic activity against EMT-6 tumour-bearing Balb/c mice (disulphonated analogue demonstrated greater photoactivity than the mono-derivative).[3]\n\n#### Metallo-naphthalocyanines\n\nWork with zinc NC with various amido substituents revealed that the best phototherapeutic response ([Lewis lung carcinoma](Lewis_lung_carcinoma \"Lewis lung carcinoma\") in mice) with a tetrabenzamido analogue. Complexes of silicon (IV) NCs with two axial ligands in anticipation the ligands minimise aggregation. Disubstituted analogues as potential photodynamic agents (a siloxane NC substituted with two methoxyethyleneglycol ligands) are an efficient photosensitiser against Lewis lung carcinoma in mice. SiNC[OSi(i-Bu)2-n-C18H37]2 is effective against Balb/c mice MS-2 fibrosarcoma cells. Siloxane NCs may be efficacious photosensitisers against EMT-6 tumours in Balb/c mice. The ability of metallo-NC derivatives (AlNc) to generate singlet oxygen is weaker than the analogous (sulphonated) metallo-PCs (AlPC); reportedly 1.6â€“3 orders of magnitude less.[3]\n\nIn porphyrin systems, the zinc ion (Zn\\( ^{2+} \\)) appears to hinder the photodynamic activity of the compound. By contrast, in the higher/expanded \\( \\pi \\)-systems, zinc-chelated dyes form complexes with good to high results.[3]\n\nAn extensive study of metallated texaphyrins focused on the lanthanide (III) metal ions, Y, In, Lu, Cd, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm and Yb found that when diamagnetic Lu (III) was complexed to texaphyrin, an effective photosensitiser (Lutex) was generated. However, using the paramagnetic Gd (III) ion for the Lu metal, exhibited no photodynamic activity. The study found a correlation between the excited-singlet and triplet state lifetimes and the rate of ISC of the diamagnetic texaphyrin complexes, Y(III), In (III) and Lu (III) and the atomic number of the cation.[3]\n\nParamagnetic metallo-texaphyrins displayed rapid ISC. Triplet lifetimes were strongly affected by the choice of metal ion. The diamagnetic ions (Y, In and Lu) displayed triplet lifetimes ranging from 187, 126 and 35 \\( \\mu \\) s, respectively. Comparable lifetimes for the paramagnetic species (Eu-Tex 6.98 \\( \\mu \\) s, Gd-Tex 1.11, Tb-Tex \u003c 0.2, Dy-Tex 0.44 Ã— 10\\( ^{-3} \\), Ho-Tex 0.85 Ã— 10\\( ^{-3} \\), Er-Tex 0.76 Ã— 10\\( ^{-3} \\), Tm-Tex 0.12 Ã— 10\\( ^{-3} \\) and Yb-Tex 0.46) were obtained.[3]\n\nThree measured paramagnetic complexes measured significantly lower than the diamagnetic metallo-texaphyrins.[3]\n\nIn general, singlet oxygen quantum yields closely followed the triplet quantum yields.[3]\n\nVarious diamagnetic and paramagnetic texaphyrins investigated have independent photophysical behaviour with respect to a complex's magnetism. The diamagnetic complexes were characterised by relatively high fluorescence quantum yields, excited-singlet and triplet lifetimes and singlet oxygen quantum yields; in distinct contrast to the paramagnetic species.[3]\n\nThe +2 charged diamagnetic species appeared to exhibit a direct relationship between their fluorescence quantum yields, excited state lifetimes, rate of ISC and the atomic number of the metal ion. The greatest diamagnetic ISC rate was observed for Lu-Tex; a result ascribed to the heavy atom effect. The heavy atom effect also held for the Y-Tex, In-Tex and Lu-Tex triplet quantum yields and lifetimes. The triplet quantum yields and lifetimes both decreased with increasing atomic number. The singlet oxygen quantum yield correlated with this observation. \n\nPhotophysical properties displayed by paramagnetic species were more complex. The observed data/behaviour was not correlated with the number of unpaired electrons located on the metal ion. For example: \n\n- ISC rates and the fluorescence lifetimes gradually decreased with increasing atomic number.\n- Gd-Tex and Tb-Tex chromophores showed (despite more unpaired electrons) slower rates of ISC and longer lifetimes than Ho-Tex or Dy-Tex.\n## Applications\n\n### Acne\n\nPhotodynamic therapy (PDT) is under investigation in clinical trials as a treatment for moderate to severe [acne](Acne \"Acne\").[23] A systematic review conducted in 2016 found that PDT is a \"safe and effective method of treatment\" for acne of different severities.[24] As of 2025, phase 2b trials for topical aminolevulinic acid (ALA)-PDT (Ameluz) in moderate to severe acne vulgaris are ongoing, with FDA submission planned for 2026.[](https://www.biospace.com/press-releases/biofrontera-inc-announces-last-patient-out-in-phase-2b-study-of-ameluz-aminolevulinic-acid-hci-topical-gel-10-for-the-treatment-of-moderate-to-severe-acne-vulgaris) The treatment may cause severe redness and moderate to severe pain and burning sensation in some people. _([see also: Levulan](Levulan \"Levulan\"))_ One phase II trial, while it showed improvement, was not superior to blue/violet light alone.[25]\n\n### Cancer\n\nThe FDA has approved photodynamic therapy to treat actinic keratosis, advanced cutaneous T-cell lymphoma, Barrett esophagus, basal cell skin cancer, esophageal (throat) cancer, non-small cell lung cancer, and squamous cell skin cancer (Stage 0). Photodynamic therapy is also used to relieve symptoms of some cancers, including esophageal cancer when it blocks the throat and non-small cell lung cancer when it blocks the airways.[26]\n\nWhen cells that have absorbed photosensitizers are exposed to a specific wavelength of light, the photosensitizer produces a form of oxygen, called an oxygen radical, that kills them. Photodynamic therapy (PDT) may also damage blood vessels in the tumor, which prevents it from receiving the blood it needs to keep growing. PDT may trigger the immune system to attack tumor cells, even in other areas of the body.[26][27]\n\nPDT is a minimally invasive treatment approved for age-related macular degeneration and certain cancers such as skin, lung,[28] esophageal, and head and neck cancers.[32][33][34][35] It is under investigation for other cancers, including mesothelioma[29][30] and bile-duct cancers.[31] Psoriasis and acne treatments with PDT remain investigational.\n\nIn February 2019, medical scientists announced that [iridium](Iridium \"Iridium\") attached to [albumin](Albumin \"Albumin\"), creating a [photosensitized molecule](Photosensitizer \"Photosensitizer\"), can penetrate [cancer cells](Cancer_cells \"Cancer cells\") and, after being irradiated with light, destroy the cancer cells.[36][37]\n\n#### Photoimmunotherapy\n\n[Photoimmunotherapy](Photoimmunotherapy \"Photoimmunotherapy\") is an oncological treatment for various cancers that combines photodynamic therapy of tumor with immunotherapy treatment. Combining photodynamic therapy with immunotherapy enhances the immunostimulating response and has synergistic effects for metastatic cancer treatment.[38][39][40]\n\n#### Vascular targeting\n\nSome photosensitisers naturally accumulate in the [endothelial cells](Endothelial_cell \"Endothelial cell\") of [vascular tissue](Vascular_tissue \"Vascular tissue\") allowing 'vascular targeted' PDT. \n\n[Verteporfin](Verteporfin \"Verteporfin\") was shown to target the neovasculature resulting from macular degeneration in the macula within the first thirty minutes after intravenous administration of the drug. \n\nCompared to normal tissues, most types of cancers are especially active in both the uptake and accumulation of photosensitizers agents, which makes cancers especially vulnerable to PDT.[41] Since photosensitizers can also have a high affinity for [vascular](Blood_vessel \"Blood vessel\") [endothelial cells](Endothelial_cell \"Endothelial cell\").[42]\n\n### Ophthalmology\n\nAs cited above, verteporfin was widely approved for the treatment of [wet age-related macular degeneration](Wet_age-related_macular_degeneration \"Wet age-related macular degeneration\") beginning in 1999. The drug targets the neovasculature that is caused by the condition. \n\n### Antimicrobial effects\n\nPhotodynamic skin disinfection is effective at killing [topical](Topical_medication \"Topical medication\") [microbes](Microbe \"Microbe\"), including [drug-resistant](Drug_resistance \"Drug resistance\") [bacteria](Bacteria \"Bacteria\"), [viruses](Virus \"Virus\"), and [fungi](Fungus \"Fungus\").[43] Photodynamic disinfection remains effective after repeat treatments, with no evidence of resistance formation.[44] The method can effectively treat polymicrobial antibiotic resistant [_Pseudomonas aeruginosa_](Pseudomonas_aeruginosa \"Pseudomonas aeruginosa\") and [methicillin-resistant _Staphylococcus aureus_](Methicillin-resistant_Staphylococcus_aureus \"Methicillin-resistant Staphylococcus aureus\") biofilms in a maxillary sinus cavity model.[45]\n## History\n\n### Modern era\n\nIn the late nineteenth century, Finsen successfully demonstrated phototherapy by employing heat-filtered light from a carbon-arc lamp (the \"Finsen lamp\") in the treatment of a tubercular condition of the skin known as lupus vulgaris, for which he won the 1903 Nobel Prize in Physiology or Medicine.[3]\n\nIn 1913 another German scientist, Meyer-Betz, described the major stumbling block of photodynamic therapy. After injecting himself with haematoporphyrin (Hp, a photosensitiser), he swiftly experienced a general skin sensitivity upon exposure to sunlightâ€”a recurrent problem with many photosensitisers.[3]\n\nThe first evidence that agents, photosensitive synthetic dyes, in combination with a light source and oxygen could have potential therapeutic effect was made at the turn of the 20th century in the laboratory of Hermann von Tappeiner in Munich, Germany. Germany was leading the world in industrial dye synthesis at the time.[3]\n\nWhile studying the effects of acridine on paramecia cultures, Oscar Raab, a student of von Tappeiner observed a toxic effect. Fortuitously Raab also observed that light was required to kill the paramecia.[46] Subsequent work in von Tappeiner's laboratory showed that oxygen was essential for the 'photodynamic action' â€“ a term coined by von Tappeiner.[47]\n\nVon Tappeiner and colleagues performed the first PDT trial in patients with skin carcinoma using the photosensitizer, eosin. Of six patients with a facial basal cell carcinoma, treated with a 1% eosin solution and long-term exposure either to sunlight or arc-lamp light, four patients showed total tumour resolution and a relapse-free period of 12 months.[48]\n\nIn 1924 Policard revealed the diagnostic capabilities of hematoporphyrin fluorescence when he observed that ultraviolet radiation excited red fluorescence in the sarcomas of laboratory rats.[49] Policard hypothesized that the fluorescence was associated with endogenous hematoporphyrin accumulation. \n\nIn 1948 Figge and co-workers[50] showed on laboratory animals that porphyrins exhibit a preferential affinity to rapidly dividing cells, including malignant, embryonic and regenerative cells. They proposed that porphyrins could be used to treat cancer. \n\nPhotosensitizer Haematoporphyrin Derivative (HpD), was first characterised in 1960 by Lipson.[51] Lipson sought a diagnostic agent suitable for tumor detection. HpD allowed Lipson to pioneer the use of endoscopes and HpD fluorescence.[52] HpD is a porphyrin species derived from haematoporphyrin. Porphyrins have long been considered as suitable agents for tumour photodiagnosis and tumour PDT because cancerous cells exhibit significantly greater uptake and affinity for porphyrins compared to normal tissues. This had been observed by other researchers prior to Lipson. \n\nThomas Dougherty and co-workers[53] at Roswell Park Comprehensive Cancer Center in Buffalo, New York, clinically tested PDT in 1978. They treated 113 cutaneous or subcutaneous malignant tumors with HpD and observed total or partial resolution of 111 tumors.[54] Dougherty helped expand clinical trials and formed the International Photodynamic Association, in 1986.[55]\n\nHpD, under the brand name Photofrin, was the first PDT agent approved for clinical use in 1993 to treat a form of bladder cancer in Canada. Over the next decade, both PDT and the use of HpD received international attention and greater clinical acceptance and led to the first PDT treatments approved by U.S. Food and Drug Administration Japan and parts of Europe for use against certain cancers of the oesophagus and non-small cell lung cancer.[3]\n\n[56] Photofrin had the disadvantages of prolonged patient photosensitivity and a weak long-wavelength absorption (630 nm). This led to the development of second generation photosensitisers, including Verteporfin (a benzoporphyrin derivative, also known as Visudyne) and more recently, third generation targetable photosensitisers, such as antibody-directed photosensitisers.[3]\n\nIn the 1980s, David Dolphin, Julia Levy and colleagues developed a novel photosensitizer, verteporfin.[57][58] Verteporfin, a porphyrin derivative, is activated at 690 nm, a much longer wavelength than Photofrin. It has the property of preferential uptake by neovasculature. It has been widely tested for its use in treating skin cancers and received FDA approval in 2000 for the treatment of wet age related macular degeneration. As such it was the first medical treatment ever approved for this condition, which is a major cause of vision loss. \n\nRussian scientists pioneered a photosensitizer called Photogem which, like HpD, was derived from haematoporphyrin in 1990 by Mironov and coworkers. Photogem was approved by the Ministry of Health of Russia and tested clinically from February 1992 to 1996. A pronounced therapeutic effect was observed in 91 percent of the 1500 patients. 62 percent had total tumor resolution. A further 29 percent had \u003e50% tumor shrinkage. In early diagnosis patients 92 percent experienced complete resolution.[59]\n\nRussian scientists collaborated with NASA scientists who were looking at the use of LEDs as more suitable light sources, compared to lasers, for PDT applications.[60][61][62]\n\nSince 1990, the Chinese have been developing clinical expertise with PDT, using domestically produced photosensitizers, derived from Haematoporphyrin.[63] China is notable for its expertise in resolving difficult-to-reach tumours.[64]\n## Miscellany\n\nPUVA therapy uses psoralen as photosensitiser and UVA ultraviolet as light source, but this form of therapy is usually classified as a separate form of therapy from photodynamic therapy.[65][66]\n\nTo allow treatment of deeper tumours some researchers are using internal chemiluminescence to activate the photosensitiser, with recent advances including \"all-in-one\" systems and covalent linkage strategies enhancing efficacy in hypoxic environments.[67]\n\n[](https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cptc.202500145)"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761884943395,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"** Dougherty, Thomas J. (17 June 1998). [\\\"Photodynamic Therapy\\\"](https://academic.oup.com/jnci/article/90/12/889/960771). _JNCI: Journal of the National Cancer Institute_. **90** (12): 889â€“905\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jnci/90.12.889](https://doi.org/10.1093%2Fjnci%2F90.12.889). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4592754](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9637138](https://pubmed.ncbi.nlm.nih.gov/9637138).\",\"description\":\"1. **^** Dougherty, Thomas J. (17 June 1998). [\\\"Photodynamic Therapy\\\"](https://academic.oup.com/jnci/article/90/12/889/960771). _JNCI: Journal of the National Cancer Institute_. **90** (12): 889â€“905\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/jnci/90.12.889](https://doi.org/10.1093%2Fjnci%2F90.12.889). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4592754](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9637138](https://pubmed.ncbi.nlm.nih.gov/9637138).\",\"url\":\"https://academic.oup.com/jnci/article/90/12/889/960771\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ Wang, SS; J Chen; L Keltner; J Christophersen; F Zheng; M Krouse; A Singhal (2002). \\\"New technology for deep light distribution in tissue for phototherapy\\\". _Cancer Journal_. **8** (2): 154â€“63\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/00130404-200203000-00009](https://doi.org/10.1097%2F00130404-200203000-00009). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11999949](https://pubmed.ncbi.nlm.nih.gov/11999949). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24376095](https://api.semanticscholar.org/CorpusID:24376095).\",\"description\":\"2. ^ _**a**_ _**b**_ Wang, SS; J Chen; L Keltner; J Christophersen; F Zheng; M Krouse; A Singhal (2002). \\\"New technology for deep light distribution in tissue for phototherapy\\\". _Cancer Journal_. **8** (2): 154â€“63\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1097/00130404-200203000-00009](https://doi.org/10.1097%2F00130404-200203000-00009). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11999949](https://pubmed.ncbi.nlm.nih.gov/11999949). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24376095](https://api.semanticscholar.org/CorpusID:24376095).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"$1f\",\"description\":\"$20\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535827\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** Skovsen Esben, Snyder John W., Lambert John D. C., Ogilby Peter R. (2005). \\\"Lifetime and Diffusion of Singlet Oxygen in a Cell\\\". _The Journal of Physical Chemistry B_. **109** (18): 8570â€“8573\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1021/jp051163i](https://doi.org/10.1021%2Fjp051163i). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16852012](https://pubmed.ncbi.nlm.nih.gov/16852012).`{{cite journal}}`: CS1 maint: multiple names: authors list (link)\",\"description\":\"4. **^** Skovsen Esben, Snyder John W., Lambert John D. C., Ogilby Peter R. (2005). \\\"Lifetime and Diffusion of Singlet Oxygen in a Cell\\\". _The Journal of Physical Chemistry B_. **109** (18): 8570â€“8573\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1021/jp051163i](https://doi.org/10.1021%2Fjp051163i). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16852012](https://pubmed.ncbi.nlm.nih.gov/16852012).`{{cite journal}}`: CS1 maint: multiple names: authors list (link)\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** Devika, Sivakumar; Rakhi, Raju; Y.T., Kamal; Shahana, Salam (3 January 2023). [_Porphyrinoid Photosensitizers for Targeted and Precise Photodynamic Therapy: Progress in Fabrication_](https://www.intechopen.com/chapters/85515). London: intechopen. p. 145-174. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-83768-471-7.\",\"description\":\"5. **^** Devika, Sivakumar; Rakhi, Raju; Y.T., Kamal; Shahana, Salam (3 January 2023). [_Porphyrinoid Photosensitizers for Targeted and Precise Photodynamic Therapy: Progress in Fabrication_](https://www.intechopen.com/chapters/85515). London: intechopen. p. 145-174. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-83768-471-7.\",\"url\":\"https://www.intechopen.com/chapters/85515\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ Allison, RR; et al. (2004). [\\\"Photosensitizers in clinical PDT\\\"](http://bmlaser.physics.ecu.edu/literature/2004%2005_Photosensitizers%20in%20clinical%20PDT.pdf) (PDF). _Photodiagnosis and Photodynamic Therapy_. **1** (1): 27â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S1572-1000(04)00007-9](https://doi.org/10.1016%2FS1572-1000%2804%2900007-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25048062](https://pubmed.ncbi.nlm.nih.gov/25048062).\",\"description\":\"6. ^ _**a**_ _**b**_ Allison, RR; et al. (2004). [\\\"Photosensitizers in clinical PDT\\\"](http://bmlaser.physics.ecu.edu/literature/2004%2005_Photosensitizers%20in%20clinical%20PDT.pdf) (PDF). _Photodiagnosis and Photodynamic Therapy_. **1** (1): 27â€“42\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S1572-1000(04)00007-9](https://doi.org/10.1016%2FS1572-1000%2804%2900007-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25048062](https://pubmed.ncbi.nlm.nih.gov/25048062).\",\"url\":\"http://bmlaser.physics.ecu.edu/literature/2004%2005_Photosensitizers%20in%20clinical%20PDT.pdf\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** Huang Z (June 2005). [\\\"A review of progress in clinical photodynamic therapy\\\"](https://web.archive.org/web/20070705002752/http://www.tcrt.org/index.cfm?CFID=14600455\u0026CFTOKEN=63356510\u0026d=3022\u0026c=4179\u0026p=12984\u0026do=detail). _Technol. Cancer Res. Treat_. **4** (3): 283â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/153303460500400308](https://doi.org/10.1177%2F153303460500400308). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1317568](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317568). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15896084](https://pubmed.ncbi.nlm.nih.gov/15896084). Archived from the original on 5 July 2007. Retrieved 17 April 2012.\",\"description\":\"7. **^** Huang Z (June 2005). [\\\"A review of progress in clinical photodynamic therapy\\\"](https://web.archive.org/web/20070705002752/http://www.tcrt.org/index.cfm?CFID=14600455\u0026CFTOKEN=63356510\u0026d=3022\u0026c=4179\u0026p=12984\u0026do=detail). _Technol. Cancer Res. Treat_. **4** (3): 283â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/153303460500400308](https://doi.org/10.1177%2F153303460500400308). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1317568](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1317568). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15896084](https://pubmed.ncbi.nlm.nih.gov/15896084). Archived from the original on 5 July 2007. Retrieved 17 April 2012.\",\"url\":\"https://web.archive.org/web/20070705002752/http://www.tcrt.org/index.cfm?CFID=14600455\u0026CFTOKEN=63356510\u0026d=3022\u0026c=4179\u0026p=12984\u0026do=detail\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ _**c**_ O'Connor, Aisling E, Gallagher, William M, Byrne, Annette T (2009). [\\\"Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochemistry and Photobiology, Sep/Oct 2009\\\"](http://findarticles.com/p/articles/mi_qa3931/is_200909/ai_n42040200/pg_7/). _Photochemistry and Photobiology_.`{{cite news}}`: CS1 maint: multiple names: authors list (link)\",\"description\":\"8. ^ _**a**_ _**b**_ _**c**_ O'Connor, Aisling E, Gallagher, William M, Byrne, Annette T (2009). [\\\"Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochemistry and Photobiology, Sep/Oct 2009\\\"](http://findarticles.com/p/articles/mi_qa3931/is_200909/ai_n42040200/pg_7/). _Photochemistry and Photobiology_.`{{cite news}}`: CS1 maint: multiple names: authors list (link)\",\"url\":\"http://findarticles.com/p/articles/mi_qa3931/is_200909/ai_n42040200/pg_7/\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Foster, TH; BD Pearson; S Mitra; CE Bigelow (2005). \\\"Fluorescence anisotropy imaging reveals localization of meso-tetrahydroxyphenyl chlorin in the nuclear envelope\\\". _Photochemistry and Photobiology_. **81** (6): 1544â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1562/2005-08-11-RN-646](https://doi.org/10.1562%2F2005-08-11-RN-646). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16178663](https://pubmed.ncbi.nlm.nih.gov/16178663). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19671054](https://api.semanticscholar.org/CorpusID:19671054).\",\"description\":\"9. **^** Foster, TH; BD Pearson; S Mitra; CE Bigelow (2005). \\\"Fluorescence anisotropy imaging reveals localization of meso-tetrahydroxyphenyl chlorin in the nuclear envelope\\\". _Photochemistry and Photobiology_. **81** (6): 1544â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1562/2005-08-11-RN-646](https://doi.org/10.1562%2F2005-08-11-RN-646). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16178663](https://pubmed.ncbi.nlm.nih.gov/16178663). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19671054](https://api.semanticscholar.org/CorpusID:19671054).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Wilson, JD; CE Bigelow; DJ Calkins; TH Foster (2005). [\\\"Light Scattering from Intact Cells Reports Oxidative-Stress-Induced Mitochondrial Swelling\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387). _[Biophysical Journal](Biophysical_Journal \\\"Biophysical Journal\\\")_. **88** (4): 2929â€“38\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005BpJ....88.2929W](https://ui.adsabs.harvard.edu/abs/2005BpJ....88.2929W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1529/biophysj.104.054528](https://doi.org/10.1529%2Fbiophysj.104.054528). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1305387](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15653724](https://pubmed.ncbi.nlm.nih.gov/15653724).\",\"description\":\"10. **^** Wilson, JD; CE Bigelow; DJ Calkins; TH Foster (2005). [\\\"Light Scattering from Intact Cells Reports Oxidative-Stress-Induced Mitochondrial Swelling\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387). _[Biophysical Journal](Biophysical_Journal \\\"Biophysical Journal\\\")_. **88** (4): 2929â€“38\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005BpJ....88.2929W](https://ui.adsabs.harvard.edu/abs/2005BpJ....88.2929W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1529/biophysj.104.054528](https://doi.org/10.1529%2Fbiophysj.104.054528). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1305387](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15653724](https://pubmed.ncbi.nlm.nih.gov/15653724).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1305387\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Mellish, Kirste; R Cox; D Vernon; J Griffiths; S Brown (2002). \\\"In Vitro Photodynamic Activity of a Series of Methylene Blue Analogues\\\". _Photochemistry and Photobiology_. **75** (4): 392â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1562/0031-8655(2002)075\u003c0392:ivpaoa\u003e2.0.co;2](https://doi.org/10.1562%2F0031-8655%282002%29075%3C0392%3Aivpaoa%3E2.0.co%3B2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12003129](https://pubmed.ncbi.nlm.nih.gov/12003129). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [198157591](https://api.semanticscholar.org/CorpusID:198157591).\",\"description\":\"11. **^** Mellish, Kirste; R Cox; D Vernon; J Griffiths; S Brown (2002). \\\"In Vitro Photodynamic Activity of a Series of Methylene Blue Analogues\\\". _Photochemistry and Photobiology_. **75** (4): 392â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1562/0031-8655(2002)075\u003c0392:ivpaoa\u003e2.0.co;2](https://doi.org/10.1562%2F0031-8655%282002%29075%3C0392%3Aivpaoa%3E2.0.co%3B2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12003129](https://pubmed.ncbi.nlm.nih.gov/12003129). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [198157591](https://api.semanticscholar.org/CorpusID:198157591).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Wilson, Brian C; Michael S Patterson (2008). \\\"The physics, biophysics, and technology of photodynamic therapy\\\". _[Physics in Medicine and Biology](Physics_in_Medicine_and_Biology \\\"Physics in Medicine and Biology\\\")_. **53** (9): R61 â€“ R109. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/0031-9155/53/9/R01](https://doi.org/10.1088%2F0031-9155%2F53%2F9%2FR01). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18401068](https://pubmed.ncbi.nlm.nih.gov/18401068). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4366743](https://api.semanticscholar.org/CorpusID:4366743).\",\"description\":\"12. **^** Wilson, Brian C; Michael S Patterson (2008). \\\"The physics, biophysics, and technology of photodynamic therapy\\\". _[Physics in Medicine and Biology](Physics_in_Medicine_and_Biology \\\"Physics in Medicine and Biology\\\")_. **53** (9): R61 â€“ R109. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/0031-9155/53/9/R01](https://doi.org/10.1088%2F0031-9155%2F53%2F9%2FR01). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18401068](https://pubmed.ncbi.nlm.nih.gov/18401068). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4366743](https://api.semanticscholar.org/CorpusID:4366743).\",\"url\":\"Physics_in_Medicine_and_Biology \\\"Physics in Medicine and Biology\\\"\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Lee, TK; ED Baron; THH Foster (2008). [\\\"Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126). _Journal of Biomedical Optics_. **13** (3): 030507. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2008JBO....13c0507L](https://ui.adsabs.harvard.edu/abs/2008JBO....13c0507L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1117/1.2939068](https://doi.org/10.1117%2F1.2939068). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2527126](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18601524](https://pubmed.ncbi.nlm.nih.gov/18601524).\",\"description\":\"13. **^** Lee, TK; ED Baron; THH Foster (2008). [\\\"Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126). _Journal of Biomedical Optics_. **13** (3): 030507. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2008JBO....13c0507L](https://ui.adsabs.harvard.edu/abs/2008JBO....13c0507L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1117/1.2939068](https://doi.org/10.1117%2F1.2939068). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2527126](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18601524](https://pubmed.ncbi.nlm.nih.gov/18601524).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527126\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** [\\\"Definition of porfimer sodium\\\"](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/porfimer-sodium). _www.cancer.gov_. 2 February 2011. Retrieved 6 March 2022.\",\"description\":\"14. **^** [\\\"Definition of porfimer sodium\\\"](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/porfimer-sodium). _www.cancer.gov_. 2 February 2011. Retrieved 6 March 2022.\",\"url\":\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/porfimer-sodium\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Kessel, David (2 October 2019). [\\\"Photodynamic Therapy: A Brief History\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404). _Journal of Clinical Medicine_. **8** (10): 1581. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/jcm8101581](https://doi.org/10.3390%2Fjcm8101581). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2077-0383](https://search.worldcat.org/issn/2077-0383). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6832404](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31581613](https://pubmed.ncbi.nlm.nih.gov/31581613).\",\"description\":\"15. **^** Kessel, David (2 October 2019). [\\\"Photodynamic Therapy: A Brief History\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404). _Journal of Clinical Medicine_. **8** (10): 1581. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.3390/jcm8101581](https://doi.org/10.3390%2Fjcm8101581). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2077-0383](https://search.worldcat.org/issn/2077-0383). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6832404](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31581613](https://pubmed.ncbi.nlm.nih.gov/31581613).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832404\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Neville, Anne (5 October 2018). [\\\"Thomas Dougherty, Ph. D., developed modern cancer therapy\\\"](https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html). _Buffalo News_. Retrieved 6 March 2022.\",\"description\":\"16. **^** Neville, Anne (5 October 2018). [\\\"Thomas Dougherty, Ph. D., developed modern cancer therapy\\\"](https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html). _Buffalo News_. Retrieved 6 March 2022.\",\"url\":\"https://buffalonews.com/obituaries/thomas-dougherty-ph-d-developed-modern-cancer-therapy/article_2b9aeeb1-532d-5d32-9a55-84109d645f7a.html\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** [\\\"Remembering Dr. Dougherty, Chief Emeritus, PDT Center â€“ American Society for Photobiology\\\"](https://photobiology.org/remembering-dr-dougherty-chief-emeritus-pdt-center/). Retrieved 6 March 2022.\",\"description\":\"17. **^** [\\\"Remembering Dr. Dougherty, Chief Emeritus, PDT Center â€“ American Society for Photobiology\\\"](https://photobiology.org/remembering-dr-dougherty-chief-emeritus-pdt-center/). Retrieved 6 March 2022.\",\"url\":\"https://photobiology.org/remembering-dr-dougherty-chief-emeritus-pdt-center/\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** [\\\"Package Insert Access Data FDA\\\"](https://web.archive.org/web/20140817050738/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf) (PDF). Archived from [the original](https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf) (PDF) on 17 August 2014.\",\"description\":\"18. **^** [\\\"Package Insert Access Data FDA\\\"](https://web.archive.org/web/20140817050738/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf) (PDF). Archived from [the original](https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf) (PDF) on 17 August 2014.\",\"url\":\"https://web.archive.org/web/20140817050738/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020451s020lbl.pdf\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** [\\\"Single-agent phototherapy system diagnoses and kills cancer cells | KurzweilAI\\\"](http://www.kurzweilai.net/single-agent-phototherapy-system-diagnoses-and-kills-cancer-cells). _www.kurzweilai.net_. 2 November 2015. Retrieved 27 April 2016.\",\"description\":\"19. **^** [\\\"Single-agent phototherapy system diagnoses and kills cancer cells | KurzweilAI\\\"](http://www.kurzweilai.net/single-agent-phototherapy-system-diagnoses-and-kills-cancer-cells). _www.kurzweilai.net_. 2 November 2015. Retrieved 27 April 2016.\",\"url\":\"http://www.kurzweilai.net/single-agent-phototherapy-system-diagnoses-and-kills-cancer-cells\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Michael R. Hamblin; [Tayyaba Hasan](Tayyaba_Hasan \\\"Tayyaba Hasan\\\") (2004). [\\\"Photodynamic therapy: a new antimicrobial approach to infectious disease?\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071049). _Photochem Photobiol Sci_. **3** (5): 436â€“450\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2004PhPhS...3..436H](https://ui.adsabs.harvard.edu/abs/2004PhPhS...3..436H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/b311900a](https://doi.org/10.1039%2Fb311900a). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3071049](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071049). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15122361](https://pubmed.ncbi.nlm.nih.gov/15122361).\",\"description\":\"20. **^** Michael R. Hamblin; [Tayyaba Hasan](Tayyaba_Hasan \\\"Tayyaba Hasan\\\") (2004). [\\\"Photodynamic therapy: a new antimicrobial approach to infectious disease?\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071049). _Photochem Photobiol Sci_. **3** (5): 436â€“450\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2004PhPhS...3..436H](https://ui.adsabs.harvard.edu/abs/2004PhPhS...3..436H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/b311900a](https://doi.org/10.1039%2Fb311900a). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3071049](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071049). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15122361](https://pubmed.ncbi.nlm.nih.gov/15122361).\",\"url\":\"Tayyaba_Hasan \\\"Tayyaba Hasan\\\"\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Boumedine, RS; DC Roy (2005). \\\"Elimination of alloreactive T cells using photodynamic therapy\\\". _Cytotherapy_. **7** (2): 134â€“143\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/14653240510027109](https://doi.org/10.1080%2F14653240510027109). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16040392](https://pubmed.ncbi.nlm.nih.gov/16040392).\",\"description\":\"21. **^** Boumedine, RS; DC Roy (2005). \\\"Elimination of alloreactive T cells using photodynamic therapy\\\". _Cytotherapy_. **7** (2): 134â€“143\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1080/14653240510027109](https://doi.org/10.1080%2F14653240510027109). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16040392](https://pubmed.ncbi.nlm.nih.gov/16040392).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Tang, HM; MR Hamblin; CM Yow (2007). [\\\"A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933783). _J Infect Chemother_. **13** (2): 87â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10156-006-0501-8](https://doi.org/10.1007%2Fs10156-006-0501-8). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2933783](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933783). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17458675](https://pubmed.ncbi.nlm.nih.gov/17458675).\",\"description\":\"22. **^** Tang, HM; MR Hamblin; CM Yow (2007). [\\\"A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933783). _J Infect Chemother_. **13** (2): 87â€“91\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10156-006-0501-8](https://doi.org/10.1007%2Fs10156-006-0501-8). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2933783](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933783). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17458675](https://pubmed.ncbi.nlm.nih.gov/17458675).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933783\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Clinical trial number _[NCT00706433](https://www.clinicaltrials.gov/show/NCT00706433)_ for \\\"Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne\\\" at [ClinicalTrials.gov](ClinicalTrials.gov \\\"ClinicalTrials.gov\\\")\",\"description\":\"23. **^** Clinical trial number _[NCT00706433](https://www.clinicaltrials.gov/show/NCT00706433)_ for \\\"Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne\\\" at [ClinicalTrials.gov](ClinicalTrials.gov \\\"ClinicalTrials.gov\\\")\",\"url\":\"https://www.clinicaltrials.gov/show/NCT00706433\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Keyal, U.; Bhatta, A.K.; Wang, X.L. (June 2016). \\\"Photodynamic therapy for the treatment of different severity of acne: A systematic review\\\". _Photodiagnosis and Photodynamic Therapy_. **14** : 191â€“199\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.pdpdt.2016.04.005](https://doi.org/10.1016%2Fj.pdpdt.2016.04.005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27090488](https://pubmed.ncbi.nlm.nih.gov/27090488).\",\"description\":\"24. **^** Keyal, U.; Bhatta, A.K.; Wang, X.L. (June 2016). \\\"Photodynamic therapy for the treatment of different severity of acne: A systematic review\\\". _Photodiagnosis and Photodynamic Therapy_. **14** : 191â€“199\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.pdpdt.2016.04.005](https://doi.org/10.1016%2Fj.pdpdt.2016.04.005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27090488](https://pubmed.ncbi.nlm.nih.gov/27090488).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** [\\\"DUSA Pharmaceuticals (DUSA) to Stop Developing Phase 2 Acne Treatment\\\"](https://web.archive.org/web/20090906045231/http://www.biospace.com/news_story.aspx?NewsEntityId=114055). Biospace. 23 October 2008. Archived from [the original](http://www.biospace.com/news_story.aspx?NewsEntityId=114055) on 6 September 2009. Retrieved 30 July 2009.\",\"description\":\"25. **^** [\\\"DUSA Pharmaceuticals (DUSA) to Stop Developing Phase 2 Acne Treatment\\\"](https://web.archive.org/web/20090906045231/http://www.biospace.com/news_story.aspx?NewsEntityId=114055). Biospace. 23 October 2008. Archived from [the original](http://www.biospace.com/news_story.aspx?NewsEntityId=114055) on 6 September 2009. Retrieved 30 July 2009.\",\"url\":\"https://web.archive.org/web/20090906045231/http://www.biospace.com/news_story.aspx?NewsEntityId=114055\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"_**a**_ _**b**_ [\\\"Photodynamic Therapy to Treat Cancer - National Cancer Institute\\\"](https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy). _www.cancer.gov_. 6 September 2011. Retrieved 6 March 2022.\",\"description\":\"26. ^ _**a**_ _**b**_ [\\\"Photodynamic Therapy to Treat Cancer - National Cancer Institute\\\"](https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy). _www.cancer.gov_. 6 September 2011. Retrieved 6 March 2022.\",\"url\":\"https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Gollnick, Sandra O.; Owczarczak, Barbara; Maier, Patricia (June 2006). [\\\"Photodynamic therapy and anti-tumor immunity\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987). _Lasers in Surgery and Medicine_. **38** (5): 509â€“515\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20362](https://doi.org/10.1002%2Flsm.20362). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3683987](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16788921](https://pubmed.ncbi.nlm.nih.gov/16788921).\",\"description\":\"27. **^** Gollnick, Sandra O.; Owczarczak, Barbara; Maier, Patricia (June 2006). [\\\"Photodynamic therapy and anti-tumor immunity\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987). _Lasers in Surgery and Medicine_. **38** (5): 509â€“515\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20362](https://doi.org/10.1002%2Flsm.20362). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3683987](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16788921](https://pubmed.ncbi.nlm.nih.gov/16788921).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683987\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** Loewen, Gregory M.; Pandey, Ravindra; Bellnier, David; Henderson, Barbara; Dougherty, Thomas (2006). [\\\"Endobronchial photodynamic therapy for lung cancer\\\"](https://onlinelibrary.wiley.com/doi/10.1002/lsm.20354). _Lasers in Surgery and Medicine_. **38** (5): 364â€“370\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20354](https://doi.org/10.1002%2Flsm.20354). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16788932](https://pubmed.ncbi.nlm.nih.gov/16788932). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [2773899](https://api.semanticscholar.org/CorpusID:2773899).\",\"description\":\"28. **^** Loewen, Gregory M.; Pandey, Ravindra; Bellnier, David; Henderson, Barbara; Dougherty, Thomas (2006). [\\\"Endobronchial photodynamic therapy for lung cancer\\\"](https://onlinelibrary.wiley.com/doi/10.1002/lsm.20354). _Lasers in Surgery and Medicine_. **38** (5): 364â€“370\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20354](https://doi.org/10.1002%2Flsm.20354). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16788932](https://pubmed.ncbi.nlm.nih.gov/16788932). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [2773899](https://api.semanticscholar.org/CorpusID:2773899).\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/lsm.20354\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** Ong, Yi Hong; Kim, Michele M.; Finlay, Jarod C.; Dimofte, Andreea; Singhal, Sunil; Glatstein, Eli; Cengel, Keith A.; Zhu, Timothy C. (29 December 2017). [\\\"PDT Dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT)\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607). _Physics in Medicine and Biology_. **63** (1): 015031. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/1361-6560/aa9874](https://doi.org/10.1088%2F1361-6560%2Faa9874). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-9155](https://search.worldcat.org/issn/0031-9155). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5952607](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29106380](https://pubmed.ncbi.nlm.nih.gov/29106380).\",\"description\":\"29. **^** Ong, Yi Hong; Kim, Michele M.; Finlay, Jarod C.; Dimofte, Andreea; Singhal, Sunil; Glatstein, Eli; Cengel, Keith A.; Zhu, Timothy C. (29 December 2017). [\\\"PDT Dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT)\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607). _Physics in Medicine and Biology_. **63** (1): 015031. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1088/1361-6560/aa9874](https://doi.org/10.1088%2F1361-6560%2Faa9874). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-9155](https://search.worldcat.org/issn/0031-9155). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5952607](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29106380](https://pubmed.ncbi.nlm.nih.gov/29106380).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952607\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** Du, Kevin L.; Both, Stefan; Friedberg, Josephy S.; Rengan, Ramesh; Hahn, Stephen M.; Cengel, Keith A. (1 September 2010). [\\\"Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma\\\"](https://doi.org/10.4161%2Fcbt.10.5.12616). _Cancer Biology \u0026 Therapy_. **10** (5): 425â€“429\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4161/cbt.10.5.12616](https://doi.org/10.4161%2Fcbt.10.5.12616). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1538-4047](https://search.worldcat.org/issn/1538-4047). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20699634](https://pubmed.ncbi.nlm.nih.gov/20699634). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1516239](https://api.semanticscholar.org/CorpusID:1516239).\",\"description\":\"30. **^** Du, Kevin L.; Both, Stefan; Friedberg, Josephy S.; Rengan, Ramesh; Hahn, Stephen M.; Cengel, Keith A. (1 September 2010). [\\\"Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma\\\"](https://doi.org/10.4161%2Fcbt.10.5.12616). _Cancer Biology \u0026 Therapy_. **10** (5): 425â€“429\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.4161/cbt.10.5.12616](https://doi.org/10.4161%2Fcbt.10.5.12616). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [1538-4047](https://search.worldcat.org/issn/1538-4047). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20699634](https://pubmed.ncbi.nlm.nih.gov/20699634). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [1516239](https://api.semanticscholar.org/CorpusID:1516239).\",\"url\":\"https://doi.org/10.4161%2Fcbt.10.5.12616\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Patel, Janaki; Rizk, Nada; Kedia, Prashant; Sharaiha, Reem Z.; Kahaleh, Michel (1 April 2015). [\\\"Cholangioscopy-assisted photodynamic therapy for cholangiocarcinoma\\\"](https://www.giejournal.org/article/S0016-5107\\\\(14\\\\)02280-9/abstract). _Gastrointestinal Endoscopy_. **81** (4): 1012â€“1013\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.gie.2014.09.060](https://doi.org/10.1016%2Fj.gie.2014.09.060). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0016-5107](https://search.worldcat.org/issn/0016-5107). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25484323](https://pubmed.ncbi.nlm.nih.gov/25484323).\",\"description\":\"31. **^** Patel, Janaki; Rizk, Nada; Kedia, Prashant; Sharaiha, Reem Z.; Kahaleh, Michel (1 April 2015). [\\\"Cholangioscopy-assisted photodynamic therapy for cholangiocarcinoma\\\"](https://www.giejournal.org/article/S0016-5107\\\\(14\\\\)02280-9/abstract). _Gastrointestinal Endoscopy_. **81** (4): 1012â€“1013\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.gie.2014.09.060](https://doi.org/10.1016%2Fj.gie.2014.09.060). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0016-5107](https://search.worldcat.org/issn/0016-5107). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25484323](https://pubmed.ncbi.nlm.nih.gov/25484323).\",\"url\":\"https://www.giejournal.org/article/S0016-5107\\\\(14\\\\\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"** [\\\"International Photodynamic Association (IPA)\\\"](https://www.internationalphotodynamic.com/). _International Photodynamic Association (IPA)_. Retrieved 6 March 2022.\",\"description\":\"32. **^** [\\\"International Photodynamic Association (IPA)\\\"](https://www.internationalphotodynamic.com/). _International Photodynamic Association (IPA)_. Retrieved 6 March 2022.\",\"url\":\"https://www.internationalphotodynamic.com/\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Biel, Merrill A. (September 2007). [\\\"Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers\\\"](https://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.2007.00153.x). _Photochemistry and Photobiology_. **83** (5): 1063â€“1068\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1751-1097.2007.00153.x](https://doi.org/10.1111%2Fj.1751-1097.2007.00153.x). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-8655](https://search.worldcat.org/issn/0031-8655). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17880501](https://pubmed.ncbi.nlm.nih.gov/17880501). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24183038](https://api.semanticscholar.org/CorpusID:24183038).\",\"description\":\"33. **^** Biel, Merrill A. (September 2007). [\\\"Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers\\\"](https://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.2007.00153.x). _Photochemistry and Photobiology_. **83** (5): 1063â€“1068\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1751-1097.2007.00153.x](https://doi.org/10.1111%2Fj.1751-1097.2007.00153.x). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0031-8655](https://search.worldcat.org/issn/0031-8655). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17880501](https://pubmed.ncbi.nlm.nih.gov/17880501). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [24183038](https://api.semanticscholar.org/CorpusID:24183038).\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.2007.00153.x\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Schweitzer, Vanessa Gayl; Somers, Melissa L. (January 2010). [\\\"PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx\\\"](https://onlinelibrary.wiley.com/doi/10.1002/lsm.20881). _Lasers in Surgery and Medicine_. **42** (1): 1â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20881](https://doi.org/10.1002%2Flsm.20881). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20077493](https://pubmed.ncbi.nlm.nih.gov/20077493). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41342278](https://api.semanticscholar.org/CorpusID:41342278).\",\"description\":\"34. **^** Schweitzer, Vanessa Gayl; Somers, Melissa L. (January 2010). [\\\"PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx\\\"](https://onlinelibrary.wiley.com/doi/10.1002/lsm.20881). _Lasers in Surgery and Medicine_. **42** (1): 1â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/lsm.20881](https://doi.org/10.1002%2Flsm.20881). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0196-8092](https://search.worldcat.org/issn/0196-8092). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20077493](https://pubmed.ncbi.nlm.nih.gov/20077493). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41342278](https://api.semanticscholar.org/CorpusID:41342278).\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/lsm.20881\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Rigual, Nestor R.; Thankappan, Krishnakumar; Cooper, Michele; Sullivan, Maureen A.; Dougherty, Thomas; Popat, Saurin R.; Loree, Thom R.; Biel, Merrill A.; Henderson, Barbara (August 2009). [\\\"Photodynamic Therapy for Head and Neck Dysplasia and Cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853). _Archives of Otolaryngologyâ€“Head \u0026 Neck Surgery_. **135** (8): 784â€“788\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archoto.2009.98](https://doi.org/10.1001%2Farchoto.2009.98). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0886-4470](https://search.worldcat.org/issn/0886-4470). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2810853](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19687399](https://pubmed.ncbi.nlm.nih.gov/19687399).\",\"description\":\"35. **^** Rigual, Nestor R.; Thankappan, Krishnakumar; Cooper, Michele; Sullivan, Maureen A.; Dougherty, Thomas; Popat, Saurin R.; Loree, Thom R.; Biel, Merrill A.; Henderson, Barbara (August 2009). [\\\"Photodynamic Therapy for Head and Neck Dysplasia and Cancer\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853). _Archives of Otolaryngologyâ€“Head \u0026 Neck Surgery_. **135** (8): 784â€“788\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archoto.2009.98](https://doi.org/10.1001%2Farchoto.2009.98). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [0886-4470](https://search.worldcat.org/issn/0886-4470). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2810853](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19687399](https://pubmed.ncbi.nlm.nih.gov/19687399).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810853\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"** [University of Warwick](University_of_Warwick \\\"University of Warwick\\\") (3 February 2019). [\\\"Simply shining light on dinosaur metal compound kills cancer cells\\\"](https://www.eurekalert.org/pub_releases/2019-02/uow-ssl013119.php). _[EurekAlert!](EurekAlert! \\\"EurekAlert!\\\")_. Retrieved 3 February 2019.\",\"description\":\"36. **^** [University of Warwick](University_of_Warwick \\\"University of Warwick\\\") (3 February 2019). [\\\"Simply shining light on dinosaur metal compound kills cancer cells\\\"](https://www.eurekalert.org/pub_releases/2019-02/uow-ssl013119.php). _[EurekAlert!](EurekAlert! \\\"EurekAlert!\\\")_. Retrieved 3 February 2019.\",\"url\":\"University_of_Warwick \\\"University of Warwick\\\"\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"** Zhang, Pingyu; et al. (15 December 2018). [\\\"Nucleus-Targeted Organoiridiumâ€“Albumin Conjugate for Photodynamic Cancer Therapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315). _[Angewandte Chemie](Angewandte_Chemie \\\"Angewandte Chemie\\\")_. **58** (8): 2350â€“2354\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/anie.201813002](https://doi.org/10.1002%2Fanie.201813002). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6468315](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30552796](https://pubmed.ncbi.nlm.nih.gov/30552796).\",\"description\":\"37. **^** Zhang, Pingyu; et al. (15 December 2018). [\\\"Nucleus-Targeted Organoiridiumâ€“Albumin Conjugate for Photodynamic Cancer Therapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315). _[Angewandte Chemie](Angewandte_Chemie \\\"Angewandte Chemie\\\")_. **58** (8): 2350â€“2354\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/anie.201813002](https://doi.org/10.1002%2Fanie.201813002). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6468315](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30552796](https://pubmed.ncbi.nlm.nih.gov/30552796).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468315\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z (2014). \\\"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis\\\". _Adv Mater_. **26** (48): 8154â€“62\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2014AdM....26.8154W](https://ui.adsabs.harvard.edu/abs/2014AdM....26.8154W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/adma.201402996](https://doi.org/10.1002%2Fadma.201402996). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25331930](https://pubmed.ncbi.nlm.nih.gov/25331930). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5421261](https://api.semanticscholar.org/CorpusID:5421261).\",\"description\":\"38. **^** Wang C, Xu L, Liang C, Xiang J, Peng R, Liu Z (2014). \\\"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis\\\". _Adv Mater_. **26** (48): 8154â€“62\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2014AdM....26.8154W](https://ui.adsabs.harvard.edu/abs/2014AdM....26.8154W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/adma.201402996](https://doi.org/10.1002%2Fadma.201402996). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25331930](https://pubmed.ncbi.nlm.nih.gov/25331930). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5421261](https://api.semanticscholar.org/CorpusID:5421261).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Lin, Z.; et al. (2015). [\\\"Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034). _Sci Rep_. **5** 11709\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015NatSR...511709L](https://ui.adsabs.harvard.edu/abs/2015NatSR...511709L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep11709](https://doi.org/10.1038%2Fsrep11709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4485034](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26122018](https://pubmed.ncbi.nlm.nih.gov/26122018).\",\"description\":\"39. **^** Lin, Z.; et al. (2015). [\\\"Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034). _Sci Rep_. **5** 11709\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015NatSR...511709L](https://ui.adsabs.harvard.edu/abs/2015NatSR...511709L). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep11709](https://doi.org/10.1038%2Fsrep11709). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4485034](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26122018](https://pubmed.ncbi.nlm.nih.gov/26122018).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485034\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Chen, Q.; et al. (2016). [\\\"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754). _Nat Commun_. **7** 13193\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2016NatCo...713193C](https://ui.adsabs.harvard.edu/abs/2016NatCo...713193C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ncomms13193](https://doi.org/10.1038%2Fncomms13193). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5078754](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27767031](https://pubmed.ncbi.nlm.nih.gov/27767031).\",\"description\":\"40. **^** Chen, Q.; et al. (2016). [\\\"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754). _Nat Commun_. **7** 13193\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2016NatCo...713193C](https://ui.adsabs.harvard.edu/abs/2016NatCo...713193C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ncomms13193](https://doi.org/10.1038%2Fncomms13193). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5078754](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27767031](https://pubmed.ncbi.nlm.nih.gov/27767031).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078754\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"** Park, S (May 2007). \\\"Delivery of photosensitizers for photodynamic therapy\\\". _Korean J Gastroenterol_. **49** (5): 300â€“313\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17525518](https://pubmed.ncbi.nlm.nih.gov/17525518).\",\"description\":\"41. **^** Park, S (May 2007). \\\"Delivery of photosensitizers for photodynamic therapy\\\". _Korean J Gastroenterol_. **49** (5): 300â€“313\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17525518](https://pubmed.ncbi.nlm.nih.gov/17525518).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Chen, B; BW Pogue; PJ Hoopes; T Hasan (2006). \\\"Vascular and cellular targeting for photodynamic therapy\\\". _Crit Rev Eukaryot Gene Expr_. **16** (4): 279â€“305\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1615/critreveukargeneexpr.v16.i4.10](https://doi.org/10.1615%2Fcritreveukargeneexpr.v16.i4.10). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17206921](https://pubmed.ncbi.nlm.nih.gov/17206921).\",\"description\":\"42. **^** Chen, B; BW Pogue; PJ Hoopes; T Hasan (2006). \\\"Vascular and cellular targeting for photodynamic therapy\\\". _Crit Rev Eukaryot Gene Expr_. **16** (4): 279â€“305\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1615/critreveukargeneexpr.v16.i4.10](https://doi.org/10.1615%2Fcritreveukargeneexpr.v16.i4.10). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17206921](https://pubmed.ncbi.nlm.nih.gov/17206921).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"** [\\\"PDT in Photodisinfection\\\"](https://www.internationalphotodynamic.com/pdt-in-photodisinfection). _International Photodynamic Association_. Retrieved 6 March 2022.\",\"description\":\"43. **^** [\\\"PDT in Photodisinfection\\\"](https://www.internationalphotodynamic.com/pdt-in-photodisinfection). _International Photodynamic Association_. Retrieved 6 March 2022.\",\"url\":\"https://www.internationalphotodynamic.com/pdt-in-photodisinfection\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"** Heger, Michael (2015). [\\\"Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618). _Journal of Clinical and Translational Research_. **1** (3): 140â€“167\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6410618](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30873451](https://pubmed.ncbi.nlm.nih.gov/30873451).\",\"description\":\"44. **^** Heger, Michael (2015). [\\\"Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618). _Journal of Clinical and Translational Research_. **1** (3): 140â€“167\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6410618](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30873451](https://pubmed.ncbi.nlm.nih.gov/30873451).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410618\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Biel, Merrill A.; Pedigo, Lisa; Gibbs, Aaron; Loebel, Nicolas (June 2013). [\\\"Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737). _International Forum of Allergy \u0026 Rhinology_. **3** (6): 468â€“473\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/alr.21134](https://doi.org/10.1002%2Falr.21134). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2042-6984](https://search.worldcat.org/issn/2042-6984). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3626737](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23307793](https://pubmed.ncbi.nlm.nih.gov/23307793).\",\"description\":\"45. **^** Biel, Merrill A.; Pedigo, Lisa; Gibbs, Aaron; Loebel, Nicolas (June 2013). [\\\"Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737). _International Forum of Allergy \u0026 Rhinology_. **3** (6): 468â€“473\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/alr.21134](https://doi.org/10.1002%2Falr.21134). [ISSN](ISSN_\\\\(identifier\\\\) \\\"ISSN \\\\(identifier\\\\)\\\") [2042-6984](https://search.worldcat.org/issn/2042-6984). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3626737](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23307793](https://pubmed.ncbi.nlm.nih.gov/23307793).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626737\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"** Raab, O. (1904). \\\"Ãœber die Wirkung Fluorescierenden Stoffe auf Infusorien\\\". _Zeitschrift fÃ¼r Biologie_. **39** : 524â€“546.\",\"description\":\"46. **^** Raab, O. (1904). \\\"Ãœber die Wirkung Fluorescierenden Stoffe auf Infusorien\\\". _Zeitschrift fÃ¼r Biologie_. **39** : 524â€“546.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Tappeiner, H. von; A. Jodlbauer (1904). \\\"Ãœber die Wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoen und Enzyme\\\". _Deutsches Archiv fÃ¼r Klinische Medizin_. **80** : 427â€“487.\",\"description\":\"47. **^** Tappeiner, H. von; A. Jodlbauer (1904). \\\"Ãœber die Wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoen und Enzyme\\\". _Deutsches Archiv fÃ¼r Klinische Medizin_. **80** : 427â€“487.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"** Tappeiner, H. von; H. Jesionek (1903). \\\"Therapeutische Versuche mit fluoreszierenden Stoffen\\\". _MÃ¼nchener Medizinische Wochenschrift_. **50** : 2042â€“4.\",\"description\":\"48. **^** Tappeiner, H. von; H. Jesionek (1903). \\\"Therapeutische Versuche mit fluoreszierenden Stoffen\\\". _MÃ¼nchener Medizinische Wochenschrift_. **50** : 2042â€“4.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"** Policard, A (1924). \\\"Etudes sur les aspects offerts par des tumeurs experimentales examines a la lumiere de Wood\\\". _Comptes Rendus des SÃ©ances de la SociÃ©tÃ© de Biologie et de Ses Filiales_. **91** : 1423â€“1424.\",\"description\":\"49. **^** Policard, A (1924). \\\"Etudes sur les aspects offerts par des tumeurs experimentales examines a la lumiere de Wood\\\". _Comptes Rendus des SÃ©ances de la SociÃ©tÃ© de Biologie et de Ses Filiales_. **91** : 1423â€“1424.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"** Figge, FH; GS Weiland; L. O Manganiello (August 1948). \\\"Studies on cancer detection and therapy; the affinity of neoplastic, embryonic, and traumatized tissue for porphyrins, metalloporphyrins, and radioactive zinc hematoporphyrin\\\". _Anatomical Record_. **101** (4): 657. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18882442](https://pubmed.ncbi.nlm.nih.gov/18882442).\",\"description\":\"50. **^** Figge, FH; GS Weiland; L. O Manganiello (August 1948). \\\"Studies on cancer detection and therapy; the affinity of neoplastic, embryonic, and traumatized tissue for porphyrins, metalloporphyrins, and radioactive zinc hematoporphyrin\\\". _Anatomical Record_. **101** (4): 657. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18882442](https://pubmed.ncbi.nlm.nih.gov/18882442).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"** Lipson, R. L.; E. J. Baldes (October 1960). \\\"The photodynamic properties of a particular hematoporphyrin derivative\\\". _Archives of Dermatology_. **82** (4): 508â€“516\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archderm.1960.01580040026005](https://doi.org/10.1001%2Farchderm.1960.01580040026005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [13762615](https://pubmed.ncbi.nlm.nih.gov/13762615).\",\"description\":\"51. **^** Lipson, R. L.; E. J. Baldes (October 1960). \\\"The photodynamic properties of a particular hematoporphyrin derivative\\\". _Archives of Dermatology_. **82** (4): 508â€“516\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archderm.1960.01580040026005](https://doi.org/10.1001%2Farchderm.1960.01580040026005). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [13762615](https://pubmed.ncbi.nlm.nih.gov/13762615).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"** Lipson, R. L; E. J Baldes; M. J Gray (December 1967). \\\"Hematoporphyrin derivative for detection and management of cancer\\\". _Cancer_. **20** (12): 2255â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(196712)20:12\u003c2255::AID-CNCR2820201229\u003e3.0.CO;2-U](https://doi.org/10.1002%2F1097-0142%28196712%2920%3A12%3C2255%3A%3AAID-CNCR2820201229%3E3.0.CO%3B2-U). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6073903](https://pubmed.ncbi.nlm.nih.gov/6073903). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8945080](https://api.semanticscholar.org/CorpusID:8945080).\",\"description\":\"52. **^** Lipson, R. L; E. J Baldes; M. J Gray (December 1967). \\\"Hematoporphyrin derivative for detection and management of cancer\\\". _Cancer_. **20** (12): 2255â€“7\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/1097-0142(196712)20:12\u003c2255::AID-CNCR2820201229\u003e3.0.CO;2-U](https://doi.org/10.1002%2F1097-0142%28196712%2920%3A12%3C2255%3A%3AAID-CNCR2820201229%3E3.0.CO%3B2-U). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [6073903](https://pubmed.ncbi.nlm.nih.gov/6073903). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8945080](https://api.semanticscholar.org/CorpusID:8945080).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"** Moan, J.; Q. Peng (2003). [\\\"An outline of the history of PDT\\\"](http://www.rsc.org/ebooks/archive/free/BK9780854043064/BK9780854043064-00001.pdf) (PDF). In Thierry Patrice (ed.). _Photodynamic Therapy_. Comprehensive Series in Photochemistry and Photobiology. Vol. 2\\\\. The Royal Society of Chemistry. pp. 1â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/9781847551658](https://doi.org/10.1039%2F9781847551658). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-85404-306-4.\",\"description\":\"53. **^** Moan, J.; Q. Peng (2003). [\\\"An outline of the history of PDT\\\"](http://www.rsc.org/ebooks/archive/free/BK9780854043064/BK9780854043064-00001.pdf) (PDF). In Thierry Patrice (ed.). _Photodynamic Therapy_. Comprehensive Series in Photochemistry and Photobiology. Vol. 2\\\\. The Royal Society of Chemistry. pp. 1â€“18\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/9781847551658](https://doi.org/10.1039%2F9781847551658). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-85404-306-4.\",\"url\":\"http://www.rsc.org/ebooks/archive/free/BK9780854043064/BK9780854043064-00001.pdf\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"** Dougherty, T. J; J. E Kaufman; A. Goldfarb; K. R Weishaupt; D. Boyle; A. Mittleman (August 1978). \\\"Photoradiation therapy for the treatment of malignant tumors\\\". _Cancer Research_. **38** (8): 2628â€“35\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [667856](https://pubmed.ncbi.nlm.nih.gov/667856).\",\"description\":\"54. **^** Dougherty, T. J; J. E Kaufman; A. Goldfarb; K. R Weishaupt; D. Boyle; A. Mittleman (August 1978). \\\"Photoradiation therapy for the treatment of malignant tumors\\\". _Cancer Research_. **38** (8): 2628â€“35\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [667856](https://pubmed.ncbi.nlm.nih.gov/667856).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"** [\\\"International Photodynamic Association (IPA) Newsletter: Winter Lights - Issue 3\\\"](https://www.internationalphotodynamic.com/new-blog/2018/12/31/international-photodynamic-association-ipa-newsletter-winter-lights-issue-3). _International Photodynamic Association (IPA)_. 1 January 2019. Retrieved 28 July 2025.\",\"description\":\"55. **^** [\\\"International Photodynamic Association (IPA) Newsletter: Winter Lights - Issue 3\\\"](https://www.internationalphotodynamic.com/new-blog/2018/12/31/international-photodynamic-association-ipa-newsletter-winter-lights-issue-3). _International Photodynamic Association (IPA)_. 1 January 2019. Retrieved 28 July 2025.\",\"url\":\"https://www.internationalphotodynamic.com/new-blog/2018/12/31/international-photodynamic-association-ipa-newsletter-winter-lights-issue-3\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"** [Goldman L](Leon_Goldman \\\"Leon Goldman\\\") (1990). \\\"Dye Lasers in Medicine\\\". In [Duarte FJ](F._J._Duarte \\\"F. J. Duarte\\\"); Hillman LM (eds.). _Dye Laser Principles_. Boston: [Academic Press](Academic_Press \\\"Academic Press\\\"). pp. 419â€“32\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-12-222700-4.\",\"description\":\"56. **^** [Goldman L](Leon_Goldman \\\"Leon Goldman\\\") (1990). \\\"Dye Lasers in Medicine\\\". In [Duarte FJ](F._J._Duarte \\\"F. J. Duarte\\\"); Hillman LM (eds.). _Dye Laser Principles_. Boston: [Academic Press](Academic_Press \\\"Academic Press\\\"). pp. 419â€“32\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-12-222700-4.\",\"url\":\"Leon_Goldman \\\"Leon Goldman\\\"\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"** Richter, A.; Sternberg, E.; Waterfield, E.; Dolphin, D.; Levy, J.G. (1990). \\\"Characterization of Benzoporphyrin Derivative, A New Photosensitizer\\\". In Hasan, Tayyaba (ed.). _Advances in Photochemotherapy_. Vol. 997\\\\. The International Society for Optical Engineering. pp. 145â€“150\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989SPIE..997..132R](https://ui.adsabs.harvard.edu/abs/1989SPIE..997..132R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1117/12.960196](https://doi.org/10.1117%2F12.960196). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [95511635](https://api.semanticscholar.org/CorpusID:95511635). `{{cite book}}`: `|journal=` ignored (help)\",\"description\":\"57. **^** Richter, A.; Sternberg, E.; Waterfield, E.; Dolphin, D.; Levy, J.G. (1990). \\\"Characterization of Benzoporphyrin Derivative, A New Photosensitizer\\\". In Hasan, Tayyaba (ed.). _Advances in Photochemotherapy_. Vol. 997\\\\. The International Society for Optical Engineering. pp. 145â€“150\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989SPIE..997..132R](https://ui.adsabs.harvard.edu/abs/1989SPIE..997..132R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1117/12.960196](https://doi.org/10.1117%2F12.960196). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [95511635](https://api.semanticscholar.org/CorpusID:95511635). `{{cite book}}`: `|journal=` ignored (help)\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"** Richter, A.; Waterfield, E.; Jain, A.K.; Sternberg, E.; Dolphin, D.; Levy, J.G. (1990). \\\"Photosensitizing potency of benzoporphyrin derivative (BPD) in a mouse tumor model\\\". _Photochemistry and Photobiology_. **52** (3): 495â€“500\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1751-1097.1990.tb01791.x](https://doi.org/10.1111%2Fj.1751-1097.1990.tb01791.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2284343](https://pubmed.ncbi.nlm.nih.gov/2284343). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [2913557](https://api.semanticscholar.org/CorpusID:2913557).\",\"description\":\"58. **^** Richter, A.; Waterfield, E.; Jain, A.K.; Sternberg, E.; Dolphin, D.; Levy, J.G. (1990). \\\"Photosensitizing potency of benzoporphyrin derivative (BPD) in a mouse tumor model\\\". _Photochemistry and Photobiology_. **52** (3): 495â€“500\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1751-1097.1990.tb01791.x](https://doi.org/10.1111%2Fj.1751-1097.1990.tb01791.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2284343](https://pubmed.ncbi.nlm.nih.gov/2284343). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [2913557](https://api.semanticscholar.org/CorpusID:2913557).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"** [\\\"Centre of laser medicine â€” Historical Aspects of Photodynamic Therapy Development\\\"](http://www.magicray.ru/ENG/lecture/L2/2.html). Retrieved 5 August 2011.\",\"description\":\"59. **^** [\\\"Centre of laser medicine â€” Historical Aspects of Photodynamic Therapy Development\\\"](http://www.magicray.ru/ENG/lecture/L2/2.html). Retrieved 5 August 2011.\",\"url\":\"http://www.magicray.ru/ENG/lecture/L2/2.html\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"** [\\\"Innovation (November/December 97) â€” Space Research Shines Life-Saving Light\\\"](https://web.archive.org/web/20041030065457/http://ipp.nasa.gov/innovation/Innovation56/light.htm). Archived from [the original](https://ipp.nasa.gov/innovation/Innovation56/light.htm) on 30 October 2004. Retrieved 5 August 2011.\",\"description\":\"60. **^** [\\\"Innovation (November/December 97) â€” Space Research Shines Life-Saving Light\\\"](https://web.archive.org/web/20041030065457/http://ipp.nasa.gov/innovation/Innovation56/light.htm). Archived from [the original](https://ipp.nasa.gov/innovation/Innovation56/light.htm) on 30 October 2004. Retrieved 5 August 2011.\",\"url\":\"https://web.archive.org/web/20041030065457/http://ipp.nasa.gov/innovation/Innovation56/light.htm\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"** [\\\"Photonic Clinical Trials\\\"](https://web.archive.org/web/20060503201343/http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm). Archived from [the original](http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm) on 3 May 2006. Retrieved 5 August 2011.\",\"description\":\"61. **^** [\\\"Photonic Clinical Trials\\\"](https://web.archive.org/web/20060503201343/http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm). Archived from [the original](http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm) on 3 May 2006. Retrieved 5 August 2011.\",\"url\":\"https://web.archive.org/web/20060503201343/http://www.warplighttherapy.com/WARP10_ClinicalTrialsAndStudies.htm\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"** Whelan, HT; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2001). \\\"Hematoporphyrin derivative for detection and management of cancer\\\". _Space Technology and Applications International Forum_. CP552: 35â€“45.\",\"description\":\"62. **^** Whelan, HT; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2001). \\\"Hematoporphyrin derivative for detection and management of cancer\\\". _Space Technology and Applications International Forum_. CP552: 35â€“45.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"** Huang, Z; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2006). \\\"Photodynamic therapy in China: Over 25 years of unique clinical experience: Part Oneâ€”History and domestic photosensitizers\\\". _Photodiagnosis and Photodynamic Therapy_. **3** (1): 3â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S1572-1000(06)00009-3](https://doi.org/10.1016%2FS1572-1000%2806%2900009-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25049020](https://pubmed.ncbi.nlm.nih.gov/25049020).\",\"description\":\"63. **^** Huang, Z; EV Buchmann; NT Whelan; SG Turner; V Cevenini; H Stinson; R Ignatius; T Martin; J Cwiklinski; GA Meyer; B Hodgson; L Gould; M Kane; G Chen; J Caviness (2006). \\\"Photodynamic therapy in China: Over 25 years of unique clinical experience: Part Oneâ€”History and domestic photosensitizers\\\". _Photodiagnosis and Photodynamic Therapy_. **3** (1): 3â€“10\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S1572-1000(06)00009-3](https://doi.org/10.1016%2FS1572-1000%2806%2900009-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25049020](https://pubmed.ncbi.nlm.nih.gov/25049020).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"** Qui, HX; Y Gu; FG Liu; NY Huang; HX Chen; J Zeng (2007). \\\"Clinical Experience of Photodynamic Therapy in China\\\". _Complex Medical Engineering_ : 1181â€“1184.\",\"description\":\"64. **^** Qui, HX; Y Gu; FG Liu; NY Huang; HX Chen; J Zeng (2007). \\\"Clinical Experience of Photodynamic Therapy in China\\\". _Complex Medical Engineering_ : 1181â€“1184.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"** Finlan, L. E.; Kernohan, N. M.; Thomson, G.; Beattie, P. E.; Hupp, T. R.; Ibbotson, S. H. (2005). \\\"Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet a therapy on p53 phosphorylation in normal human skin in vivo\\\". _British Journal of Dermatology_. **153** (5): 1001â€“1010\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1365-2133.2005.06922.x](https://doi.org/10.1111%2Fj.1365-2133.2005.06922.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16225614](https://pubmed.ncbi.nlm.nih.gov/16225614). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [35302348](https://api.semanticscholar.org/CorpusID:35302348).\",\"description\":\"65. **^** Finlan, L. E.; Kernohan, N. M.; Thomson, G.; Beattie, P. E.; Hupp, T. R.; Ibbotson, S. H. (2005). \\\"Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet a therapy on p53 phosphorylation in normal human skin in vivo\\\". _British Journal of Dermatology_. **153** (5): 1001â€“1010\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1365-2133.2005.06922.x](https://doi.org/10.1111%2Fj.1365-2133.2005.06922.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16225614](https://pubmed.ncbi.nlm.nih.gov/16225614). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [35302348](https://api.semanticscholar.org/CorpusID:35302348).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"** [Champva Policy Manual, Chapter: 2, Section: 30.11, Title: PDT (Photodynamic Therapy) and PUVA (Photochemotherapy)](http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm) [Archived](https://web.archive.org/web/20120114173954/http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm) 2012-01-14 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\") at U.S. Department of Veterans Affairs. Date: 12/23/2011\",\"description\":\"66. **^** [Champva Policy Manual, Chapter: 2, Section: 30.11, Title: PDT (Photodynamic Therapy) and PUVA (Photochemotherapy)](http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm) [Archived](https://web.archive.org/web/20120114173954/http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm) 2012-01-14 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\") at U.S. Department of Veterans Affairs. Date: 12/23/2011\",\"url\":\"http://www.va.gov/hac/forbeneficiaries/champva/policymanual/champva/chapter2/1c2s30-11.htm\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"** Laptev R, Nisnevitch M, Siboni G, Malik Z, Firer MA (July 2006). [\\\"Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622). _Br. J. Cancer_. **95** (2): 189â€“96\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjc.6603241](https://doi.org/10.1038%2Fsj.bjc.6603241). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2360622](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16819545](https://pubmed.ncbi.nlm.nih.gov/16819545).\",\"description\":\"67. **^** Laptev R, Nisnevitch M, Siboni G, Malik Z, Firer MA (July 2006). [\\\"Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622). _Br. J. Cancer_. **95** (2): 189â€“96\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjc.6603241](https://doi.org/10.1038%2Fsj.bjc.6603241). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2360622](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16819545](https://pubmed.ncbi.nlm.nih.gov/16819545).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360622\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"** Hou, Beibei; Zheng, Bin; Yang, Weitao; Dong, Chunhong; Wang, Hanjie; Chang, Jin (15 May 2017). \\\"Construction of near infrared light triggered nanodumbbell for cancer photodynamic therapy\\\". _Journal of Colloid and Interface Science_. **494** : 363â€“372\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017JCIS..494..363H](https://ui.adsabs.harvard.edu/abs/2017JCIS..494..363H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jcis.2017.01.053](https://doi.org/10.1016%2Fj.jcis.2017.01.053). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28167424](https://pubmed.ncbi.nlm.nih.gov/28167424).\",\"description\":\"68. **^** Hou, Beibei; Zheng, Bin; Yang, Weitao; Dong, Chunhong; Wang, Hanjie; Chang, Jin (15 May 2017). \\\"Construction of near infrared light triggered nanodumbbell for cancer photodynamic therapy\\\". _Journal of Colloid and Interface Science_. **494** : 363â€“372\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017JCIS..494..363H](https://ui.adsabs.harvard.edu/abs/2017JCIS..494..363H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.jcis.2017.01.053](https://doi.org/10.1016%2Fj.jcis.2017.01.053). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28167424](https://pubmed.ncbi.nlm.nih.gov/28167424).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"\\\"very short-lived (1Î£g â‰¤ 0.33 milliseconds (methanol), undetectable in H2O/D2O)\\\"\",\"explanation\":\"The reported lifetime of 0.33 ms for the O2(1Î£g+) state in methanol is incorrect; actual lifetimes in liquid solutions are on the order of nanoseconds (e.g., ~10-100 ns in polar solvents like methanol), not milliseconds. This error misrepresents the photophysical properties and could mislead understanding of the relaxation process.\",\"fixedText\":\"Correct the lifetime to \\\"on the order of 10-100 nanoseconds in methanol\\\" and note it is undetectable in aqueous environments due to rapid quenching.\",\"evidenceSource\":\"Standard photochemistry references, e.g., Gorman, A.A. (1992) in Advances in Photochemistry; confirmed via web search results indicating ns scale in solutions.\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"\\\"with a typical lifetime of approximately 40 nanoseconds in biological systems.\\\"\",\"explanation\":\"The lifetime of singlet oxygen (1Î”g) in biological systems is typically 10-100 nanoseconds only in lipid environments, but averages ~3 Î¼s in cellular aqueous compartments (e.g., cytoplasm). Stating 40 ns broadly misstates the scale, affecting calculated diffusion distances (~15 nm vs. ~100-300 nm) and the mechanism's spatial extent.\",\"fixedText\":\"Revise to \\\"with a typical lifetime of ~10-100 ns in lipid bilayers and up to ~3 Î¼s in aqueous cellular environments, allowing diffusion up to ~100-300 nm in vivo.\\\"\",\"evidenceSource\":\"[4] Skovsen et al. (2005), reporting ~3 Î¼s in HeLa cells; consistent with literature on 1O2 lifetime in cells.\"},{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"\\\"It is rapidly eliminated from cells, in an average of 3 Î¼s.[4]\\\" (from ROS subsection) vs. \\\"with a typical lifetime of approximately 40 nanoseconds in biological systems.[3]\\\" (from Type-II subsection)\",\"explanation\":\"The two statements contradict each other on the lifetime of singlet oxygen in cells (3 Î¼s vs. 40 ns), creating confusion about the fundamental photophysical parameter central to PDT efficacy.\",\"fixedText\":\"Harmonize by using the correct range as in the quantitative fix above, citing [4] for cellular context.\",\"evidenceSource\":\"[4] supports 3 Î¼s; [3] appears erroneous in this context.\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Entire Type-II subsection lifetimes and processes, cited to [3]\",\"explanation\":\"[3] (Josefsen \u0026 Boyle 2008) contains the incorrect 0.33 ms value for 1Î£g+ and may imply the 40 ns error, but these do not align with established photochemistry (e.g., 1Î£g+ lifetime is ns, not ms; 1Î”g in cells is Î¼s). Citation supports overall mechanisms but not these specific quantitative claims.\",\"fixedText\":\"Retain [3] for qualitative mechanisms but add or replace citation for quantitative lifetimes with [4] or new authoritative source.\",\"evidenceSource\":\"[3] text as browsed; cross-verified with [4] and standard refs like Wild et al. (1985) on O2 excited states.\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"N/A\",\"explanation\":\"The section could benefit from noting that the relative contributions of Type I vs. Type II pathways depend on photosensitizer, oxygen concentration, and environment (e.g., Type II dominates in oxygenated tissues), as this is a key knowledge gap for understanding PDT variability.\",\"fixedText\":\"Add a brief clarifying sentence in the Photochemical reactions subsection.\",\"evidenceSource\":\"[3] and [12] Wilson \u0026 Patterson (2008).\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"$21\",\"explanation\":\"This paragraph describes applications of PDT, including specific conditions and antimicrobial uses, which duplicates content covered in the separate \\\"Applications\\\" section of the article (including subsections like Acne, Cancer, Ophthalmology, Antimicrobial effects). Including it here in \\\"Photosensitizers\\\" misplaces application details outside the scope of discussing photosensitizer properties and types.\",\"fixedText\":\"Remove the entire paragraph as it belongs in the Applications section.\",\"evidenceSource\":\"article_structure provided\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Photosensitizers commercially available for clinical use include Allumera, [Photofrin](Photofrin \\\"Photofrin\\\"), [Visudyne](Visudyne \\\"Visudyne\\\"), [Levulan](Levulan \\\"Levulan\\\"), [Foscan](Foscan \\\"Foscan\\\"), [Metvix](Metvix \\\"Metvix\\\"), [Hexvix](Hexvix \\\"Hexvix\\\"), [Cysview](Cysview \\\"Cysview\\\") and [Laserphyrin](Laserphyrin \\\"Laserphyrin\\\"),\",\"explanation\":\"Allumera is a topical cream for cosmetic photodynamic therapy (PDC) to improve skin appearance (e.g., wrinkles, pores), not approved for clinical medical use in treating diseases like cancer or dermatological conditions. Including it misrepresents it as a clinical photosensitizer alongside FDA/EMA-approved medical agents.\",\"fixedText\":\"Remove Allumera from the list of commercially available for clinical use.\",\"evidenceSource\":\"[](https://www.lajollalaser.com/how-allumera-works/); [](https://www.biospace.com/photocure-announces-positive-allumera-tm-trial-results-for-delivering-significant-skin-appearance-improvements)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Tetra(_m_ -hydroxyphenyl)chlorin (_m_ THPC) is in clinical trials for head and neck cancers under the trade name [Foscan](Temoporfin \\\"Temoporfin\\\").\",\"explanation\":\"Foscan (temoporfin) was approved by the EMA in 2001 for palliative treatment of head and neck squamous cell carcinoma; stating it is \\\"in clinical trials\\\" is outdated and incorrect as of 2025.\",\"fixedText\":\"Update to: \\\"Tetra(m-hydroxyphenyl)chlorin (m-THPC), marketed as Foscan, is approved in the European Union for palliative treatment of head and neck squamous cell carcinoma.\\\"\",\"evidenceSource\":\"[](https://en.wikipedia.org/wiki/Temoporfin); [](https://www.ema.europa.eu/en/medicines/human/EPAR/foscan)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Silicon naphthalocyanine attached to copolymer PEG-PCL (poly(ethylene glycol)-_block_ -poly(Îµ-caprolactone)) accumulates selectively in cancer cells and reaches a maximum concentration after about one day. The compound provides real time near-infrared (NIR) fluorescence imaging with an extinction coefficient of 2.8 Ã— 105 Mâˆ’1 cmâˆ’1 and combinatorial phototherapy with dual photothermal and photodynamic therapeutic mechanisms that may be appropriate for [adriamycin](Adriamycin \\\"Adriamycin\\\")-resistant tumors. The particles had a hydrodynamic size of 37.66 Â± 0.26 nm (polydispersity index = 0.06) and surface charge of âˆ’2.76 Â± 1.83 mV.[19]\",\"explanation\":\"Citation [19] links to a now-defunct page (404 error) with no accessible content to verify the specific claims about silicon naphthalocyanine-PEG-PCL nanoparticles, including size, PDI, charge, and therapeutic mechanisms. Unsupported claims risk inaccuracy.\",\"fixedText\":\"Remove the specific nanoparticle details and citation [19], as they cannot be verified; retain general discussion of naphthalocyanines if supported by [3].\",\"evidenceSource\":\"[19] original ref (dead link verified)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; overall section]\",\"explanation\":\"The section relies heavily on sources from 2008 or earlier (e.g., [3], [6], [7], [8]), lacking updates on advancements in photosensitizers post-2020, such as improved formulations (e.g., Ameluz for actinic keratosis, approved 2016) or emerging nanotech integrations in third-generation carriers, relevant as of 2025.\",\"fixedText\":\"Add brief note in commercially available or third generation: \\\"More recent approvals include Ameluz (BF-200 ALA) for actinic keratosis (FDA 2016). Ongoing research focuses on nanoparticle-encapsulated photosensitizers for enhanced delivery.\\\"\",\"evidenceSource\":\"[](https://www.ncbi.nlm.nih.gov/books/NBK617062/); article date context\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"several cancers such as skin, lung,[28] brain, mesothelioma,[29][30] bladder, bile-duct,[31] esophageal, and head and neck cancers.[32][33][34][35]\\\"\",\"explanation\":\"The claims for brain, bladder, mesothelioma, and bile-duct cancers lack supporting citations for standard clinical use and are not FDA-approved; PDT for these is investigational or historical (bladder indication for Photofrin was approved in 1998 but removed from labeling by 2011 due to safety/efficacy concerns). Brain cancer PDT is only in clinical trials, not approved or routinely used.\",\"fixedText\":\"Remove \\\"brain, bladder\\\" from the list; qualify mesothelioma and bile-duct as investigational with citations; retain cited/approved cancers (skin, lung, esophageal, head/neck).\",\"evidenceSource\":\"[26] (NCI FDA approvals list); American Cancer Society (May 2025): approved only for actinic keratosis, Barrett's esophagus, basal/squamous skin cancers, esophageal, and early NSCLC; no brain, bladder, mesothelioma, or bile-duct.\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"\\\"PDT is a minimally invasive treatment that is used to treat many conditions including acne, psoriasis, age related macular degeneration\\\"\",\"explanation\":\"Psoriasis treatment with PDT is investigational/promising but not a standard or approved use; it is not routinely \\\"used\\\" like AMD (FDA-approved with verteporfin). Acne is off-label/in trials in the US. Misstates scope as established treatment.\",\"fixedText\":\"Qualify psoriasis and acne as investigational or under study; retain AMD as approved.\",\"evidenceSource\":\"[26] (NCI); National Psoriasis Foundation (2025): standard phototherapies are UVB/PUVA, not PDT; PDT for psoriasis in trials/reviews as alternative but not first-line.\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"\\\"Initial results have shown for it to be effective as a treatment only for severe acne.\\\"\",\"explanation\":\"Systematic reviews indicate PDT efficacy for moderate to severe acne, not limited to severe only; the cited trial [23] is for severe, but broader evidence shows applicability to different severities.\",\"fixedText\":\"Revise to \\\"effective for moderate to severe acne\\\" or remove \\\"only for severe\\\".\",\"evidenceSource\":\"[24] (2016 review: \\\"for the treatment of different severity of acne\\\"); 2024 systematic review (Nov 2024): effective for acne vulgaris generally.\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"\",\"explanation\":\"Section lacks recent updates on clinical status as of 2025, e.g., ongoing phase 2b trials for acne (Biofrontera's Ameluz, last patient Aug 2025, FDA submission planned 2026); no new FDA approvals for expanded cancer indications since last refs.\",\"fixedText\":\"Add note on ongoing acne trials and confirm no new cancer approvals post-2020.\",\"evidenceSource\":\"ClinicalTrials.gov (NCT07089368, Jul 2025); Biofrontera press release (Aug 2025).\"}],\"slug\":\"Photodynamic_therapy\",\"title\":\"Photodynamic therapy\",\"content\":\"$22\",\"description\":\"Photodynamic therapy\\n\\nPhotodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death...\",\"metadata\":{\"categories\":[\"PDT\"],\"lastModified\":\"1761553076\",\"contentLength\":\"51915\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"35205\",\"recentViews\":\"35205\",\"dailyAvgViews\":1173.5,\"qualityScore\":1,\"lastViewed\":\"1761884943\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761884943387,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Photodynamic_therapy\"],\"queryHash\":\"[\\\"page\\\",\\\"Photodynamic_therapy\\\"]\"}]},\"children\":\"$L23\"}]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Photodynamic therapy\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"PDT\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Photodynamic_therapy\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Photodynamic therapy\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Photodynamic_therapy\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Photodynamic therapy\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.076Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Photodynamic therapy\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance used in conjunction with molecular oxygen to elicit cell death (phototoxicity).[1] PDT is used in treating acne, wet age-related macular degeneration, psoriasis, and herpes. It is used to treat malignant cancers,[2] including head and neck, lung, bladder and skin. Advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L24\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"25:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"26:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="NzRhNzc2NDgtODZlMC00MzdkLTk4NTEtNDkzMjJkYTU3Zjg0">self.__next_f.push([1,"23:[\"$\",\"$L25\",null,{\"children\":[\"$\",\"$L26\",null,{\"slug\":\"Photodynamic_therapy\"}]}]\n"])</script></body></html>